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The aim of this study was to determine whether breast milk had a 
stimulating effect on the development of immune responses in infants. 
Breast- and bottle- fed infants were studied from birth to 9 months of age. 
Several significant differences in immune responses were found between the 
groups. These differences were related to age and fell into two main time 
periods. 
In the early neonatal period, lymphocytes from breast-fed infants 
showed significantly greater spontaneous proliferation and proliferative 
responses to the T cell mitogen PHA to vitro than cells from bottle-fed 
infants. This may be due to a stimulatory effect to vivo of the growth 
factors and lymphokines in human milk acting on T cells and/or their 
precursors. Serum immunoglobulin levels did not however, reflect this 
increased lymphocyte responsiveness and although salivary IgM and IgA 
levels were significantly increased in the breast-fed infants at 6 days of 
age, this may have been due to residual milk immunoglobulins. 
In contrast, by 3 to 9 months of age, the cells from the bottle-fed 
group showed significantly greater to vitro proliferation of all classes of 
lymphocytes than the cells from the breast- fed infants. Salivary IgM and 
IgA levels and serum IgM antibodies to commensal gut organisms were also 
significantly higher in bottle-fed infants at this time. This indicated a 
higher rate of to vivo stimulation of the immune system in bottle-fed 
infants. It is suggested that this is due to an increased exposure of 
bottle-fed 'infants to antigenic material at mucosal surfaces and a greater 
uptake of these local antigens into the systemic circulation. 
Breast-feeding may therefore have contrasting effects on the 
development of immune responses, a stimulating effect by growth factors, 
particularly in the early immature period, and a suppressive effect 
resulting indirectly from exclusion of antigens (including those of a 
potentially harmful nature). 
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Prances Cornford 
Collected Poems 
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CHAPTER 1 
HISTORICAL INTRODUCTION 
The aim of this study is to determine whether human milk has any 
active role in the development of the immune system in breast-fed 
infants. In order to investigate this possibi]ity, several aspects of 
immunity have been investigated in both breast-fed and bottle-fed 
infants. Although much work has been done in the past on human milk, 
the study of impunity in infants has been less thoroughly investigated 
due to the ethical difficulties in obtaining sufficient material from 
healthy infants. The development of microculture techniques for 
lymphocytes, and more sensitive assays for detection of 
immunoglobulins and antibodies, has enabled the present study to be 
conducted using very small volumes of infant blood and secretions. 
Because of the lack of material from infants, much of the work on 
the role of milk in protecting newborn offspring has been done in 
animals. Although animals have proved valuable models, the variations 
in milk proteins between species, and the differences in placentation 
and the post-partum intestinal uptake of macromolecules by the 
neonatal gut, have meant that these studies are frequently only of 
relevance to the particular species studied. This introduction will 
therefore be concerned primarily with work carried out on human milk 
and on the development of immunity in human infants. Work in other 
species will only be referred to where it is directly relevant to the 
human studies. 
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The review of previous work is divided into three sections. The 
first section will deal with the history of infant feeding in England 
and other industrialised countries, and the effect that changes in 
feeding patterns have had on infection rates and incidence of allergic 
disease. The second section will review the anti-infective properties 
of human milk, and the third section will be concerned with the immune 
status of the infant at birth and during the first year of life. 
SECTION A- INFANT FEEDING 
1) History of infant Feeding 
Infant feeding is a very emotive subject. Many thousands of 
articles have been written, expounding the virtues of either breast or 
bottle as far as nutrition, convenience, mother-infant bonding, 
frequency of infections and many other aspects of infant care are 
concerned. But whereas today's mothers in Europe and North America 
have a choice between breast-feeding, or bottle- feeding using a 
variety of commercially available and relatively cheap cow milk 
preparations, as recently as a century ago there was no safe 
alternative to breast milk. This meant that any mother who was unable 
to feed her infant had to find another lactating mother (wet nurse), 
or the infant was likely to die. In fact the use of wet nurses spread 
beyond the demands of necessity to become merely a convenience, and by 
the 17th and 18th centuries as many as 15% of infants were being 
nursed away from their mother's home by wet-nurses, often until 2 
years of age (Sussman, 1977). 
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During the second half of the 19th century, the Industrial 
Revolution had two important affects on the pattern of infant feeding. 
First, the improvement in transport and marketing of cow milk made it 
more readily available to people living in the towns. Second, social 
changes resulted in a greater need for women to work in the factories, 
rather than to stay at home and feed their infants. Although the 
feeding of raw cow milk to infants was known to be extremely 
hazardous, it became more and more common at this time (Jellife and 
Jellife, 1979), sometimes amidst appalling conditions of poverty and 
hygiene. During the last quarter of the 19th century, the realisation 
of the asssociation between micro-organisms and disease, led to the 
introduction of sterilisation of milk for infants. This was a major 
step in the increase in popularity of bottle-feeding. From about 
ia90, with the development of the milk formula industry and 
improvement of the quality of cow milk preparations, these formulae 
became cheaper and wet nurses became relatively more expensive. This 
resulted in a rapid decline in wet nursing during the first 20 years 
of this century. As the milk formula industry developed, it 
inevitably set about creating a need for its products. Advertisements 
extolled the virtues of rival brands and emphasised that cow milk 
preparations were not only nutritionally satisfactory and more 
convenient than breast milk, they were also somehow more modern and 
more hygienic. The propaganda was successful and following the 
decline in wet nursing came a similar decline in breast- feeding 
generally (Fig. 1- 1). 
Figures available on the rates of breast-feeding vary according 
to area and also social class, with the lower social classes tending 
to favour bottle- feeding. Studies between 1924-1929 indicated that 
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Figure 1-1 
Incidence of breast-feeding and infant mortality rates in 
Western Europe and U. S. A. 
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in parts of the U. S. A. over 90% of infants were initially breast-fed 
(Grulee, Sanford and Herron, 1934). Spence (1938) reported a fall in 
breast-feeding from 88% to 75% in a4 year period between 1933-1936. 
By the 1940's this figure had fallen to 65% and by 1972 to 28% 
(Nutrition Committee, 1978). A similar decline in the rate of 
breast-feeding occurred in England, with a fall from 70% in the late 
1930's (Robinson, 1951), to 28% in 1972 (DHSS report, 1974). The 
figures for Scotland are even lower, with as few as 1% attempting to 
breast-feed in one study between 1974-6 (Goel, House and Shanks, 
1978). Associated with this decline in the number of mothers 
attempting to breast-feed, was a reduction in the duration of 
successful breast-feeding (Jellife and Jelliffe, 197%). 
Apart from the effects of breast- or bottle-feeding on infection 
rates, which are discussed in detail below, there have been many 
investigations comparing the nutritional and biochemical composition 
of human milk and cow milk formulae, (DHSS, 1974; Nutrition 
Committee, 1978). The areas of study have concentrated on protein and 
lipid content, on nitrogen, iron and vitamins, as well as on renal 
solute loads. Improvements in formulae have resulted in bottle-fed 
infants having similar serum calcium, urine osmolality and plasma urea 
to those of breast-fed infants (Addy, 1976). 
Recent reports have indicated that the decline in breast-feeding 
has now been reversed (Nutrition Committee, 1978). However, a social 
trend of this nature is slow to change and re-education takes many 
decades to reach all levels of society. The fact that the determined 
promotion of breast-feeding at Northwick Park Hospital has resulted in 
up to 85% of infants receiving exclusive breast-feeding for at least 
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the first week of life is encouraging. Other centres are also 
beginning to report similar success rates (Wharton, 1982). 
2) Infection rates in infants: effects of feeding method. 
The remarkable decline in breast-feeding in Europe and the U. S. A. 
during the first 70 years of this century, occurred in spite of 
overwhelming evidence that bottle-feeding resulted in higher infant 
morbidity and mortality rates. One of the reasons for this was that 
during this period in the industrialised countries, there was a very 
remarkable decline in infant mortality generally (Fig. 1- 1). This 
was due to greatly improved sanitation and living standards, better 
medical facilities and the introduction of antiseptics and 
antibiotics. This general decline in infant mortality and morbidity, 
detracted from the relative infection rates in the two feeding groups. 
Perhaps the true hazards of bottle-feeding only became appreciated 
when cow milk formulae started to be promoted in underdeveloped 
countries, with disastrous results for the mortality rates. 
In the 17th and 18th centuries, documentation of infection rates 
in infants fed by wet nurses in comparison to those fed by their own 
mothers was poor, but by the latter half of the 19th century, records 
indicate that the mortality of infants fed by wet nurses was higher 
(Sussman, 1977). This may be due to associated adverse factors such 
as the higher illegitimacy rate among wet nursed children, and the 
fact that the wet nurses themselves were often extremely poor, 
frequently prostitution was their only alternative means of earning a 
living. Their own infants either starved or were passed down to 
cheaper (and therefore poorer) wet nurses. The earliest records of 
any careful studies on infection rates in infants fed boiled cow milk 
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preparations, and those fed by their own mothers at the breast, are by 
Bockh (as quoted by l4ellander, Vahlquist and Mellbin, 1959). Bockh 
studied infants in Berlin for three 1 year periods at 10 year 
intervals from 1885, and showed that the mortality rate was much 
higher in the artificially fed infants but that this rate fell more 
rapidly than for the breast-fed infants during the 20 year period of 
the study. In England, Newman in 1906 (as quoted by Goldman and 
Smith, 1973) noted six times more cases of gastroenteritis in 
bottle-fed infants than in breast-fed infants. 
In an extensive study of 20,000 infants conducted in Chicago 
between 1924-1929, Grulee, Sanford and Herron (1934) showed that 
although only 8.5% of the infants studied were totally bottle-fed, 
this group accounted for 66% of the mortality. They also showed that 
morbidity caused by gastroenteritis, respiratory tract infections and 
other diseases was considerably higher in the bottle-fed group. It is 
interesting to note that in spite of the overwhelming evidence 
presented for the protective benefits of breast milk, in the 
discussion that followed their paper, the validity of the results was 
questioned in view of the continued improvement of cow milk 
preparations! In 1936-42, another extensive study by Robinson (1951) 
in a poor area of Liverpool, again showed significantly lower 
morbidity and mortality from infections (gastroenteritis, respiratory 
tract, otitis and infectious fevers) in breast-fed infants. In this 
study, in addition to the marked benefits of breast-feeding, both 
smaller family size and more rapid medical attention were also 
associated with lower morbidity and mortality, although social class 
was not found to have any direct effect on infection rates. 
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Smaller studies comparing the feeding groups continued to show a 
protective effect of breast milk, (Smellie, 1939; Ebbs and Mulligan, 
1942; Mellander, Vahlquist and Mellbin, 1959; Ironside, Tuxford and 
Heyworth, 1970; Winberg and Wessner, 1971). A powerful argument on 
the protective role of colostrum and milk came from the control of two 
epidemics of diarrhoea caused by Eschertchta colt in nurseries, by 
feeding colostrum to the infected infants, after antibiotic therapy 
had failed to control the outbreak (Svirsky-Gross, 1958; Tassovatz 
and Kotsitch, 1961). Although evidence was accumulating on the 
anti-infective role of breast-feeding, some studies in more affluent 
areas suggested that high levels of hygiene and medical care could 
reduce the infection rates in bottle-fed infants to those found in 
breast-fed infants (Stevenson, 1947; Norval and Kennedy, 1949; 
Stewart and Westropp, 1953). Since there was a trend for the higher 
social classes to breast-feed, it was suggested that the differences 
between the groups could be attributed to better living conditions 
rather than to the type of milk. However, in a study in rural Chile, 
where only the wealthier families could afford the cow milk formulae, 
Plank and Milanesi (1973) showed that as living standards rose, more 
infants were totally bottle-fed and infant mortality increased. It 
was not until the late 1970's, (Cunningham, 1977; 1979) that studies 
in the U. S. A. showed that even after socio-educational status, family 
size, day care exposure and birthweight were taken into account, there 
was still a significant protective effect of breast milk, particularly 
in the early months and against the more serious illnesses. This has 
since been confirmed in other countries for gastrointestinal 
infections (Chandra, 1979; Gunn et aL, 1979; Whorwell et at, 1979; 
France, Harmer and Steele, 1980) and respiratory tract infections 
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(Pullan et al., 1980), including one study on respiratory tract 
infections in the Harrow area (Watkins, Leeder and Corkhill, 1979). 
3) Breast-feeding and allergy 
Although few now question the role of breast milk in protecting 
newborn infants against infectious diseases, particularly in areas of 
poor hygiene and high disease incidence, the role of human milk in 
protecting against allergy is more controversial. Chandra (1978) 
showed that siblings of children with atopic disease had significantly 
less eczema, recurrent wheezing and lower serum IgE levels for up to 3 
years if they were exclusively breast-fed for at least 8 weeks from 
birth. Saarinen at W. (1979) showed a similar reduction in atopic 
disease in breast-fed infants who had a high risk of atopy, and 
suggested that both breast milk and allergen exclusion were needed. 
More recently, Fergusson, Horwood and Shannon (1983) were unable to 
demonstrate any reduction in the incidence of asthma in breast-fed 
infants, although the infants studied were not from families with a 
history of allergy. It appears that in selected groups of infants who 
have a high risk of developing allergies, breast-feeding may play a 
role in at least delaying the onset of allergic diseases however, 
allergen exclusion for the first few months and graduated weaning are 
also important factors (Bjorksten, 1983). 
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SECTION B- ANTI-INFECTIVE PROPERTIES OF HUMAN MILK 
The lower incidence of infections in breast-fed infants has led 
to the investigation of colostrum and milk for antimicrobial factors. 
Detection of specific antibodies by agglutination and bactericidal 
techniques was first described in the early 1900's (reviewed in 
Nordbring, 1957). Non-specific antimicrobial activity was also 
demonstrated at this time (see Mellander, Vahiquist and Mellbin, 
1959). Since the discovery of secretory IgA (sIgA), and with the 
development of more sensitive techniques for detecting class- specific 
antibodies and other antimicrobial proteins, many different 
antimicrobial systems have been demonstrated in human milk. These 
have been the subject of several reviews (Hanson and Winberg, 1972= 
Goldman and Smith, 1973; Head, 1977; Butler, 1979; Welsh and May, 
1979). The individual systems and their known interactions to vttro 
will be outlined below; it must be emphasised that the relative 
importance of each component to vtvo for the human neonate remains to 
be elucidated. 
1) Non-specific factors 
These are factors, demonstrated in human milk, that either 
directly or indirectly inhibit the growth of several species of 
micro-organisms. 
i) Control of Normal Gut Flora 
The establishment of a commensal gut flora is an important part of the 
infants, gut defences and there are several properties of human milk 
which are known to influence the development of normal gut flora 
(Borriello and Stephens, 1984). Gyorgy, (1971) has demonstrated 
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nitrogen containing oligo- and polysaccharides which enhance the 
growth of anaerobic Lactobacilli (bifidus factor). The pH of the 
stools of the breast-fed infant is lower than that of artificially fed 
infants (Ross and Dawes, 1954); this may be due to the predominance 
of the Lactobacilli and the low buffering capacity of human milk 
(Bullen and Willis, 1971). Low pH enhances the antimicrobial 
properties of formic acid and other intestinal fatty acids and 
produces an environment generally unfavourable for the growth of 
intestinal pathogens such as enteropathogenic E. coLt. 
Receptor analogues may also have a role in modulating gut flora. 
Williams and Gibbons (1975) have demonstrated inhibition of 
streptococcal attachment to epithelial cells by antigenically similar 
salivary glycoproteins. In human milk, Holmgren, Svennerholm and 
Lindblad (1983) have isolated receptor-like glycocompounds which 
inhibit Vtbrto choLerae adherence. The specificity and to-vivo 
function of these receptor analogues has yet to be determined. 
ii) Enzymes 
Lysozyme is present in large quantities in mature human milk 
(200-300µg/ml), and is one of the few proteins which increases in 
concentration during lactation (Goldman at aL, 1982). It has been 
shown to kill a variety of gram-positive and gram-negative organisms 
to vttro (Reiter, 1978). Some workers have demonstrated a role of 
lysozyme in an IgA and complement mediated killing system (Ward law, 
1962: Adinolfi at aL, 1966), although other workers have not 
confirmed these results (Heddle at aL, 1975). Lactoperoxidase is an 
enzyme present at low levels in human milk and at higher levels in 
infant saliva (Gothefors and Marklund, 1975). In a system involving 
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thiocyanate and hydrogen peroxide, the enzyme produces an intermediate 
oxidation product of the thiocyanate which is bactericidal against a 
variety of organisms to vitro (Reiter et at, 19631 Stephens, Harkness 
and Cockle, 1979). 
iii) Iron binding proteins 
Human milk contains between 1-6mg/ml lactoferrin and a smaller 
quantity of transferrin (15-20µg/ml). These iron binding proteins 
have been shown to have a strong bacteriostatic effect to vttro 
(Masson at aL, 1966) probably because chelated iron is unavailable to 
the bacteria. Some bacteria (such as E. coLt) are able to by-pass this 
inhibitory effect by secreting iron sequestering compounds 
(enterochelins) which are then actively taken up by the organisms. A 
bacteriostatic system against these organisms, involving IgG and 
]actoferrin, has been demonstrated to vitro, and experiments in guinea 
pigs have suggested this system may be important to vivo (Bullen, 
Rogers and Leigh, 1972). A similar to-vitro bacteriostatic system has 
been demonstrated for sIgA and lactoferrin (Rogers and Synge, 1978) 
Spik at at., 1978). This potentiation of lactoferrin by antibody may 
be mediated by immunoglobulin blockade of bacterial enterochelin 
secretion (Rogers and Synge, 1978). 
iv) Cell growth factors 
The discovery of growth factors in milk has been relatively recent, 
and their role in immune defence is at present purely speculative. 
They will be discussed in more detail in future chapters but initial 
work is summarised here. 
29 
Hoerlein (1957) described an increase in specific antibody 
production in the sera of piglets fed colostrum, compared with those 
deprived of colostrum. Although the possibility was mentioned that a 
factor in colostrum might be stimulating or enhancing antibody 
production, this possibility was not pursued. Again in pigs, Heird 
and Hansen (1977) recorded an 82% increase in the small intestinal 
mans during the first 24 hours of life in suckled compared with 
artificially fed piglets. These workers suggested a growth factor in 
colostrum for intestinal mucosa, and subsequently, epithelial growth 
factors have been identified, not only in animal milk (Klagsburn, 
1980; Schwartz and Heird, 1981) but also in human milk (Klagsburn, 
1978; Tapper, Klagsburn and Neumann, 1979; Carpenter, 1980). These 
may play a role in defence against infections and allergy by 
increasing maturation of the gut epithelium, thereby reducing the 
uptake of potentially antigenic macromolecules. 
Factors capable of modu]ating the immune response have also been 
detected in human milk and are secreted by milk cells to vttro. These 
include secretory component (Crago et aL, 1981), lymphokines such as 
lymphocyte derived chemotactic factor (LDCF), alpha- and 
gamma-interferon (Emodi and Just, 1974; Keller et at, 1981) and 
prostaglandin E and F (Lucas and Mitchell, 1980). Pittard and Bill 
(1979a and b) have demonstrated a high molecular weight factor, 
released by breast milk cells, which stimulated cord blood lymphocytes 
to produce IgA but not IgG or IgM. The possibility that these factors 
might be important to vivo was an important consideration in the 
initiation of the present study. 
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2) Specific factors 
Some of the earliest studies on milk, described antibody activity 
to a number of organisms (Ratner, 1927, as quoted by Nordbring, 1957). 
We now know that many of these antibodies are produced by lymphocytes 
in the mammary gland of the mother. Many viable lymphocytes and other 
leucocytes are also transfered to the infant gut via colostrum and 
milk. Although not all of these cells are specific in their action, 
they are included in this section for convenience. 
i) Cells 
The presence of cells in milk was first described by Donne in 1839, 
and in 1845 he published a collection of photomicrographs of what he 
called colostral corpuscles. These were later shown to be fat-laden 
macrophages (Smith and Goldman, 1968). Extensive studies on the 
leucocytes in colostrum have shown between 0.5-10 x 106 viable 
cells/ml. These consist of macrophages (80-90%), lymphocytes (5-15%) 
and a few neutrophils. As lactation becomes established, the cell 
concentration falls to about one fiftieth of that in colostrum, but 
because the daily milk volume increases, the total number received by 
the infant remains large (Lawton and Shortridge, 1977). 
a) Macrophages 
Milk macrophages are large, amoeboid and highly phagocytic cells, and 
have many of the features of activated macrophages (Goldman, 1977). 
They have been shown to phagocytose Staphylococci, E. coLf and Candtda 
aLbtcans to vitro and also secrete the complement components C3 and 
C4, and lysozyme and lactoferrin (Goldman and Smith, 1973). in-vitro 
cultures of macrophages have also been shown to release large 
quantities of sIgA, suggesting they may have a role in storing this 
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immunoglobulin (Pittard, Polmar and Fanaroff, 1977; Weaver et at, 
1982). They are also capable of interacting with milk lymphocytes 
(Smith and Goldman, 1970) and responding to lymphokines. Work in rats 
by Pitt, Barlow and Heird (1977) has demonstrated that macrophages are 
important in protecting against Xlebsiella-induced necrotising 
enterocolitis. 
b) Lymphocytes 
Colostrum contains approximately 2x 105 lymphocytes/ml, comprising 
about 50% T cells and 34% B cells (Diaz-Jouanen and Williams, 1974). 
These T cells respond to allogeneic lymphocytes in a manner similar to 
peripheral blood lymphocytes (PBL), but the response to mitogens such 
as PHA is lower (Parmely, Beer and Billingham, 1976). They also 
respond to antigenss, but compared to PBL there is a greater 
responsiveness to those antigens found at secretory surfaces such as 
E. colt and tuberculin (PPD) and a lower response to antigens more 
likely to have been encountered systemically such as tetanus toxoid. 
This has led Parmely et at (1977) to suggest a separate population of 
T cells involved in the secretory immune system. 
The role of these colostral and milk T cells in the suckled 
infant is not known. The lower pH of the newborn infants stomach may 
allow survival of viable lymphocytes into the small intestine. 
Whether these cells can enter the gut tissues or circulation of the 
infant is not known. In rats, Beer, Billingham and Head (1974) have 
demonstrated that milk lymphocytes were capable of initiating graft 
versus host disease in fostered allogeneic recipients. In humans, 
Mohr (1973) and Schlesinger and Covelli (1977) have shown transfer of 
tuberculin sensitivity from mother to infant in breast-fed (but not 
bottle-fed) infants. This could be due to cell transfer but it might 
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also be due to the transfer of soluble factors. However, other 
workers have not confirmed these observations (Chandra, 1978). 
Further evidence that milk cells do not pass into the infants tissues 
comes from studies in infants with severe combined immunodeficiency 
disease who are receiving breast milk. These infants have not shown 
any evidence of graft versus host disease or chimaerism (Ogra, 1979). 
The B lymphocytes of human colostrum and milk have been shown to 
differentiate into plasma cells to vttro and secrete IgA (Murillo and 
Goldman, 1970). Experiments in rabbits (Montgomery, Cohn and Lally, 
1973) and later in humans (Goldblum at at, 1975) have shown the 
appearance of antigen- specific B cells in milk following oral 
challenge with antigen. This suggested a route of migration of 
lymphocytes from gut to mammary gland, and Roux at aL (1977) have 
demonstrated that the B cells of milk do come from a precursor 
population primed in the gut. The localisation in the mammary gland 
appears to be under hormonal control (Weisz-Carrington at aL, 1978). 
ii) Inmunoglobulins 
The predominant immunoglobulin of human milk is slgA and this occurs 
in concentrations of up to 100mg/ml in early colostrum. Levels 
decline rapidly during the first week of lactation to a basal level of 
1-2mg/ml (McClelland, McGrath and Samson, 1978). IgM and IgG 
antibodies also occur in colostrum and milk but the concentrations are 
only 10% and 3% respectively of those in serum. 
The sIgA molecule, first isolated and characterised by Heremans 
(Heremans, Heremans and Schultze, 1959), consists of two monomeric IgA 
molecules joined by aJ chain (Koshland, 1975). A polypeptide 
molecule called secretory component (SC) is attached to this dimer as 
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it passes through the epithelial cells overlying the mucous surfaces 
(Brandzaeg, 1978). The transfer mechanism of IgA molecules via 
secretory component receptors on the epithelial cells, seems to depend 
on the presence of the J chain. The mechanism does not operate for 
serum monomeric IgA but does operate for IgM, which also contains aJ 
chain. The amino-acid sequences of the heavy chain (a-chain) confer 
on the IgA molecule several important properties. First, several 
intra-chain disulphide bridges give more areas of compact folding than 
other immunoglobulin heavy chains. This appears to be important in 
rendering the molecule resistant to proteolysis by the enzymes found 
at many secretory surfaces - particularly the gut. This property is 
further enhanced by the glycine-rich secretory component. Second, the 
IgA molecule readily forms disulphide bonds with the mucin 
glycoproteins, thus forming a tight association with the mucous coat. 
Third, dimeric IgA from milk (without SC) has been shown to bind to 
specific receptors on buccal epithelial cells in breast-fed neonates 
(Roberts, Wincup and Harries, 1980). These receptors are thought to 
be SC as they are blocked by anti-SC antibodies. 
Studies on the stools of breast-fed infants have indicated that 
over 70% of milk IgA survives transit through the infants' gut (Kenny, 
Boesman and Michaels, 1967; Ogra et at, 1977). The question of 
absorption of sIgA by the newborn infant remains contraversial and is 
discussed in more detail in Chapter 6. Whether or not small amounts 
of IgA are absorbed, it is apparent that the main activity of the milk 
sIgA is within the gut of the infant, and several antimicrobial 
mechanisms of sIgA have been investigated. 
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Anti-adhesive properties have been demonstrated for aIgA from the 
parotid gland (Williams and Gibbons, ]972) and for colostral and milk 
antibodies in pigs (Rutter at at, 1976). Antibodies to the pill of 
E. cott have also been demonstrated in human milk (Svanborg-Eden at at, 
1979). Agglutinating aIgA antibodies are present in colostrum and 
milk against many intestinal organisms (McClelland at at., 1972) and 
it has been suggested that aggglutinated organisms may be less able to 
colonise the gut epithelium (Cantey, 1978). Neutralising antibodies 
to bacterial toxins (Ho]. mgren at at, 1976; Wada at at, 1980) are 
present in milk and virus-neutralising antibody activity has been 
demonstrated against several viruses (Welsh and May, 1979). The 
activities of aIgA as an opsonin or complement activating antibody are 
less certain. Lamm (1976) has reviewed several conflicting reports on 
opsonisation but the decisive factor may be the necessity for IgA 
receptors to be present on the opsonising cells (Bienenstock and 
Befus, 1980). Although sIgA aggregates have been shown to activate 
the alternative pathway of complement to vitro (Colten and 
Bienenstock, 1974), it is not known whether the conditions in the 
infant gut favour complement activation. However, the presence of all 
nine components of complement in human milk (Nakajima, Baba and 
Tamura, 1977) may be of significance in this respect. A 
bacteriostatic activity of sIgA in combination with lactoferrin has 
already been discussed. This inhibition appears to be more effective 
against pathogenic serotypes than commensal strains (Stephens at at., 
1981) and this selective inhibition could be important in controlling 
the growth of pathogens, while allowing establishment of harmless 
commensal strains. 
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The activities of sIgA described are primarily effective in 
limiting attachment or growth of organisms, rather than in killing 
them. Attachment and growth are both prerequisites for the 
establishment of an infection and may explain why pathogens such as 
Shigella and enteropathogenic E. cott have been isolated from the 
stools of breast-fed babies in the apparent absence of disease (Mata 
and Urrutia, 1971). 
iii) Specificities of antibodies in milk. 
An extensive review of the early literature on the specificities of 
antibodies in milk is given by Nordbring (1957). These studies used 
techniques which relied upon secondary properties of antibody 
molecules such as agglutination and bactericidal activity and 
therefore favoured the detection of IgG and IgM molecules. Antitoxins 
to diphtheria and tetanus toxins, antistaphylolysin and 
antistreptolysin, and agglutinins to BordetelLa pertussts, typhoid and 
dysentery bacilli were all found, but with the exception of the 
enteric organisms (i. e. typhoid and dysentery) the titres in 
colostrum and milk were always much lower than the titres found in 
serum. More recent work has shown that specific antibodies to a 
variety of organisms are present in milk. These organisms include 
CLostrtdtum tetant, Corynebactertum dtphthertae, DtpLococcus 
pnoumontae, E. coLt, Salmonella, Shigella, HaemophtLus tnfLuenzae, 
Streptococci, Staphylococci, (Hanson and Winberg, 1972; Hanson at aL, 
1975; 1978; Welsh and May, 1979) and BactLLus fragtLts (Ste-Marie, 
Lee and Brown, 1974). Antibodies to microbial toxins from Z. coLt and 
V. choLerae (Stoliar at at., 1976) and CL. dtfftctLe (Wads at at., 1980) 
have also been demonstrated. viral antibodies present in milk include 
antibodies to polio, rotavirus, ECHO, coxsackie, and influenza viruses 
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(Welsh and May, 1979). Human milk has also been shown to contain 
antibodies against various food antigens such as cow milk proteins 
(McCle]land and McDonald, 1976). 
SECTION C- Ilßrl)NOLOGICAL STATUS OF THE NEONATE I 
SYSTEMIC ID44MITY 
In this section the non-specific and specific defences of newborn 
human infants will be reviewed. Increased susceptibility to 
infections (compared with adults) suggests that their immune system is 
deficient in some aspects. The evidence for this will be discussed 
for both the systemic and local defences. In order to set the infant 
studies in context, a brief review of adult lymphocyte function will 
be given and the relevance of the tn"vttro functional assays available 
will be discussed. 
1) Lymphocytes and their function. 
Lymphocytes are derived from haemopoetic stem cells in the adult 
bone- narrow. Their central role in immune responses was demonstrated 
by Gowans (1959) who showed, by cannulation of the thoracic duct in 
rats, that they were part of a recirculating pool of cells, which when 
depleted, caused loss of immune competence. Subsequent work has 
distinguished two major populations of lymphocytes, one which 
differentiates under the influence of the thymus (T cells) and the 
other which differentiates under the influence of the bone- marrow (B 
cells). 
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T cells are important in cell-mediated immunity and in modulation 
of immune responses. Several sub-populations of T cells have been 
described according to function. These include helper or inducer, 
suppressor, cytotoxic and delayed type hypersensitivity T cells. In 
fact these sub-populations can be further sub-divided, for example at 
least two types of T helper cells may act during induction of the 
immune response (Reinherz et at, 1981), while different T helper cells 
may stimulate different classes of inmunoglobulin (Lum, Benveniste and 
Blaese, 1980). T cell subsets can be distinguished to some degree by 
surface markers. In the mouse, these markers have been well 
characterised (Cantor, 1979). In the human, subsets can be 
distinguished by monoclonal antibodies such as OKT4 and OKT8, but the 
surface molecules against which these antibodies are directed have yet 
to be characterised. However, whether these subsets of T cells are 
distinct and separate populations, or whether they are capable of 
changing function under different conditions remains unclear (Eardley, 
Staskawicz and Gershon, 1976) Farrant and Knight, 1979). 
The B cell population is important in humoral immunity. Most B 
cells can be distinguished by the presence of immunoglobulin on the 
surface membrane. After stimulation with antigen, the cells bearing 
Ig receptors for that antigen will proliferate and/or differentiate 
into immunoglobulin secreting cells. For most antigens, T cell help 
and monocytes are also necessary (T- dependent antigens), but some 
polysaccharide antigens can elicit antibody production in the absence 
of T cells (T-independent antigens). A review of tests for assessing 
immune status is given in a report on Immunodeficiency (Chandra et at, 
1978). Some of the tn-vttro functional assays used in this study are 
outlined below and will be discussed further in Chapters 4 and S. 
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2) In-vitro tests of lymphocyte activation and function. 
The study of lymphocyte activation and function to vitro using 
specific antigens presents difficulties, particularly in non-immune 
donors, since such a small number of cells are specific for any one 
antigen. several plant lectins and other compounds have been found to 
induce polyclonal stimulation of particular types of lymphocytes, and 
these have been extensively used in studies on lymphocyte activation 
and function to vttro (Greaves and Janossy, 1972). A limitation of 
these polyclonal activators is that none of them act on one cell 
population only. Different activators can, however, be used to study 
T cell proliferation (e. g. phytohaemagglutinin - PHA), T helper cell 
function in antibody production (pokeweed mitogen - PWM), and B cell 
proliferation and function (Epstein-Barr Virus - EBV, and bacterial 
extracts from organisms such as Staph. aureus and Nocardia). 
i) Phytohaemagglutinin (PHA) 
Soluble PHA has been shown by some workers to activate T cells only 
(Rich and Pierce, 1973), although when it is bound to plastic, B cells 
are also activated. However, others have indicated B cells may also 
be stimulated to proliferate (Sharkey, Danielle and Nowell, 1981). 
PHA stimulated T cells produce soluble mediators (lymphokines) which 
in turn will act on other cell populations. The magnitude of the 
proliferative response varies widely with the dose of PHA (Rich and 
Pierce, 1973). 
ii) PWM 
Pokeweed mitogen (PWM) stimulates both T and B cells to proliferate. 
Peripheral blood B cells are activated in aT dependent manner, that 
is they will not proliferate or differentiate in the absence of T 
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cells (Keightly, Cooper and Lawton, 1976). Under optimal conditions, 
PWM stimulated B cells will secrete immunoglobulin to vitro, but the 
response is dependant on mitogen dose, T: B cell ratios and cell 
concentrations (Janossy et aL, 1977). Monocytes are also necessary, 
although too many can be inhibitory (Montazeri et a?., 1980= 
Qaelig-Meyling and Waldman, 1981). Cells responding to either 
PEQA or PWM appear to be distinct rather than the different mitogens 
affecting similar cells in different ways (Greaves and Janossy, 1972). 
iii) Staph. aureus (Cowan) (SAC) 
Several bacterial components have been found to be mitogenic for 
B cells (Bank and Forsgren, 1978; Waldmann and Broder, 1982) 
including a strain of Staph. aureus (Cowan I) (SAC) with a high content 
of Protein A. This bacterium activates B cells and macrophages, with 
B cells being stimulated to secrete immunoglobulin. Pryjma at at 
(1980) demonstrated that although Ig production in PWM and SAC was 
comparable, only SAC was active in cultures depleted of T cells. This 
stimulation was also resistant to influence by suppressor cells 
generated by co-stimulation with concanavalin A. This indicates that 
stimulation by SAC may be less thymus dependent than PWM. 
iv) Allogeneic lymphocytes 
When mixtures of allogeneic lymphocytes are co-culturod, cells of both 
populations will proliferate in response to the foreign 
histocompatibility antigens on the surface of the other cells. 
Mitomycin-C treatment of one population will prevent proliferation of 
the treated cells, but still enables them to stimulate the other 
population to respond. This reaction is termed a one-way mixed 
lymphocyte reaction (MLR). Blantcxgctnic: factor:; are produced during 
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this response, but proliferation is not essential to their appearence 
as the factors are still produced even when both populations are 
treated with mitomycin-C (Hirschberg, Rankin and Thorsby, 1974). 
Although the response has been shown to be due to proliferation of T 
cells, B cells and antigen- presenting cells are more effective 
stimulators in the MLR (Kuntz, Innes and Weksler, 1976; Horwitz and 
Garrett, 1977). 
v) Specific antigen 
Specific antigens such as tetanus toxoid, Candida, PPD and influenza 
virus will induce proliferation in lymphocytes from immune donors, but 
not in non- immune donor cells (Leiken and Oppenheim, 1970; Alford, 
Cartwright and Sell, 1976; Callard, 1979). In a tetanus toxoid 
induced system, Geha, Mudawwar and Schneeberger (1977) demonstrated 
that factors were produced which could also stimulate autologous and 
heterologous B cells in a non-specific manner, resulting in a 
polyclonal proliferation subsequent to the specific induction. As 
with the PWM system, immunoglobulin and specific antibody production 
to vitro require optimal concentrations of T and B cells and 
monocytes. 
3) Ontogeny of circulating lymphocytes. 
In the human foetus, stem cells start to enter the thymus by the 
eighth week of gestation. By the loth week, thymic cells respond to 
Pty, to vttro, and spleen and blood cells respond 3-4 weeks later 
(Jones, 1968) August at at, 1971; Stites and Pavia, 1979). 
Responsiveness to a]logeneic lymphocytes (MLR) can be found in foetal 
liver cells from 7.5 weeks gestation. These MLR responsive cells are 
not responsive to PHA, suggesting that different populations of T 
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cells respond to the two stimuli (Carr, Stites and Fudenberg, 1973). 
B cells can be found in the foetal liver from 8 weeks gestation; 
from 9-10 weeks these have surface IgM receptors and IgG receptors can 
be detected shortly afterwards. By the beginning of the second 
trimester, the foetus has adult proportions of B cells expressing the 
different classes of immunoglobulin (Gotoff, 1974= Lawton and Cooper, 
1979). Cultures of foetal tissues indicate that lymphocytes start to 
secrete IgM spontaneously between 10-12 weeks gestation, IgG by 12 
weeks but IgA is not detected in tissue cultures before 30 weeks, 
although some has been detected in foetal serum (Gitlin and Biasucci, 
1969). The techniques used by these workers, however, were only 
sufficiently sensitive to detect 2µq/ml or more of IgA. This low 
level of foetal imnunoglobulin synthesis of all classes is not thought 
to represent a functional deficiency but rather a lack of antigenic 
stimulation, since intrauterine infections can cause production of 
large quantities of IgM and smaller quantities of IgG and IgA to utero 
(Alford et W., 1967; McMurray and Rey, 1981). 
4) Immune function of the neonate at birth. Studies on cord blood. 
The anatomy of the immune system is fully developed by 
parturition. However, it is antigenically inexperienced and 
functionally deficient (Stiehm, Winter and Bryson, 1979). The 
efficiency of the placenta results in most infants receiving little 
antigenic stimulation to utero. The birth process and the ensuing 
contact with the external environment results in a massive onslaught 
of antigenic material, not the least of which arises from the 
colonisation of the gut with normal flora, which happens within hours 
of birth. Reduced immune responses suggest that the intact immune 
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system is functionally deficient and several studies have indicated 
that this is the case. 
i) Cell-mediated immunity 
Cord blood lymphocytes (CBL) have a higher rate of background 
proliferation than adult cells during tn-vttro culture, and 
incorporate 6-10 times more isotope. When stimulated with low doses 
of PHA, the responses of CBL are significantly greater than adult PBL 
(Fife at aL, 1974), although at higher doses of PHA the responses are 
comparable (Carr, Stites and Fudenberg, 1972). These differences can 
be explained by the demonstration that the optimal stimulating dose of 
PHA is higher for adult cells, but the maximal proliferation at 
optimal PHA dose is considerably higher in CBL (Ben-Zwi at a!., 1977). 
The proliferative response of CBL's also occurs more rapidly than that 
of adult cells (Yoffey at al., 1978). Total lymphocyte concentration 
in cord blood is higher than adult blood, although the proportion of T 
cells is lower (Davis and Galant, 1975= Diaz-Jouanen, Strickland and 
Williams, 1975= Ben-Zwi at a&, 1977). Proliferative responses to 
allogeneic lymphocytes (MLR) are comparable to adult levels (Stiehm, 
Winter and Bryson, 1979). However, the delayed type hypersensitivity 
reaction is diminished and the proliferative response to antigens is 
lower (Leiken and Oppenheim, 1970) Alford, Cartwright and Sell, 
1976). Cell-mediated lympholysis is also reduced (Stiehm, Winter and 
Bryson, 1979). 
In addition to proliferative responses, stimulated T cells and 
macrophages may also secrete factors (lymphokines) which are capable 
of modulating immune responses. In CBL cultures, production of 
macrophage migration inhibition factor (MIF) is reduced (Winter et aL, 
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1978) but lymphocyte migration inhibition factor production is 
comparable to adult levels (Stiehm, Winter and Bryson, 1979). 
Lymphotoxin production has been reported at only 40% of adult levels 
(Eife et at, 1974). Natural (a-) interferon production has been 
reported as normal (Gotoff, 1974) but gamma-interferon production is 
reduced (Stiehm, Winter and Bryson, 1979; Taylor and Bryson, 1981). 
The latter workers attributed this to a functionally immature 
macrophage. 
Cord blood macrophages have also been shown to be deficient in 
their ability to phagocytose polystyrene spheres (Schuit and Powell, 
1980). However, Ziabinger, Mannhalter and Eibl (1983) have found 
neonatal macrophages to be mature with regards to surface Ia 
expression, release of interleukin r and presentation of antigen. 
Several studies have indicated that the MLR between maternal and 
infant lymphocytes is depressed in comparison with paternal and infant 
cells. This is particularly apparent when the infant cells are the 
stimulators (Field and Caspary, 1971; Lawler, Ukaejiofo and Reeves, 
1975; Toivanen and Granberg, 1980). The mechanism of this 
suppression is not known, although it is thought to be due to foetal T 
suppressor cells (Toivanen and Granberg, 1980) and may be important in 
the protection of the developing foetus. 
ii) B cell responses and immunoglobulin production to vitro 
There are several possible reasons why imnunoglobulin production is 
lower in the neonate. First, the appropriate T or B cells may be 
absent; second, the B cells may be immature; third, there may be a 
lack of help (from T cells or macrophage interactions) and fourth, 
there may be an excess of suppression. In a PWM driven system, 
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Hayward and Lawton (1977) demonstrated that CBL's generated fewer 
plasma cells than adult PBL's, and the response was almost exclusively 
IgM. Using T/B separation techniques, they showed that adult T cells 
enhanced antibody production in cord blood B cells, particularly for 
IgG and IgA classes, but newborn T cells were not as efficient at 
helping adult B cells. This suggested a helper T cell deficiency in 
newborns, with T cells generally balanced towards suppression. Other 
workers have also found newborn T cells to be inefficient helpers 
(Andersson, Bird and Britton, 1980; Miyagawa et eV, 1980), although 
yet others have suggested aB cell immaturity is also responsible 
(Hayward and Lydyard, 1979; Ferguson and Cheung, 1981). Leiken and 
Oppenheim (1970) suggested a lack of antigen specific B cells was 
responsible for the deficient proliferative response to the antigen 
tetanus toxoid. 
The reduced immune responses of neonates are the result of 
complex interactions of cell populations which are maturing at 
different rates. The functional immaturities of helper and suppressor 
T cells, B cells and monocytes are all critical factors. The role of 
monocytes has been less thoroughly investigated but there are 
suggestions that their role may be more critical in neonates than in 
adults (Hutchins and Steele, 1983). 
iii) Immunoglobulins in cord blood 
Although foetal Ig synthesis is low and is largely of the IgM class, 
maternal IgG is transported across the placenta to the foetus. This 
occurs passively from about the 15th week of gestation and actively 
during the last trimester (Larsen and Galask, 1977). At term the 
foetal blood has 10-15% more IgG than maternal blood, with a 
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concentration between 10-15mg/ml (Kohler and Parr, 1966; Allansmith 
et a&, 1968). Not all subclasses of IgG cross the placenta to the 
same extent and transport of IgG2 is lower than other subclasses. 
Nevertheless the specificity of maternally acquired IgG represents the 
antigenic exposure of the mother. Examination of allotypic (Gm) 
markers has indicated that the contribution of foetal IgG is minimal 
in cord blood (Martensson and Fudenberg, 1965). igM concentrations in 
cord blood are about 10% of adult levels (100µg/ml) and IgA 
concentrations are only about 0.1% (1-29q/ml), a level which is 
frequently below the threshold of the less sensitive techniques such 
as radial imaunodiffusion (Berg, 1969). 
iv) Non-specific immunity, neutrophils. 
Cord blood neutrophils have immature nuclear morphology but can 
phagocytose and kill Staph. aureus and E. cott at rates approaching 
those of adult cells. However opsonising antibodies (IgM) and 
complement are low in cord blood and this results in a general defect 
in phagocytosis (Dosset, Williams and Quie, 1969). Neutrophils also 
migrate less well than adult cells, both randomly and chemotactically. 
5) Changes in impunity with age. 
i) Immunoglobulin levels 
Maternal IgG is catabolised by the infant with a half-life of 25-30 
days (Wiener, 1951). Levels decline over the first few months of 
life, and reach their nadir between 3-6 months at 4-4.5mg/ml. After 
this time, infant IgG secretion is greater than maternal IgG 
catabolism, and by 1 year concentrations are about 6mg/ml (Stiehm and 
Fudenberg, 1966= Berg, 1969). Adult IgG levels are reached by 11-12 
years of age (Berg and Johanson, 1969) or earlier (Buckley, Dees and 
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O'Fallon, 1967; Allarnsmith et aL, 1968). 
There have been several reports that maternal antibodies may 
exert a suppressive effect on neonatal immune responses (Cooke and 
Jones, 1943 Peterson and Christie, 1951). The latter workers found 
that the reponses to pertussis and diphtheria vaccination were 
significantly lower in infants with maternally acquired specific 
antibodies but did not find this inhibitory effect for tetanus toxoid 
vaccination. Inhibition may be overcome by increasing the dose of 
antigen (Miller, 1980). 
IgM concentrations rise fairly rapidly during the first few weeks 
of life and then more steadily (Stiehm and Pudenberg, 1966; Berg, 
1969). This period of rapid increase corresponds with the 
colonisation of the gut with micro- organisms. By the end of the 
first year of life, IgM concentrations have reached approximately half 
adult levels (540µq/ml, Stiehm and Fudenberg, 1.966; 700µq/ml, Berg, 
1969). Adult levels are reached by 4 years of age (Berg and 
Johansson, 1969) or earlier (Buckley, Dees and O'Fallon, 1967). 
IgA concentrations rise steadily during the first year to 
approximately 300µq/ml (Stiehm and Pudenberg, 1966; Haworth and 
Dilling, 1966; Berg, 1969) but do not reach adult concentrations 
until puberty (Allansmith st W., 1968; Berg and Johansson, 1969). 
Several studies have indicated that increased exposure to 
antigens results in higher concentrations of all classes of 
immunoglobulins. Berg, (1969) compared children with recurrent 
infections with those remaining free from infections during the first 
year and found significantly higher inmunoglobulins, particularly of 
b 
47 
the Iglu and IgA classes, as early as 3 weeks of age. Gerrard et aZ.., 
(1977) compared Ig levels in white and Cree Indian communities in 
Saskatchewan, and found the Indian community, with greater exposure to 
infectious agents, had significantly higher levels of IgG, IgM, IgD 
and IgA. 
ii) Lymphocyte function to vitro 
Although the development of serum immunoglobulin concentrations has 
been well studied in healthy infants, very few comprehensive studies 
have been performed on the progressive development of lymphocyte 
function to vitro. Alford, Cartwright and Sell (1976) have studied 
proliferation of infant lymphocytes from birth to 20 months. They 
showed that unstimulated and PHA stimlated proliferation was higher 
than that of CBL during the first few months of life, but had declined 
to adult levels by 20 months. Proliferative responses to antigens 
such as streptolysin and Candida were lower when account was taken of 
the high background proliferation. Andersson, Bird and Britton (1981) 
have made a sequential study of B lymphocyte function in infants from 
birth to 2 years of age. Using EBV, which is aT independant 
activator of B cells, they found that IgM was secreted at adult levels 
from birth, but IgG secretion was deficient until 2 years of age, with 
G2 and G4 subclasses being slower to mature than Gl and G3. Using 
PWM, a T-dependent B cell activator, imnunoglobulin was not secreted 
at all until after 6 months of age, due to an immaturity of T helper 
cells. 
Lymphokine production is also variable. Winter et aL (1978) have 
shown that the deficiency of gamma-interferon production lasts beyond 
the first week of life, although classical interferon production at 1 
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week was normal. However, Keller et aL (1983) demonstrated that 
infants less than 1 week of age were able to produce adult levels of 
leucocyte derived chemotactic factor (LDCF) in response to mitogen. 
SECTION D- IMMUNOLOGICAL STATUS OF THE INFANT II 
LOCAL IMMUNITY 
The existence of a separate secretory immune system was first 
suggested by Hanson (1961), and since then several studies (Tomasi et 
aL, 1965; Heremans, 1975; Bienenstock, 1974) have established the 
local immune system as a unique protective process present at all 
epithelial surfaces in direct contact with the environment (e. g. 
intestine, bronchial tree, and genitourinal tract). This local system 
is independent of systemic immune responses and is stimulated by 
antigen at mucosal surfaces. 
1) Gut associated lymphoid tissue (GAIT) and Lymphocyte pathways. 
Lymphoid tissue belonging to the secretory immune system 
underlays all mucosal epithelia and is found in the stroma of all 
external glands. The heaviest concentrations occur in the gut, in 
Peyer's patches and throughout the lamina propria, which is the site 
of the heaviest antigenic load. Crabbe and Heremans (1966) 
demonstrated that plasma cells in these tissues were secreting 
primarily IgA; this contrasts with IgG which was produced by plasma 
cells in other lymphoid tissues such as spleen and peripheral lymph 
nodes. 
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The newborn infant is virtually devoid of a functionally 
diferentiated immune system in the gut during the first week of life 
(Handberg and Aarskog, 1975) due to lack of antigenic stimulation to 
utero. However, colonisation of the gut with micro-organisms and 
ingestion of food antigens soon after birth results in a fairly rapid 
development of local lymphoid tissues and appearance of sIgA by 2-4 
weeks post-partum (Seiner, Merrill and Claman, 1968). 
Gowans and Knight (3.964) showed in rats that thoracic duct 
lymphocytes, when adoptively transferred, returned primarily to the 
small intestine of the recipients. Subsequently, rtipopulation 
experiments have shown that Peyer's patches contain a precursor 
population of cells largely destined to make IgA in the intestine 
several days after transfer (Craig and Cebra, 1971). The exact route 
of migration of these cells is not clear but the mesenteric lymph 
nodes (MLN) are thought to be important in the IgA cell cycle (Husband 
and Gowans, 1978; Roux at aL, 1979). Similar properties of lymphoid 
tissue of the bronchus, together with repopulation studies, has led 
Bienenstock ( 1974; Bienenstock and Befus, 1980) to suggest a 
common mucosal associated immune system (HALT). 
The factors controlling the mucosal localisation of the precursor 
cells are largely unknown. Secretory component was thought to be 
important but does not now appear to be (Bienenstock and Befus, 1980). 
Hormones can affect migration to certain locations such as the mangy 
gland, cervix and vagina (Weisz- Carrington et al., 1978) but are not 
always involved at other sitrs (McDermott, Clark and Bienenstock, 
1980). Antigen seems to amplify the localisation of the cells but is 
not essential as localisation still occurs in the absence of antigen 
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(Pierce and Gowans, 1975). The role of chemotaxis has yet to be 
determined (Parrot, 1979). Kawanishi, Saltzman and Strober (1983) 
have demonstrated in mice, the presence of aT call in Peyer's patches 
which stimulated surface IgM bearing cells to differentiate into 
surface Igh bearing cells. This T cell could not be demonstrated in 
cultures of spleen cells. Whether these T cells have any effect on B 
cell localisation is not known. 
2) Secretory imnunoglobulins 
The structure and properties of the IgA molecule which make it 
particularly suited to the secretory surfaces have been discussed 
previously (Section B2ii). The quantities of ininunoglobulins in the 
secretions of newborn infants are very low. Haworth and Dilling 
(1966), using radial inmunodiffusion, could not detect IgA in saliva 
before 2 weeks of age, but showed that detectable levels did occur in 
saliva before serum, and that the salivary and serum IgA levels were 
not correlated. Seiner, Merrill and Claman (1968) noted that IgA in 
saliva rose rapidly during the first few weeks of life. They 
suggested that salivary IgA reached adult levels within 2-3 months, 
however more recent work using improved electroimnunodiffueion 
techniques for detecting sIgA, has indicated that adult levels are not 
reached until 6-8 years (Burgio et at, 1980). 
Secretory IgA is also the predominant imnunoglobulin at most 
other secretory sites, although IgG may also be present in similar 
quantities at sites such as the nasopharynx (Cohen, Goldberg and 
London, 1970) and duodenum (Lebenthal, Clark and Kim, 1980). Specific 
antibodies to a number of organisms have been demonstrated, especially 
to those colonising the gut and other surfaces (Shearman, Parkin and 
ý 
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McClelland, 1972; Welliver and Ogra, 1978; Sohl-Akerlund et aL, 
1979). The relative deficiences of these antibodies during the first 
few months, at the sites of highest antigenic load including the mouth 
and the rest of the gastrointestinal tract, highlights the potential 
importance of the IgA contained within breast milk. 
3) Local non-specific defence mechanisms 
In addition to the specific cell-mediated immunity and antibody 
production, the infant is also endowed with a number of non-specific 
defence mechanisms. Many of the non-specific antimicrobial factors 
found in milk (described above) are also present at other secretory 
surfaces. These include lactoferrin and enzymes such as lysozyme and 
lactoperoxidase (Gothefore and Marklund, 1975). Non-specific factors 
controlling the development of normal gut flora and limiting the 
growth of potential pathogens have been reviewed (Borriello and 
Stephens, 1984). The acid pH of the stomach is certainly an important 
defence factor in adults, although in newborn infants the stomach 
appears to have a higher pH (Miller, 1941 Agunod et cL, 1969). 
Mucins (glycoproteins and glycolipids) in the mucous coat may act like 
the receptor analogues of milk (Section Bli) and limit the attachment 
of micro-organisms. Organisms which cannot adhere are more easily 
removed by mechanisms such as peristalsis in the gut and the ciliary 
movement of the upper respiratory tract. The importance of the normal 
gut flora in defence has already been discussed (Section Bli). In 
addition to the mechanisms described, there is also evidence that the 
normal gut flora is essential for the development of the gut lymphoid 
tissue, since in gnotobiotic animals reared in a sterile environment, 
there is considerable reduction in gut lymphoid tissue (Ottaway, Rose 
and Parrot, 1979). 
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SECTION E- EFFECT OF DIET ON IMMUNITY 
Although no comprehensive studies have been conducted on immunity 
in infants reared on different but nutritionally adequate diets, there 
have been many studios on tho effect of undernutrition on immunity. 
These will be briefly reviewed in order to emphasise the'important 
effects food (or lack of it) can have on the development of the immune 
system. Direct effects are often difficult to determine as 
malnutrition and infections frequently occur together. There have 
been many studies on various aspects of protein-calorie and single 
nutrient deficiencies. These are reviewed by Chandra (1980) and Dowd 
and Heatley (1.984). 
Tn protein-calorie malnutrition, cell-mediated immunity oeeems to 
be more severely affected than humoral immunity. There in a reduction 
in lymphoid anatomy at all sites (thymus, spleen, lymph nodes, total 
circulating lymphocytes). Most T cell functions are reduced, such as 
delayed cutaneous hypersensitivity, immunity to intracellular 
organisms, responses to T cell mitogens and lymphokine production. 
However B cell function is more variable. Serum immunoglobulin levels 
are often raised, usually due to repeated infections or increased 
uptake of food and other gut associated antigens (Chandra, 1915). B 
cell numbers may be normal or reduced, and response to mitogens such 
as PWM are increased. However, both specific antibody responses and 
secretory immunoglobulins are decreased. Non-specific immunity, such 
as phagocyte function or complement levels may be normal or decreased. 
Single dietary deficiencies which also impair immune responses are 
iron, zinc, folate and vitamin Bi2, vitamin C, vitamin A and 
pyridoxine (Chandra, 1980). 
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SECTION F- PLAN OF THESIS 
Existing evidence for the role of milk in passive protection in 
the infants gut is now fairly conclusive. The implications that milk 
may also have an active role in development of immunity in the infant 
comes from the prolonged resistance to infection beyond the weaning 
period, the increased resistance to systemic as well as 
gastrointestinal infections, and the increasing evidence for the 
presence of lymphokines and other growth factors in milk. 
The aim of this study was to use a range of tests for 
cell-mediated and humoral immunity to determine whether the maturation 
of the infants immune defences, which normally occur during the first 
few months of life, were being enhanced or modulated in any way by 
breast milk. The protocol chosen for this was as follows: - 
1) Subjects - 30 infants chosen for study; 
a) 15 completely bottle-fed 
b) 15 breast-fed, with records of supplements 
2) Age at which samples were taken - Infants studied on five 
occasions; 
a) 6 days 
b) 6 weeks 
c) 3 months 
d) 6 months 
e) 9 months 
3) Samples - 
a) blood (heparinised and clotted) 
b) saliva. 
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4) Teats on serum and secretions for estimation of immune 
function to vtuoj 
a) total IgG, IgM and IgA 
b) specific antibodies to tetanus toxoid (G, M and A) 
c) specific antibodies to commensal E. coLt (G, M and A) 
5) Tests on lymphocytes for estimation of immune function 
to vttrof 
a) lymphocyte proliferative responses to PEW, PWM, SAC, 
M, R and TI 
b) production of imnunoglobulins and specific antibodies. 
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CHAPTER 2 
)Q TERIALS AND METHODS 
SECTION A- SUBJECTS AND SAMPLES 
1) Selection of infants 
Full-term healthy infants were recruited to the study with full 
parental consent. Mothers were informed about the study by antenatal 
clinic counsellors or National Childbirth Trust volunteers during 
pregnancy, or by the author during their first 4 days post-partum. 
The choice of breast- or bottle-feeding was left entirely to the 
mother and no pressure was exerted on the mothers to prolong 
breast-feeding because of the study. Twenty-nine of the thirty, 
infants were born at Northwick Park Hospital (NPH), infant 03 was born 
at Schrodells Hospital, Watford. All families lived in the Harrow or 
Watford area. Breast-fed infants were selected from families highly 
motivated to succeed at breast-feeding, and many had successfully 
breast-fed a previous infant. Bottle-fed infants were selected from 
families who had decided pre-partum to bottle-feed, so that the 
infants were not put to the breast at any time. An attempt was made 
to select families who seemed most likely to complete the 9 month 
study period and to be reliable in recording methods of feeding, 
intercurrent infections etc.. For this reason, mothers with a poor 
understanding of English, those felt by the nursing staff to be 
'unreliable', and anyone slightly hesitant about volunteering were 
excluded from the study. One mother (of infant 21) withdrew from the 
study after the first visit. 
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During the study, mothers were encouraged to approach the NPH 
paediatricians with any problems, however minor, that they had with 
the infants. 
2) Visits and Questionnaires 
Infants were studied on 5 occasions; at 6 days, 6 weeks, 3,6 
and 9 months. The first visit was planned to coincide with the 
Guthrie Test; for most infants this visit was in the Maternity Unit 
at MPH. Most other visits were at the families' home, but on a few 
occasions infants were brought to the Day Care Unit in the Out Patient 
Department. A questionnaire was filled out for each infant. This 
included details of maternal age, duration of pregnancy and any 
associated problems, paternal occupation, number of siblings and their 
feeding group with duration of breast-feeding, and infant sex and 
birth weight. Mothers were asked to keep a record of any infections 
the infants contracted, whether these were treated, and any 
vaccinations they received. This information was recorded on the 
questionnaire at each visit together with feeding details such as 
formula type (SMA Gold Cap or Ostermilk Complete Formula), supplements 
of breast-fed infants with cow milk products, inclusion of cereals and 
other solids in the diet, and details of weaning. All mothers were 
asked to avoid feeding the infants, if possible, for at least 2 hours 
before each visit in order to minimise contamination of saliva samples 
with breast milk immunoglobulins. 
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3) Collection of samples 
Blood samples (1-5m1) were collected at each visit by a 
Paediatrician from NPH (see acknowledgements). This was usually done 
by venepuncture from the antecubital fossa, volar surface of the 
forearm or dorsum of the hand. In a few cases heel-prick samples were 
used. Samples for cell studies were mixed with preservative-free 
heparin (20 units/ml blood), and processed on the day of collection. 
Total cell counts were performed on duplicate dilutions in Isoton II 
azide-free balanced electrolyte solution (Coulter Electronics) in the 
Haematology Department at NPH using a Coulter Counter (Model S-plus 
Iv, Coulter Electronics, Florida, U. S. A. ). Films for differential WBC 
counts were stained with May-Grunwald and giemsa stain in the 
Haematology Department but counted by the author. 
Samples for serology were collected into 600µl capillary blood 
serum separators (Microtainer, Becton-Dickinson, Wembley, Middx. ). 
Once clotted, these samples were spun at 15000 xg (Eppendorf 
Microfuge ), and the serum removed and stored at -700C. Aliquots for 
immunoglobu]in assays by nephelometry were stored at 4°C. 
Saliva specimens were collected by placing a polyvinyl catheter 
(blue line umbilical cannula 6FG, Portex Ltd., Hythe, Kent) under the 
tongue and applying gentle auction. Samples were stored at -70°C, 
either undiluted or the catheter was washed out in 200µl phosphate 
buffered saline (PBS). 
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SECTION B- MATERIALS 
1) Phytohaemagglutinin (PHA) 
PHA (Wellcome Laboratories) 10mg/ml, was diluted to 2mg/ml in 
sterile saline and stored in 200µl aliquots at -70°C. The same batch 
was used throughout. Thawed aliquots were diluted to 20µg/ml for use, 
which gave a final concentration of 1µq/ml in the cell cultures. 
Di]uted PHA was kept at -70°C for up to 1 week only. 
2) Pokeweed mitogen (PWM) 
PWM (Sigma, London) was reconstituted in sterile saline to 2mg/ml 
and stored as described for PHA. it was used at a final concentration 
of 1µq/m1 in the cell proliferation studies. 
3) Tetanus toxoid (TT) 
Immunopurified TT (14mg/ml, approximately 7000 Lf units/ml) was 
kindly supplied by Dr R. O. Thomson, Wellcome Foundation, Beckenham, 
Kent. For the radioimmunoassay (RIA), it was diluted to 25OLfu/ml 
(50Oµg/ml) in PBS and stored at -70°C. For cell culture work it was 
diluted to 40ng/ml (0.02Lfu/ml) in Iscove's modified Dulbecco's medium 
(IMDM) and stored at -70°C. 
4) Preparation of mitogen from StaphyLococcus aureus (SAC). 
The method of Banck and Forsgren (1978) was used. Staph. aureus 
Serotype I (Cowan), NCTC 8503, was obtained from the National 
Collection of Type Cultures (Central PHL, Colindale Ave., London). 
Organisms were cultured overnight at 4°C in lOOml of brain heart 
infusion broth (Oxoid) containing 1% proteose peptone, spun and killed 
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by resuspending in 60ml 0.5% formaldehyde and leaving at room 
temperature (RT) for 3 hrs. Bacteria were heat-treated for 3mi. ns at 
80°C, washed 3 times in PBS, resuspended lt10 v/v in RPMI 1640 (Flow 
Laboratories) with bicarbonate (2 q/L, pH 7.4) containing penicillin 
(100 I. U. /ml), streptomycin (100µg/ml) and L-glutamine (2mM/ml), and 
stored at -70°C. Sterility was checked by culture on blood agar 
plates (Oxoid). 
5) Preparation of E. coLt '0' lipopolysaccharide (LPS) antigen 
This pool of antigens was used in specific antibody assays of 
serum and secretions and in preparation of the anti-E. coLt standard 
serum (Section Dii). Antibody production to a pool of six commensal 
strains was used as a paradigm of responses to non-pathogenic 
organisms encountered as part of the normal gut flora. Six commensal 
strains of E. cott, commonly isolated in the London area, were supplied 
by Dr. B. Rowe (Central P. H. L. S., Colindale). Their serotypes were 
O1K1H7,02K]H4,04K3H5, O6K2acH1,015K14H4,075K? H5. The strains were 
subcultured on to Columbia agar plates (Oxoid), incubated overnight at 
37°C, harvested into saline (0.85%), and adjusted to 12xl09 orgs/ml. 
A crude extract of '0' LPS was prepared by boiling the suspensions for 
2hrs and centrifuging at 5000 xg for 30mins; the supernatants were 
pooled and stored at -70°C. 
6) Preparation of stimulator cells for mixed lymphocyte reaction (MLR) 
Stimulator cells were mitomycin-C treated before aliquotting and 
freezing in order to obtain a uniform preparation which could be 
rapidly reconstituted for each assay. 
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i) Cell culture 
A heterozygous B cell line, Cla-4, was obtained from Dr A. Levin (CRC). 
The tissue type of this line was A2,29j B12,27t Cwlj Bw4; DR7, DR3. 
Cells were rapidly thawed from liquid nitrogen by the following 
method. The ampoule was placed in a 37°C water bath until the cell 
pellet had almost completely thawed. Culture medium (50% RPMI 1640 
with bicarbonate, 50% Eagles MEM (Flow), plus added pen/strep and 
L-glutamine) containing 20% foetal calf serum (FCS) was added dropwise 
over a period of 5 minutes, to give a final volume of lOml. The cells 
were transfered to a 250ml tissue culture flask (Nunc) and incubated 
in a humid 37°C incubator containing 5% C02. Cells were fed every 2-3 
days with medium containing 10% FCS, to give approximately double the 
volume. Cultures were split into fresh flasks when the volume reached 
40m1. 
ii) Mitomycin-C treatment 
Approximately 600m1 medium containing 1x106 cells/ml was pooled and 
spun at 1000rpm for 10 mina in 50m1 conical tubes (Falcon Plastics). 
Pellets were resuspended and pooled in a total of 30m1 RPMI 1640 with 
Hepes (20mM, pH 7.2). To this was added mitomycin-C (Sigma) to give 
40-50µg/ml cell suspension (3ml of 500µg/ml solution). Suspensions 
were incubated 30mins at 37°C, and washed 3 times in RPMI 1646 with 
Hepes. Cells were resuspended in RPMI 1640 with Eagles containing 5% 
DMSO to a final concentration of approximately 100 x 1O6 cells/ml. 
iii) Freezing of stimulator cells 
Cell suspensions were dispensed into cooled cryotubes (Nunc Plastics) 
in 100µl volumes (i. e. lOx106cells/vial). Tubes were placed in a 
glycerol bath at -30°C for 3omins and then rapidly transfered to 
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liquid nitrogen. Two batches of cells were necessary to complete the 
study, these batches gave very similar results when set up in parallel 
in an MLR. Viability of thawed vials was checked with trypan blue and 
was between 60-70%. 
SECTION C- CELL CULTURES 
1) Serum free culture medium for proliferation experiments 
For mononuclear cell proliferation studies, Iscove's Modified 
Dulbecco's Medium (IMDM) from Flow Laboratories was used. IMDM powder 
was reconstituted in distilled water and bicarbonate (15.12g/5L, pH 
7.4) added. The medium was filter sterilised at 37°C through a warmed 
filter (maximum volume 5L) in order to allow maximal penetration of 
lipid through the filter. 
2) Serum-free medium for to-vitro imnunoglobulin production 
Although the above medium supported good proliferative responses 
with all stimulants used, the lipid content was found to be 
unsatisfactory for specific antibody production to vttro (Farrant et 
at, 1984). For these cultures, supplements of transferrin (TF), 
bovine serum albumin (BSA) and soy lipid were added to the basic IMDM 
according to the method of Iscove and Melchers (1978) as described by 
Farrant et at, (1984). 
i) Basic medium 
IMDM powder (Gibco) containing L-glutamine and 25mM Hepes buffer was 
made up to 1 litre according to the manufacturers instructions using 
pyrogen free water (Travenol Laboratories Ltd., Norfolk), and 3.024g 
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NaHCO3 (Analar), taking care to protect it from the light. Medium was 
sterilised by filtration through a 0.22Mm filter and stored in 20ml 
volumes in the dark at 4°C. The osmolarity of the medium was checked 
as 280 mCsmolar, and the pH was 7.2 after equilibration with 10% C02. 
ii) Transferrin 
Substantially iron-free TF (Sigma, London) was 30% saturated with iron 
as follows. A 4mg/ml solution of ferric chloride was made using O. 1mM 
HCl diluted in pyrogen-free water. To 100mg TF was added 1.06m1 basic 
IMDM containing Pen/Strep lO0I. U. /ml and 50µl of the ferric chloride 
solution. 
iii) Delipidated Bovine serum albumin 
BSA (Behring Institute) was delipidated as follows. Dextran T40. 
(200mg, Pharmacia) was dissolved in 200m1 pyrogen-free water, 2g 
activated charcoal (Norit-OL, SDH) was added, mixed and left at RT 
30mins with occasional agitation. BSA (log) was added to this and 
left to dissolve with a minimum of stirring. The pH was adjusted to 
3.0 by dropwise addition of N110 HC1 with stirring. The mixture was 
then heated to 56°C for 30mins with frequent agitation. Charcoal was 
partially removed by centrifugation at 2700g for 20mins. The 
supernatant was adjusted to pH5.5 using N NaOH and the remainder of 
the charcoal was removed by passing the supernatant successively 
through 1.2µm and 0.45µm filters. To deionise the BSA, 20m1 Amberlite 
monobed resin MB-1 (BDH) was added, the mixture stirred and left 
overnight at 4°C. The BSA was concentrated to 50ml (i. e. 20%) over 
an Amicon P1410 membrane, adjusted to pH7.0 with N HC1, sterilised by 
passing through a 0.22µm filter, aliquotted and stored at 4°C. 
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iv) Soybean lipid 
Soybean lecithin (PH75, Natterman Chemie GMBH, 5000 Koln 30, Germany), 
30mg, was weighed into a 25m1 beaker (3omm wide x 45mm deep). To this 
was added 20m1 IM DK without added bicarbonate (pH6.8 adjusted with 
NaOH) containing Pen/Strep and 1% delipidated BSA. The beaker was 
packed in ice and the lipid sonicated at maximum amplitude using a 1cm 
probe (KSE soniprobe) for 5mins. The sonicated lipid was sterilised 
using a 0.22µm filter, aliquoted and stored at 4°C. Supplements were 
added immediately before use, to 2Oml basic I DM was added 40Oµl BSA, 
400µ1 soybean lipid and 5µl TF to give final concentrations of 
BSA-4mg/ml, lipid-20µg/ml, and TF-22.5µg/ml. Pen/Strep and 
L-glutamine were also added. The medium was kept well gassed with 10% 
c02 during the setting up of cell cultures. 
3) Microculture technique 
The Terasaki plate microculture system described by O'Brien at aL 
(1979) was used for all cell culture work. 
i) Separation of cells from peripheral blood 
Heparinised blood was mixed with IMDM (Flow) containing Pen/Strep and 
L-glutamine. A volume ratio of 1: 2 was found to give the best cell 
yield for blood volumes betweem 1-5m1. The blood was layered on to 
2m1 Ficoll-Paque (Pharmacia) in lOml conical centrifuge tubes 
(Sterilin) and spun at 1800rpm (650 x 4) for 35mins. Mononuclear 
cells were harvested from the interface, washed twice and resuspended 
in IMOM to approximately 8xlO6cells/ml. Cells were counted in a 
haemocytometer (Improved Neubauer, Hawksley Ltd. ) after diluting the 
cell suspension 1t1O in it acetic acid containing a little crystal 
violet. Before culture, cell concentrations were adjusted to give 1, 
64 
2 and 4x 106 cells/ml (and 8x 106 if sufficient cells). 
ii) Terasaki plate microculture system 
Suspensions were dispensed into Terasaki microculture plates (Falcon 
Plastics Ltd. ) in 20µ1 volumes using a Hamilton syringe with a 
repeating dispensing unit. This volume gave a domed meniscus in the 
wells. All cultures were set up in duplicate. A control row with no 
stimulant was included for each plate. Separate plates were set up 
for each day of harvest (see below). For samples of low volume, 
priority was given as follows: - no stimulant, PHA, PWM, SAC, MLR, TT. 
For large volumes, extra harvest days and/or higher cell 
concentrations (8 x 106) were included. Stimulants were added in lµl 
volumes to give final concentrations of PHA 1µq/ml, PWM 1µq/ml, SAC 
1/2000, and TT 0.00lLfu/ml (see Chapter 4 for titrations). Plates 
wr+. re incubated inverted without lids (See Fig. 2- 1) in equilibrated 
boxes containing 0.85% saline, at 37°C in a humid incubator with 5% 
C02 (Leec Ltd. Nottingham) for up to 6 days. 
iii) Mixed lymphocyte cultures 
Cultures were set up as described above except that cells were 
dispensed in 10µl volumes of double the final concentration. Mitomycin 
treated Cla-4 stimulator cells were thawed rapidly from liquid 
nitrogen by agitating the vial in a 37°C water bath. Cells were 
resuspended by dropwise addition of IMDM to give 4x 106 cells/ml 
(2.5m1). These cells were added to the responder cells in IOµ1 
volumes and two control wells were included containing stimulator 
cells only, to check the efficacy of the mitomycin treatment. 
Figure 2-1 
Terasaki plate culture system 
T 
ý-/ 
a 
--------------------- -- ----- 
a) Meniscus of medium on which cells grow 
b) Support to hold culture plate above saline 
c) 0.85% saline 
d) Humidified box 
e) Loosely fitting lid to allow gassing of cultures 
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Figure 2-2 
Terasaki plate harvester 
C 
............... 
F: " ". ý F. ": :' r. " ". ý ýýý ............ ............ 
............ ............ ............ ............ ............ ........... 
.......... .......... .......... 
a) Polycarbonate harvester base 
b) Soles for removal of wash fluids 
c) Wells into which rims of Terasaki plate fit 
d) Glass-fibre filter 
e) Rims of Terasaki plate 
f) Template Terasaki plate for cutting 60 filter discs on to harvester 
67 
iv) Harvesting cultures for proliferation studies 
Preliminary experiments (see Chapter 4) showed the maximum 
proliferative responses of infant lymphocytes to PEW occurred on about 
the third day of culture while PWM, SAC and MLR responses were maximal 
at 4-5 days. It was therefore decided to harvest all cultures on days 
3 and 5, and on day 4 if cell numbers permitted. For pulsing, plates 
were suspended inverted in a bracket and lµl of [3H-methyl] thymidine 
(Amersham Radiochemicals Ltd. ) at 2Ci/mmol was added without 
disturbing the cell pellet on the meniscus. This gave a final 
concentration of 1µg/ml of thymidine (O. 16pCi/well). Plates were 
reincubated for 2hrs at 37°C. The cell pellets were harvested on to 
glass-fibre paper (Titertek, Flow Laboratories) previously cut on to 
a Terasaki plate harvester, shown in Pig 2-2 (Bioenineering 
Department, CRC) as described by O'Brien et al. (1979). Suction was 
applied and the filter paper discs were washed with lOml/plate each of 
0.85% saline and 5% w/v trichloroacetic acid and dried with lOml 
methanol. Discs were transferred to plastic scintillation vials 
(Hughes and Hughes Ltd., Romford, Essex), O. 5ml scintillant (NE 260, 
Nuclear Enterprises) was added, and the tubes capped and counted in a 
Wallac LKB scintillation counter. 
SECTION D- IMMUNOGLOBULIN AND ANTIBODY ASSAYS 
Assays were compared for estimating total immunoglobulins of G, M 
and A classes (Nephelometry and RIA), tetanus toxoid antibodies (ELISA 
and RIA), and E. cott antibodies (Indirect haemagglutination (IHA), 
ELISA and RIA). The relative merits of each assay will be discussed 
in detail in Chapter 6. RIA was used routinely for all assays because 
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of its high sensitivity, low sample volume requirement, and the 
convenience of carrying out all the assays on one sample by the same 
method. The RIA was therefore used to measure total IgG, IgM and IgA, 
class-specific tetanus toxoid and E. coZ4 antibodies in all sera, 
secretions and cell culture supernatants. Total IgG, IgM and IgA 
estimations were also done routinely by nephelometry. 
1) Standards for RIA 
i) Preparation of affinity purified anti E. coLt standard 
a) Coupling of E. coLt 00' LPS antigen to Sepharose 
Epoxy-activated sepharose, lg, (Sigma) was swollen on a sintered glass 
filter with 25m1 of distilled water for 
Amins, 
and washed with a 
further 75ml. To this, lOml 0.02N NaOH was added, stirred and washed. 
with a further 100aä distilled water. E. coLt '0' LPS antigen (10ml, 
adjusted to pH 12 with N NaOH) was mixed with the swollen gel in a 
siliconised universal, and rotated on an end-over-end rotator (Citenco 
Ltd., Herts. ) at 37°C for 24hrs. The gel was washed with 100ml water 
and the remaining active groups blocked with O. lM ethanolamine (pH 
8.0) at 37°C for 4hrs on the rotator. The gel was returned to the 
filter, washed with distilled water, then alternately with acetate 
buffer (pH 4.0) and borate buffer (pH 8.0), four times, to remove non- 
covalently bound material. The coupled gel was then washed 
extensively with PBS containing 1% sodium azide, to remove weakly 
bound or adsorbed material, and stored at 4°C. 
b) Purification of serum. 
This gel was packed into a column (5m1 syringe plugged with a disc of 
glass fibre paper), washed with 25m1 PBS to remove the azide, and lOml 
of a normal human serum with a high anti-E. coLt titre added. Unbound 
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antibodies were removed by washing with 20ml PBS and anti-R. coLt 
antibodies eluted with 0.2M glycine buffer (pH 2.3) and collected into 
an equal volume of 0.3M borate buffer (pH 8.0). The antiserum was 
dialysed overnight against 2 litres PBS, filter sterilised and stored 
at -700C. 
This nominally purified antibody was standardised by RIA against 
pure preparations of IgG, IgM and IgA (see below). It was found to 
contain 6000ng/ml total IgG, 8750ng/ml total IgM and 11OOng/ml total 
IgA. As no calibrated anti-E. coLt standards were available, it was 
impossible to estimate the exact percentage of the total 
inzmunoglobulin that was specific for E. coLt. An estimation was made 
by comparing the total Ig curves directly with those for 
class-specific E. coLt antibodies. This assumes that the proportion of 
Ig molecules being bound by an optimal coating of anti-Ig will be the 
same as those being bound by an optimal coating of antigen, which is 
obviously not correct. However, this extrapolation of the curves gave 
an estimated 360ng/ml specific IgG, 400ng/ml IgM anti-E. coLt and 
150ng/ml IgA anti-E. coLß, indicating that about 5-10% of the Ig was 
specific for E. coLt. This estimation may not be unreasonable, as 
quantification of a similarly purified anti-TT serum against 
internationally standardised monoclonal antibodies indicated that 
10-15% of the Ig was specific for TT (see below). For the purpose of 
these assays, the exact ng/ml quantity of specific antibody was not 
critical, as the main function was to provide a reliable and 
reproducible standard for the relative quantitation of all sera and 
secretions in this study. 
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ii) Affinity purified anti-tetanus toxoid antiserum 
This antiserum was kindly supplied by Dr M. K. Brenner. Briefly, it was 
prepared by repeated passage of a high titre human antiserum down a 
column of tetanus toxoid bound to cyanogen bromide-activated 
sepharose. Specific antibodies were eluted, and filter sterilised. 
This preparation was standardised against a monoclonal anti-TT 
antibody (see below) for IgG, and a myeloma protein for IgM. About 
15% of the IgG was found to be specific for tetanus toxoid, and about 
10% of the IgM was specific for P. 
iii) Other standards 
a) IgG k anti-'IT monoclonal antibody 
This antibody was the kind gift of Drs R. Tiebout and W. P. Ziejlemaker, 
Nederlands Red Cross Blood Transfusion Service, Amsterdam. It had 
been prepared from an EBV-transformed cell line, and standardised by 
RIA and ELISA agaist WHO standards. 
b) IgM and IgA 
The IgM myeloma was a gift of Dr Feinstein, Animal Research institute, 
Babraham, Cambs. Human colostral IgA was kindly supplied by 
J. P. Pierce-Cretel and A. Decottignies, (Lille). It was prepared as 
described in an earlier publication (Stephens at aL, 1981). Briefly, 
human mi]k was delipidated and decaseinated, then fractionated using a 
combination of a concentration gradient of (NH4)2so4 and a pH gradient 
as described by Montreuil at aL (1960). Secretory IgA (aIgA) was 
isolated from fraction P4 obtained at 50% saturation in (NH4)2504 at 
pH 7.0. It was purified by gel filtration on two coupled columns of 
Ultrogel AcA 44 (Industrie Biologique Francaise) as described by 
Pierce-Cretel at at. (1980). This preparation was estimated to be 
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about 85% sIgA. 
2) Preparation of Iodinatated class-specific antisera for RIA 
i) Coupling of immunoglobulin to CN-Hr Sepharose 
The colostral sIgA was coupled to cyanogen bromide-activated sepharose 
(Pharmacia Fine Chemicals Ltd. ) as follows. Cyanogen-bromide 
activated Sepharose 4B (0.5g) was mixed with 50ml 16-3M ltd over a 
sintered glass filter, stirred and left 15mins to swell. Suction was 
applied and the gel was washed with a further 150m1 . 10-3M HCl. IgA 
(4mg) was dissolved in 4ml freshly made coupling buffer (O. 1M NaHCO3 
containing 0.5M NaCI). The IgA was then mixed with the swollen gel in 
a siliconised universal container and rotated end over end at RT for 
2hrs. The coupled gel was returned to the filter and washed with 50m1 
coupling buffer to remove unbound material. The gel was returned to 
the siliconised universal container and remaining active groups 
blocked by reacting with 4m1 1M ethanolamine (adjusted to pH 8.0 with 
concentrated acetic acid) for 2hrs at RT on the rotator. Non- 
covalently bound protein was removed by three washing cycles, each 
consisting of 5-lOml O. 1M acetate buffer containing 1M NaCl, pH 4.0, 
and 5-lOml O. 1M borate buffer containing 1M NaCl, pH B. O. The gel was 
then washed thoroughly with PBS+l% azide to remove weakly bound or 
adsorbed immunoglobulin. The gel was stored at 4°C in PBS/azide. 
Cn-Br sepharose coupled to IgG, and to IgM myeloma proteins were 
supplied by Dr M. K. Brenner. 
ii) Iodination of coupled anti-immunoglobulins 
The method bescribed by Brenner (1981) was used. Columns were 
prepared by removing the end of a 40oµ1 microfuge tube, plugging with 
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glass fibre and packing with 100µl swollen Sephadex G25. On to this 
was layered 20µl Sepharose 4B-coupled Ig (G, M or A). The columns 
were washed thoroughly to remove the azide. Rabbit anti-human IgA 
(a-chains and secretory component), -IgG ()am-chains) or -IgM (p-chains ) 
(Dakopatts Immunoglobulins, Denmark) were spun (0.5m1) at 15000g for 
5mins and added to the columns. Unbound antiserum was removed by 
washing with 4m1 PBS. Antisera were iodinated using the chloramine-T 
method (Hunter and Greenwood, 1962). To the top of the column was 
added 10µl (1mCi) of 
1251 labelled sodium iodide in carrier free 
medium quickly followed by 15µl freshly made chloramine-T (1.33mg/ml 
in O. 05M phosphate buffer pH 7.5). The top third of the column was 
mixed using a hypodermic needle and after 30 seconds the reaction was 
terminated by adding 25µ1 sodium metabisuiphite (4mg/mi in 0.05M 
phosphate buffer pH 7.5) and remixing the top third of the column. 
Unbound 125 I was removed by thorough washing with PBS. Radiolabelled 
antibody was eluted with 6 drops glycine buffer, pH 2.3. The first 
drop was discarded, and the next 5 drops were collected into serum 
tubes containing 120µl 0.3M borate buffer, pH 6.8 containing 1% BSA. 
The two most radioactive fractions were pooled (usually 2 and 3), 
mixed with an equal volume of glycerol and stored at -200C. 
3) Solid phase Radioi. mmunoassay method (RIA) 
i) Basic technique 
The technique of Brenner and Munro (1981) was used. For measurement 
of specific antibodies, flexible microtitre trays (Linbro, Scotland) 
were coated for ihr at RT with 20µl/well of TT (1 Lfu/ml) or the 
E. coLt 10' LPS antigen diluted 1/10 in PBS. For measurement of total 
immunoglobulins 2Oµ1 of rabbit anti-IgG (1/500), -IgM (1/750) or -IgA 
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(1/500) were substituted. The results of preliminary titrations to 
determine the optimal concentration of tetanus toxoid and E. coLt 
antigen are shown in Figures 2-3 and 2-4. A titre was supplied 
with the anti-immunoglobulins and the appropriateness of this dilution 
for coating the plates was checked, as shown for anti-IgG in Figure 2 
- 5. Coated trays were washed 6 times with PBS and remaining sites 
were blocked with PBS containing 0.2% gelatin (Oxoid), 0.2% BSA and 
0.1% sodium azide for 2-12hrs at RT (see below). After further 
washing, 20µl of serial dilutions (see relevant Chapter for dilutions 
used) of control sera, test sera, secretions or cell culture 
supernatants in blocking buffer were added. Plates were incubated 
overnight at RT, washed 6 times and to each well was added 20µl of 
125i labelled rabbit anti-human IgG, -IgM, or -IgA diluted in blocking 
buffer to give approximately 10Oc. p. s. After 2hrs at RT trays were 
washed, dried, cut up and counted in a Gamma counter (NEC 1600, 
Nuclear Enterprises, Edinburgh) for 60 seconds. 
ii) Standardisation of RIA 
Duplicate rows of the standard sera described above were included in 
each test. Two control normal adult sera were also included in each 
assay to check the reproducibility of the technique. These sera had 
also been standardised for total immunoglobulins by nephelometry. The 
reproducibility was calculated from log-transformed data as follows: - 
Reproducibilty - 97.5% C. L. - 2.5% C. L. . 
X 100 
Geometric mean 
where C. L. refers to the confidence limits of the sample. The 
results are shown in Table 2-1. 
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Figure 2-3 
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Pigure 2-5 
Titration of anti-IgG serum for RIA 
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TABLE 2-1 
PERCENTAGE REPRODUCIBILITY OF RIA 
IIMMUNOGLOBULIN 
GMA 
TOTAL Ig 66 44 38 
ANTI-RT 26 32 60 
ANTI-E. a LI 22 27 34 
The poor reproducibility for total IgG levels in serum is discussed 
futher in Chapter 6. 
a) Specificity of anti-immunoglobulins 
The specificity of the anti-immunoglobulins was checked against the 
monoclonal IgG, IgM myeloma and purified colostral IgA (Figure 2- 6). 
The IgA preparation was only 85% pure, and some of the 15% impurities 
were undoubtedly IgG. This is reflected in Figure 2-6. The 
specificity of the system for each immunoglobulin is summarised in 
Table 2-2, and this indicates between 700 to 4000-fold greater 
specificity for the relevant immunoglobulin. 
b) Non-specific binding controls 
Control rows with no antigen were included for each sample and these 
values, representing non-specific binding, were subtracted from the 
test values. For a few infant sera, a high non-specific binding of 
1gM occurred. In order to overcome this problem, experiments were 
conducted with different blocking buffers. 
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Figure 2-6. Specificity of anti-Ig sera for monoclonal IgG, IgM 
myelcma and colostral IgA preparations. 
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TABLE 2-2 
SPECIFICITY OF ANTI-Ig SERA FOR DETECTING RELEVANT Ig ISOTYPE 
ANTISERUM 
ANTI-19G ANTI-IgM ANTI-IgA 
Ig 
IgG* (monoclonal) 6000**(100) 
IgM (myeloma) 8.6 (0.13) 
IgA (colostral) 32 (0.5) 
c20 (c0.3) 
6000 (100) 
c5 ( cO. 1) 
0 (c0.05) 
1.5 (0.025) 
6000 (100) 
* Ig preparations were diluted to contain 6000ng/ml of the 
designated isotype 
** Figures are expressed as ng/ml with % specificity in parenthesis 
NB sIgA preparation was only estimated to be 65% pure 
There was a possibility that anti-BSA antibodies were present in the 
sera of infants being fed cow milk proteins. This protein was removed 
from the blocking buffer and either an extra 0.3% gelatin, or 0.2% 
globulin-free human serum albumin (Sigma) substituted. Another 
experiment was set up with a blocking buffer containing 5% normal 
sheep serum in PBS. None of these modifications made any difference 
to the non-specific binding of these sera, and results were therefore 
calculated after the subtraction of the high background values. 
c) Negative controls 
Controls with antigen but no sample were included to determine the 
non-specific binding of the iodinated anti-itmnunoglobulins. 
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CHAPTER 3 
FAMILIES AND INFANTS 
In order to compare the development of immune function in two 
groups of infants being fed either breast milk or cow milk based 
formula, it was important that the two groups were matched for all 
other aspects which might influence immunological development. 
Previous studies on the impunity of breast- and bottle-fed infants 
which investigated infection rates in the two groups showed that 
factors associated with an increased risk of infection were those 
related to the family situation; poor parental education, employment 
status, lower maternal age, higher number of siblings, overcrowding 
and poor hygiene in the home, as well as low infant birth weight and 
poor infant care (Robinson, 1951; Cunningham, 1979; Pullan st al., 
1980). In an attempt to match the two groups as closely as possible 
for these factors which might therefore be considered to affect immune 
function, details of the family situation were recorded for all 
infants, together with information about intercurrent infections. 
SECTION A- ANALYSIS OF QUESTIONNAIRES 
1) Family History 
Information about family history, maternal age, pregnancy and 
birth details are shown in Table 3-1. A detailed family medical 
history was taken for each infant. There were no families with any 
history of immunodeficiency or problems with severe infections. Note 
was also taken of any history of allergy in first or second degree 
relatives of the infant. Allergies reported in Table 3-1 include 
pollen (hayfever), foods and drugs. Eczema and asthma were also 
co 
included as allergies although their allergic basis was often 
unconfirmed. In the group of infants being breast-fed, there were 5 
cases of allergy in lot degree relatives and 3 in 2nd degree 
relatives. In the bottle- fed group there were 4 cases in lot degree 
relatives, with a possible 5th case (query eczema in an older sibling) 
and one case in a 2nd degree relative. 
2) Maternal Age 
Maternal age ranged from 20-37 years, with the an maternal age 
(+SD) at delivery being 31.3 (4.35) for the breast-feeding group and 
27.3 (4.3) for the bottle-feeding group. This 4 year difference in 
ages was significant (P-0.019) pooled t-test), and was associated 
with a higher number of previous children (see Section 5, Table 3 
4) in the breast-feeding group. 
3) Social Class and Socioeconomic Groups 
Paternal occupations were used to assess social class and 
socioeconomic groupings according to the Government Classification of 
Occupations (1980) and these are shown in Table 3-1. The 
distribution according to feeding groups is shown in Table 3-2. 
Most breast-feeding families were Social Class II (13/15) and most 
bottle-feeding families were Social Class III (9/15). This difference 
in Social Class distribution was statistically significant 
(chi-squared 14.17, P<O. 01). There was also a significant s 
difference (P < 0.05) in the socioeconomic groupings of the families, 
with a predominance of breast-feeding families (8/15) in Group 5 and 
bottle-feeding families (6/15) in Group 9. 
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TABLE 3-1 
FAMILY DETAILS 
INFANT FAMILY MATERNAL PATERNAL OCCUPATION SOCIAL SOCIOECONOMIC 
NUMBER ALLERGY AGE(YRS) CLASS GROUP 
BREAST-FED 
02 Al* 
03 Al 
22 
35 
25 
34 
29 
33 
37 
34 
33 
34 
29 
34 
29 
35 
26 
COMPUTER PROGRAMMER II 
MARKETING MANAGER II 
ACCOUNTANT Zr 
TEACHER II 
TRANSPORT MANAGER II 
VIDEOTAPE EDITOR II 
LABOURER V 
CIVIL SERVANT II 
INSURANCE BROKER II 
ANTIQUE DEALER II 
LIBRARIAN II 
SURVEYOR II 
TV MANAGEMENT II 
MECHANICAL ENGINEER III 
RETAILER II 
5 
2 
5 
5 
2 
5 
11 
5 
5 
2 
5 
5 
1 
10 
2 
05 
06 
07 
08 Al 
09 
10 
11 A2 
12 A2 
14 Al 
17 
is A2 
27 
31 Al 
MEAN( sn ) 
BOTTLE-FED 
01 - 
04 Al 
13 
15 
16 
19 
20 
22 Al 
23 
24 A2 
25 ? Al 
26 
28 
29 Al 
30 Al 
MEAN( sn ) 
31.3(4.35) 
20 
34 
30 
30 
29 
28 
31 
22 
23 
34 
24 
28 
23 
29 
25 
SERVICE ENGINEER III 
MEDICAL GAS SUPPLIER III 
MOTORMAN III 
FIREMAN III 
LECTURER Zr 
SERVICE ENGINEER III 
POSTAL WORKER IV 
ROOFING CONTRACTOR IV 
FOREMAN LAND. TRANSP. III 
MILKMAN III 
INSOLVANCY OFFICER III 
MANAGEMENT ACCOUNTANT II 
PLUMBER III 
BROADCASTING ENGINEER II 
SURVEYOR II 
9 
9 
9 
6 
5 
9 
10 
2 
8 
9 
6 
5 
9 
4 
2 
27.3(4.3) 
* Al - Allergy in lot degree relatives of infants 
A2 - Allergy in 2nd degree relatives of children 
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TABr, £3-2 
RELATIONSHIP BETWEEN FEEDING G1)UP AND SOCIAL STATUS 
SOCIAL CLASS 
I II III IV V 
BREAST- 0 13 1O1 
BOTTLE- 0492O 
CHISQOARED = 14.17 DF s3P<0.01 
SOCIOECONOMIC GROUPS 
1245689 10 11 
BREAST- 140800011 
BOZTLE- 011321610 
CHISQUARED a 16.08 DF -8 P< 0.05 
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4) Pregnancies and Births 
All pregnancies progressed normally without any significant 
medical problems, except for the mother of infant 02 who required 
Ventolin therapy following an asthmatic attack during the 4th month of 
pregnancy. Details of births are shown in Table 3-3. The infants 
were born between August 1981 and July 1982. All births occurred 
between the 38th and 41st weeks of pregnancy. The mean gestation 
times were 40.4 and 39.8 weeks for the breast- and bottle-feeding 
groups respectively. There were no major birth problems= 5 
deliveries required the use of forceps (3Br, 2Bo),. 3 were induced 
(2Br, lBo), and 2 infants were delivered by caesarian section 
(lBr, lBo). Birth weights ranged from 2.5 to 4.3kg with the means for 
the breast- and bottle-fed groups being 3.37 and 3.40kg respectively. 
There were 17 female (9Br, SBo) and 13 male (6Br, 7Bo) infants. 
5) Siblings 
The number of older siblings per family, their ages at the time 
of the birth of the infants being studied, and their feeding group are 
shown in Table 3-4. The distribution of siblings according to 
feeding group and family size is summarised in Table 3-S. 
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TABLE 3-3 
BIRTH DETAILS 
BREAST-FED GROUP BOTTLE-FED GROUP 
INF. GESTATION BIRTH BIRTH 
No. TIME(WKS) * WEIGHT SEX 
(KG) 
INF. GESTATION BIRTH BIRTH 
No. TIME(WKS) WEIGHT SEX 
02 41 I, F 3.46 F 
03 40 N 3.91 F 
05 40 N 3.18 F 
06 40 N 3.1 M 
07 40 F 3.91 M 
08 40 N 3.63 M 
09 40 N 3.55 M 
10 41 N 4.0 F 
11 40 CS 3.2 F 
12 41 N 2.94 M 
14 41 N 3.18 F 
01 40 N 3.25 N 
04 40 F 4.14 N 
13 41 I 3.62 N 
15 40 N 4.32 F 
16 39 N 3.06 N 
19 38 N 3.21 F 
20 41 N 3.2 N 
22 40 F 2.77 F 
23 40 N 3.38 M 
24 39 CS 3.62 F 
25 41 N 3.63 N 
17 42 I 3.54 F 26 38 N 3.29 F 
1B 40 N 3.2 M 28 41 N 3.92 F 
27 39.5 F 3.23 F 29 40 N 2.95 F 
31 40 N 2.5 F 
MEAN 40.4 3.37 
30 39.5 N 2.68 F 
39.8 3.40 
*i Induced 
P+ Forceps delivery 
N= Normal vaginal delivery 
CS - Caesarian section 
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NO. SIBLING SIBLING 
SIBS AGES FOOD 
SIBLING AND FEEDING DETAILS 
INF. 
No. 
OZ 
03 
05 
06 
07 
OB 
09 
10 
11 
12 
14 
17 
18 
27 
31 
MEAN 
01 
04 
13 
15 
16 
19 
20 
22 
23 
24 
25 
26 
28 
29 
30 
MEAN 
1 ly 6m Br 4t 
1 ly 4m Br 8 
2 2y llm Bo 
ly lOm Br 7 
0-- 
1 ly 5m Br 8 
2 4y loin Br 8 
2y 7m Br 11 
3 15y 3m Br 1 
14y 3m Bo 
ly 2m Br 3 
2y 3m Br 8 
1 ly 9m Br 6 
2 4y 4m Br 8 
2y 4m Br 7 
1 ly llm Br 9 
0-- 
1 3y 2m Br 10 
1 2y llm Br ? 
1 2y em Br 2 
i 
ý i 
1.2 3y 3m 
i 
TABLE 3-4 
INITIAL FORMULA SOLIDS PAST. BREAST 
FOOD ADDED ADDED COW MILK MILK 
INTRODUCED STOPPED 
Br 1.5 562 
Br -37.5 7.5 
Br -588 
Br -33 >9 
Br -3? 7.5 
Br - 3* >9 >9 
Br 133 1.5 
Br 44 >9 >9 
Br 33 >9 >9 
Br -4? 7 
Br -46 )9 
Br -48.5 8.5 
Br -48.5 8.5 
Br -46.5 3.9 
Br 1552 
3.8 7.1 
o--j SMA -28 
1 6y 2m Bo SMA -46 
1 4y 4m Br 0.2 SMA - 2.5 7 
1 4y 7m Br1.5SMA -46 
1 2y 8m Bo SMA 0.2** 49 
2 4y lm Br 7.5 SMA -? 5 
2y 9m Br 6.5 
0--( SMA - 3.5 7 
0-- SMA -4 >9 
0-- SMA -28 
1 2y 7m Br 0.2 SMA 2.5 3 5.5 
2 5y lOm Bo SMA 0.2 36 
3y 5m Bo 
0-- SMA -27 
1 3y 8m So SMA -26 
0-- SMA 125 
1 3y 5m Bo SMA -45 
0.7 3y llm 3.06 7.2 
Br - Breast milk 
Bo - Cow milk formula 
St+Qi, - S) Gold Cap, cow milk based formula 
t Figures for times are in months 
* Infant was on an allergen-free diet, see text for details 
** Age (months) formula changed from SMA to ostermilk Complete Formula 
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TABLE 3-5 
RELATIONSHIP BETWEEN FEEDING GROUP AND NUMBER OF SIBLINGS 
NUMBER OF SIBLINGS 
O123 ALL 
BREAST-FED 2931 15 
BOTTLE-FED 6720 15 
ALL 8 16 51 30 
CAI-SQUARED - 3.45 DF e3P-O. 3 
Fewer breast-fed infants had no siblings (2 Br, 6 Bo) and the 
mean number of siblings per family in the remaining families was 
higher (1.4 Br, 1.1 Bo). This resulted in an overall mean number of 
siblings per family of 1.2 in the breast-fed group and 0.7 in the 
bottle-fed group. This difference was not significant (Chi-squared - 
3.45, PT0.30). At the time of birth of the infants under study, 
sibling ages were younger in the breast-fed group. The mean age for 
the breast-fed group was Syr 3mth (2yr 5mth excluding the 14 and 15 
year old children in family 09) compared with 3yr llmth in the 
bottle-fed group. In the breast-feeding group, the length of time the 
mother had breast-fed a previous infant was a good indication of the 
likelihood of prolonged breast- feeding in the infants under study. 
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6) Feeding regimes 
Details of infant feeding are shown in Table 3-4. 
a) Breast-fed infants 
All infants in this group were exclusively breast-fed at the time of 
the first sample (6-7 days). Three infants (02,09,31) were weaned 
from the breast early (1.5-2 months )and cow milk formulae were 
introduced as early as 1 month. These infants were analysed 
separately where appropriate. The other 12 infants were breast-fed 
until at least 7 months, with 6 infants still receiving breast milk at 
the end of the 9 month study period. Solids were included fron 3 
months (mean 3.8m) and this usually involved the introduction of cow 
milk proteins as a diluent for cereals. 
b) Bottle-fed infants 
All infants were fed at NPH with SMA Gold Cap cow milk based formula 
from birth. Four infants (16,24,25,29) were later changed to 
Ostermilk Complete Formula and one infant (24) also received Cow and 
Gate formula (see Appendix for Formulae details). Solids were 
included in the diet from 2 months (mean 3.1m) which was slightly 
earlier than the breast-fed group (mean 3. ft). 
7) Intercurrent Infections 
Details of intercurrent infections and their treatment are shown 
in Table 3-6. Infections were recorded by the mothers, and where 
they were insufficiently serious to require medical attention no 
further verification was made. No attempts were made to isolate or 
identify infectious agents so many of the recorded episodes may not 
have had an infectious aetiology. This is particularly likely for the 
88 
INFj URTI 
No. NO. 
IAGE 
BREAST-FED 
02 
03 
05 
TREATED 
1 AB!! 
5 
2.5 - 
4.5 ERYTHRO 
5 OTRIVINE 
8 CALPOL/ 
8.5 ACTIPED 
99. 
0.5 - 
1 ERYTHRO 
2-3 (CROUP) 
5.5 LINCTUS 
06 
07 1.5 ERYTHFbO ! 
3 FLDXAPEN 
08 
09 
10 
11 
4.5 OTRIVINE 
1 
7- 
i- 
3.5 - 
5 CALPOL 
1- 
2- 
3.5 - 
8- 
TABLE 3-6 
INFECTIONS AND ALLERGIES 
DIARRHOEA I OTHER 
NO. AGE TREATED NO.! AGE 
ECZEMA 
INFECTION TREATED 
0 
0 
1 1* ERYTHRO 10 
0 
15 OTITIS 
AGE 
0 
10 
4 1.5 OTITISI ERYTHRO 0 
3 OTITIS1 FLOXAPEN 
6 C. POX - 
8.5 VIRUS? ** - 
1-7 
1 7* -1O i0 
0? 8 MEASLES? v-GLOB. 0 
1 
0I0 i 
12 53-24 
5.5 - 9* 
7- 
e- 
9- 
?1 PERTUSSISt ERYTHRO 0 
i 
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TABLE 3-6 continued 
BREAST-FED contd. 
14 
17 
is 
27 
31 
3- 
4 AMP 
9 .. 
3- 
5.5 
0.5 EPHEDRINE 
1- 
1.5 EPHEDRINE 
3'' 
4 
6 AMP 
1 EPHEDRINE 
3- 
7- 
9 PEN 
1.5 - 
2- 
3- 
5 ERYTHRO 
8.5 - 
10 
0 
7 PERTUSSIS ERYTMI 
2 1.5 VOMITING OBS. NPH 
5 ROSEOLA - 
0 
0 
4 
V. R. $ 
0 
0 
TOTAL 49 692 
MEAN 3.3 
BOTTLE-FED 
01 
04 
13 
15 
1ý 
31 ANOXYL 
5- 
9 ANOXYL 
31 
3 
5 
0 
0 
1 3* 
0 
18 VIRAL ERYTRRO 
o il 
ý 
i 
ý ý , i 
ý 
0 
1 4.5 - 
0 
16 12 1 PEN 113 
8 
1 0-1.5 ST. EYE CHLOR. CR 
0 
0 
0 
0 
10 
1 
ý ý 
ý3 ý 
0 
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BOTTLE-FED contd. 
19 2 5.5 - 
7 AMUXYL 
20 
122 8 
22 3 0.7 ERYTHRO 
8- 
9- 
23 10 
24 34 AMP 
6.5 N 
8.5 ERYTHRO 
25 5 0.7 LINC. 'TUS 
4.5 - 
6- 
7.5 - 
9- 
26 f0 
28 14 6-10 - 
29 3 2.5 - 
3.5 - 
9 ACTIFED 
30 3 2.5 - 
6 AMP 
9- 
TABLE 3-6 continued 
0 23 ? C. POX - 
5 ? RUBELLA 
0 
0 
1 3* PEN 
5 
1 FORM. Cfi. 
5.5 - 
9- 
10 - 
TOTAL 34 7 
MEAN 2.3 
0 i0 
2 0.7 ST. EYE GENT. DR' 1 
3 OTITIS PEN 
0 
0 
io 
3 COXSACCtE - MPH 
TO 
3 VACC. R. 
5 01 
II Antibiotic, type not known 
* Diarrhoea concurrent with URTI 
% Vaccine reaction 
** Concurrent with viral meningitis in father 
I URTI and Otitis media concurrently 
t Contact only 
0 
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episodes of diarrhoea. 
a) Upper Respiratory Tract Infections (URTI) 
The most common infection recorded was of the upper respiratory tract 
(URTI) and several children suffered recurrent infections. The 
distribution of the number of URTI episodes per infant according to 
feeding group are shown in Table 3-7. 
TABLE 3-7 
RELATIONSHIP BETWEEN FEEDING GROUP AND NUMBER OF 
UPPER RESPIRATORY TRACT INFECTIONS 
NUI4BER OF INFECTIONS 
0123456 ALL 
BREAST-FED 1141422 15 
BOTTLE-FED 3136110 15 
ALL 4277532 30 
CHI-SQUARED a 8.85 DF a6P-O. 2 
Eight breast-fed and 2 bottle-fed infants "suffered 4 or more 
episodes of URTI during the study period. The mean number of URTI for 
breast-fed infants was 3.3 episodes/child and for the bottle-fed 
infants 2.3 per child. This higher number in breast-fed infants was 
not significant (chi-squared - 8.85, Pr0.22) but was correlated with 
greater numbers of siblings in this group (chi-squared - 30.67, 
P-0.031). For infants with no siblings, there were 5/8 infections and 
for those with siblings there were 21/22. Examination of the age of 
infants at the onset of their first URTI gave a mean age of 1.8 months 
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for the breast-fed group and 2.8 months for the bottle-fed group. The 
breast- fed infants therefore not only had more infections, but 
contracted them earlier. There were a total of 19 recorded URTI 
episodes which occurred in breast-fed infants before the introduction 
of any dietary supplements, i. e. while infants were being exclusively 
breast-fed. 
b) Gastrointestinal Tract Infections 
Episodes of diarrhoea were infrequent; there were a total of 6 
episodes in the breast-fed group and 7 in the bottle-fed group. Four 
of these were associated with a change of diet (introduction of solids 
or change of milk) and were thought not to be caused by infectious 
agents. Six of the episodes occurred at the same time as an URTI or 
otitis media, and 2 (infants 30 and 31) were diagnosed as having viral 
gastroenteritis contracted from a common source. 
c) Other Infections 
Other infections (9 Br, 7 Bo) are listed in Table 3-6. All of these 
infections were considered by the mother to be sufficiently serious to 
require medical attention, and the infants were seen either by a 
general physician or an NPH paediatrician. Two breast-fed infants 
(10,12) received prophylactic treatment following contact, one for 
whooping cough and the other for measles. 
8) Allergies 
Three bottle-fed infants had mild eczema (Table 3- 6), 
associated in two of these cases with a history of eczema in one of 
the parents. One breast-fed infant (08) had moderately severe eczema. 
This family had a history. of allergy in an older sibling, and the 
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infant studied was also recruited to a study on allergy at the central 
Middlesex Hospital. He was found to be allergic to cow milk, eggs, 
gluten and citrus fruits. Both he and his mother were placed on an 
exclusion diet from 7 months of age, which resulted in a considerable 
improvement in his symptoms. 
9) Vaccination Schedules 
The recommended vaccination protocol was 3,5 and 9 months, but 
because the vaccinations were administered by general physicians or 
various 'Well-Baby' Clinics, and because of a general policy not to 
administer vaccinations while the infants were ill, there was 
considerable variation in the timing of doses and also in the number 
of doses received by 9 months (Table 3- 8). Most infants received 
triple vaccine (Diphtheria, Tetanus and Pertussis) containing 60 I. U. 
tetanus toxoid/dose. Four infants (02,11 Bra 25,28 Bo) received DT 
vaccine (Diphtheria and Tetanus with no Pertussis), infant 10 received 
only half-dose pertussis with his first dose, and infant 20 had the 
pertussis component in his first but not second dose. Infant 30 
reacted to both doses of triple vaccine with prolonged screaming and 
fever and it was recommended that the pertussis component be excluded 
from the third dose. One infant (12) did not receive any vaccinations 
during the study period. The average times for the first and second 
doses of vaccine were 4.15m and 6.75m for the breast-fed infants and 
3.75m and 6.10m for the bottle-fed infants. Because more of the 
bottle-fed infants (eight) had received their second dose before 6m 
than breast-fed infants (three), direct comparison of specific anti-TT 
responses between the groups could not be made. The infants were 
therefore allocated to the following vaccine groups according to their 
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vaccination schedule and each group analysed separately for the 
response to tetanus toxoid vaccine (see Chapter 6). 
Vaccine group Vaccine given 
I1 dose only 
II 1 dose 3-6 months, 2nd dose 6-9 months 
III 2 doses between 3 and 6 months 
IV 2 doses between 6 and 9 months 
V3 doses between 3 and 9 months 
Oral polio vaccine was usually given at the same time as the 
triple vaccine, but infants 05 and 31 were immunised at other times. 
Infants 10,04 and 22 also received BCG inoculations during the study, 
the latter because she was a suspected tuberculosis contact. 
SECTION B- GENERAL HAEMATOLOGY 
1) Total Cell Numbers 
Table 3-9 shows the total white blood cell (WBC) counts on 
heparinised blood from breast- and bottle-fed infants respectively. 
The means (±SD) are plotted in Fig. 3 - 1. There were no significant 
differences between the WBC counts of breast- or bottle-fed infants on 
any sample occasion. WBC counts ranged from 6.7 - 19.9 x 103/ml at 6 
days (mean 12.3 x 103) and then fell to 6.1 - 11.9 x 103 (mean 9.8 x 
20 
3) 
by 6 weeks. These values were comparable to those found in normal 
infants by other workers (Dallman, 1977; as shown in Table 3- 9). 
Fig. 3 -1 shows a large increase in the mean WBC count in breast-fed 
infants at 6 months. The difference between the two feeding groups 
was not significant, (P-0.053). Examination of the data on individual 
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infants shown in Table 3-9, indicated that 5 infants had very high 
counts (). 13 x 103) at that time. Comparison of the WBC count with the 
health of the infant shown in Table 3-6 showed that all infants with 
high WBC counts had suffered an infectious episode within 10 days of 
sample collection (or immediately after, infant 07). Examination of 
other infants 6 weeks or older with WBC counts >13 x 103 (Table 3- 
10) showed that 12/15 samples were collected within 3 weeks of a 
documented infection. However there were also many samples from 
infants with current or recent infections who had WBC counts below the 
mean values. 
2) Differential WBC Numbers 
Percentages of neutrophils, lymphocytes, monocytes and 
eosinophils were also measured (Table 3- 11), and the means of 
neutrophil and lymphocyte numbers are plotted in Fig 3-2. The 
percentage of lymphocytes present rose from 50 to 70% by 6 weeks and 
fell to 65% between 6-9 months. Polymorphonuclear cells fell 
correspondingly from 35 to 20% and rose to 25% by 9 months. lsonocyte 
numbers were low, 5-10%, and eosinophils constituted only 1-3% of the 
WBC. These numbers are within the normal range, as shown in Table 3- 
11 and there were no significant differences between the two feeding 
groups. Infant 08 had a high eosinophil count at 9 months (24%), this 
infant suffered from food allergies. Curiously, the eosinophil 
numbers were low while the eczema symptoms were at their worst (up to 
7 months). 
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Figure 3-1 
White blood cell numbers in infant blood 
r 0 
1 T 6 
1 
9 
Age (months) 
Figure 3-2 
Percentages of lymphocytes and neutrophils in infant blood 
ýý 
0369 
Age (months) 
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TABLE 3- 10 
INFANT AGE WBC % INFECTION 
NUMBER (MTHS) X103 LYMPHS 
RELATIONSHIP OF HIGH WBC NUMBERS TO RECENT INFECTIONS 
TIME OF INFECTION 
RELATIVE TO SAMPLE 
BREAST-FED 
02 
05 
07 
11 
17 
18 
6 14.6 79 URTI 
9 17.9 62 NO INF. RECORDED 
6 17.8 40 URTI 
6 17.8 68 CHICKEN POX 
9 13.9 44 URTI 
3 13.2 72 URTI 4 DIARRHOEA 
6 15.9 76 URTI 
9 15.9 69 VIRAL INFECTION 
3 15.1 64 URTI 
6 13.1 61 URTI 
1 WEEK PREY. 
I WEEK PREY. 
3 DAYS LATER 
1 WEEK PREV. 
10 DAYS PREY. 
10 DAYS PREV. 
3 WEEKS PREY. 
7-10 DAYS PREY. 
10 DAYS PREY. 
Hc7ITLE-FED 
04 
13 
23 
24 
3 15.0 66 NO INF PREV 2 NTH 
6 13.5 72 URTI 
3 13.2 68 MILD URTI 
6 13.3 70 NO INF RECORDED 
9 15.5 61 URTI 
3 WEEKS PREY. 
1 WEEK PREY. 
1 WEEK PREY. 
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TABLE 3- 11 
TOTAL LEUCOCYTE NUMBERS 
1 WEEK 6 WEEKS 3 ! l3NTHS 6 NDNTHS 9 PWNTHS 
NEfTP'itOPHIIS( $) 
BREAST-FED 32.6 21.3 21.1 24.1 23.4 
(±SD) (20-45) (15-28) (13-29) (13-35) (12-34) 
BOTTLE-FED 37.4 19.0 22.5 18.1 24.4 
(27-48) (13-25) (17-28) (12-24) (18-31) 
NORI4AL* 45 35 32 
LYMPHOCYTES($) 
BREAST-FED 53.7 67.8 72.1 69.9 7.6 
(38-70) (60-76) (63-81) (58-82) (55-80) 
BOTTLE-FED 50.4 71.1 67.8 72.5 66.7 
(40-60) (62-80) (62-74) (65-80) (59-74) 
NORMAL 41 56 61 
MONOCYTES($) 
BREAST-FED 10.8 9.0 5.2 4.7 5.4 
(4-18) (3-15) (2-9) (2-7) (2-8) 
BOTTLE-FED 9.4 7.2 7.2 6.9 7.1 
(6-13) (1-13) (3-11) (3-11) (3-11) 
NORMAL 975 
DOSINOPHIIS($) 
BREAST--FED 321.5 1 3.6 
(1-5) (0-3) (0-3) (0-3) (0-10) 
BOTTLE-FED 322.5 2.5 2 
(1-5) (0-4) (0-5) (0-5) (0-4) 
NORMAL 433 
* Figures from Dal]. ma n, PR. In Paediatrics, 16th Edn. 
Rudolph, Am. (ed) New York Appleton-Century-Crofts inc. 1977 
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TABLE 3- 12 
MATERNAL 
AGE 
(YEARS) 
SUMMARY OF ANALYSIS OF QUESTIONNAIRES 
% SOCIAL 
CLASS 
NO. 
SIBS 
INFECTIONS (MEAN/INFANT) 
URTI DIARRHOEA OTHER 
ECZEMA 
ZnTAL) 
uII III&IV 
BREAST 31.3 
HOZTLE 27.3 
P= 
87 13 
27 73 
1.2 
0.7 
3.3 0.4 0.6 
2.3 0.47 0.47 
1 
3 
0.019 c0.01 0.43 0.22 
ýý 
correlation 
Pa0.053 0.031 
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SECTION C- DISCUSSION 
1) Family Differences Between Feeding Groups 
Analysis of the questionnaires has shown a number of differences 
between the families of the two groups of infants, summarised in Table 
3- 12. First, the mean maternal age was 4 years higher in the 
breast-feeding group, second the number of siblings was greater in 
this group and third, there were more families in the higher Social 
Classes in the breast-fed group than the bottle-fed group. These 
differences were in part due to a sampling problem. The enthusiasm of 
the NCT counsellors meant that there was no shortage of pregnant 
ladies intending to breast-feed who were keen to be involved in the 
study. However, because of the strong encouragement at NPH for all, 
mothers to try to breast-feed, (80-90% attempt breast-feeding), it was 
fairly difficult to match the breast-fed infants with completely 
bottle-fed infants born around the same time, from families of similar 
size, age, etc. The general trend of mothers in the higher Social 
Classes to breast-feed and those in the lower Social Classes to bottle 
feed their infants, increased this selection problem. 
Are these family differences important? Certainly in studies 
with much larger sample sizes, favourable family situations (including 
higher maternal age and Social Class) have been related to lower 
infection rates (see Chapter 1). In this relatively small study 
however, the URTI rate was higher in the supposedly more favourable 
group (although this difference was not significant). One reason for 
this may be that the older age of the mothers in the breast-feeding 
group was associated with more siblings in this group. The 
association of feeding group with sibling number was not significant 
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but this higher number of siblings undoubtedly resulted in a higher 
exposure rate of the infants to infectious agents brought home from 
playgroups etc. and sibling number was significantly correlated with 
the incidence of URTI's. The infants remaining free from infections 
tended to be those without siblings and there were only two such 
infants in the breast-fed group. Other studies have also shown a 
correlation between sibling number and infection rates (Pullan at at, 
1980= Holmes, Hassanein and Miller , 1983). 
2) Role of Social Factors in Infection Rates 
The relationship between other family factors and infection rates 
in breast- and bottle-fed infants has been investigated by a number of 
workers (Cunningham, 1979; Watkins, Leeder and Corkhill, 1979k 
Pullan st aL, 1980; Bloom, Goldbloom and Stevens, 1982; Taylor et 
aL, 1982; Holmes, Hassanein and Miller, 1983). 
A criticism often levelled at breast- versus bottle-feeding 
studies is that it is mainly Social Classes I and II that breast-feed 
and Social Classes III and IV that bottle-feed, and therefore other 
factors unrelated to the method of feeding could affect any observed 
differences in infant health. Although the families in this study 
certainly tended to support this observation, many of the 
bottle-feeding mothers whose husband's occupation classified the 
family as Social Class III, had themselves either recently given up or 
were intending to continue with jobs such as nursing and teaching 
which are classified as Social class II. It is therefore questionable 
whether classifications which take no account of the education or 
employment of the mother (who for the purposes of this study must be 
more important than the father) have much value in assessing the home 
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environment of the infants. A more valuable assessment may have been 
to attempt to assess maternal care and home environment as has been 
done on more extensive studies on lower respiratory infections (Pullan 
at aL, 1980). These studies have shown an association between 
maternal education, home environment and maternal care with infection 
rates. Breast-feeding is usually associated with the more favourable 
family situations but even when these factors are corrected for, a 
benefit of breast-feeding in lowering infection rates can still be 
seen (Watkins at al, 1979). 
To assess home environment in this study would have involved 
considerable cooperation from health visitors and was felt unnecessary 
for this relatively small study on immunological aspects of the 
infants. All homes were visited during the study, and home 
environments were considered 'satisfactory to good' in all families. 
The extensive involvement of the mothers and infants required for the 
study tended to select families who were enthusiastic and interested 
in the health and well-being of their infants, and maternal care was 
considered uniformly good, regardless of the method of feeding. 
3) Breast-feeding Does Not Fully Protect the Infant 
i) Infections 
The number of infants in this study was too small to make any general 
comments on infection rates in breast- and bottle-fed infants, and the 
strong correlation of sibling number with upper respiratory infections 
may have masked any beneficial effects of breast-feeding. However the 
fact that there were 19 URTI episodes which occurred in exclusively 
breast-fed infants indicates that these infants were not being fully 
protected by breast milk, an observation made in other studies (Pullan 
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at aL, 1980). 
Although other infections during the study were infrequent, once 
again breast milk was not fully protective, as infection rates were no 
lower in breast-fed infants. This was true even for episodes of 
diarrhoea. 
ii) Allergies 
It is also impossible to comment generally on the relative frequency 
of allergies in such a small study. It is clear, however, that 
allergens can be transferred to the infant via breast milk, causing 
problems in atopic infants. This has been demonstrated by other 
workers for antigens such as cow milk proteins (Jacobsson and 
Lindberg, 1978). In addition, Allardyce and Wilson (1984) have shown 
that breast milk cells from atopic mothers secrete factors which 
stimulate cord blood lymphocytes to secrete IgE to vitro. These 
factors might also have an effect on allergic reactions in breast-fed 
infants. 
4) WBC counts and infections 
All infants had total WBC numbers within the normal ranges 
established by other workers. However, some infants showed a 
transient large increase in WBC numbers, usually associated with 
recent or current infections. The converse was not true as infections 
were not always associated with an increase in neutrophil or 
lymphocyte numbers. Other studies have also indicated that the WBC 
count in early infancy does not necessarily reflect the infective 
state of the infant (Rasmussen and Rasmussen, 1982). 
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SU)RY 
Breast-feeding was associated with significantly higher maternal 
age and social class than bottle-feeding, factors generally considered 
more favourable as far as infant care is concerned. However, there 
were also more older siblings in the breast-feeding group and there 
was a significant association between this higher sibling number and 
increased upper respiratory infections in the breast-fed infants, 
although these differences in sibling number and URTI rate between the 
groups were not significant. This increased exposure rate of the 
breast-fed infants may have masked any protective benefits due to 
breast-feeding. 
There were no significant differences between the feeding groups 
in family medical history, infant gestational age, birthweight, sex, 
total WBC numbers, leucocyte differential counts or infectious 
episodes. For the purposes of this study on the immunological 
benefits of breast-feeding therefore, these two groups were considered 
comparable, and any differences found in immune function between the 
groups could be attributed to feeding. 
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CHAPTER 4 
CELL PROLIFERATION IN VITRO 
SECTION A- INTRODUCTION 
Human milk contains several factors which can influence cell 
growth and function to uttro (see Chapter 1). These include 
lymphokines such as y--interferon, lymphocyte derived chemotactic 
factor (Keller at aL., 1981) and Prostaglandins E and F (Lucas and 
Mitchell, 1980; Blau at aL., 1983) together with growth promoting 
factors for epithelial cells such as epidermal growth factor 
(Carpenter, 1980). Whether these factors have a similar growth 
stimulating effect to vivo on cells of the breast-fed infant is not 
known. By studying infant mononuclear cell proliferation and function 
to vttro, it was hoped to determine whether these cells had been 
affected in any way by the constant intake of these factors in breast 
milk. 
When peripheral blood mononuclear cells (PBM) are cultured to 
vitro, a small number will proliferate spontaneously. The rate of 
proliferation can be measured by addition of 
3H-thymidine to the 
culture medium for a fixed time interval; the amount incorporated 
into the DNA is proportional to the rate of proliferation. A number 
of substances have been identified which, when added to these 
mononuclear cell cultures, stimulate further proliferation of a 
proportion of these cells. For this present study, a range of stimuli 
were chosen which were known to affect different populations of PBM 
cells (see Chapter 1). Phytohaemagglutinin (PHA) stimulates primarily 
T cells, pokeweed mitogen (PWM) acts on both T and B cells, whereas 
Stapb. aureus strain Cowan (SAC) is a polyclonal B cell activator. 
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When mitomycin-C treated allogeneic lymphocytes are added to the cell 
cultures, cells will proliferate in response to the foreign 
histocompatibility antigens. The responding cells are primarily T 
cells (Kuntz, Inns and Weksler, 1976) but are thought to be a 
separate population from those responding to PHA (Carr, Stites and 
Pudenberg, 1973). Antigens, when added to PBM cultures, will 
stimulate only a small number of lymphocytes, those which bear Ig 
receptors specific for that antigen. However, it should be noted that 
cells stimulated to proliferate by antigens (or other stimuli), may 
also be stimulated to secrete lymphokines, which may in turn act on 
other populations and so a proportion of the response will be 
polyclonal. 
The ability of cord blood lymphocytes (CBL) and infant peripheral 
blood lymphocytes (PBL) to respond to mitogens, allogeneic lymphocytes 
and antigens fn vitro has been investigated using various culture 
techniques (see Chapter 1 and Discussion, this Chapter). 
Conventionally, culture media for lymphocyte studies have included 
serum (either FCS or human AB) which enhances growth but is itself 
mitogenic, giving rise to high rates of 'spontaneous' proliferation. 
Different batches of serum vary in their growth supporting and 
mitogenic activity and this complicates any further studies on the 
responses of cells to various T and B cell mitogens, antigens or 
allogeneic lymphocytes. Additional proliferation, above background 
'spontaneous' proliferation, which is induced by these added stimuli, 
is frequently expressed as a ratio of stimulated to unstimulated 
proliferation. A serum-free medium has been developed by Iscove and 
Melchers (1978) which uses a modified Dulbecco's medium base with 
added supplements of lipid, transferrin and BSA. This medium supports 
109 
the growth of human lymphocytes to vitro and was used for all 
proliferation experiments in this study. The advantage is that the 
background stimulation is very low compared with serum-containing 
media, thus allowing the effects of mitogens and other stimuli to be 
more reliably interpreted. 
Previous studies on lymphocyte proliferation have generally used 
single doses of mitogens or stimulators at a single concentration of 
responding cells and proliferation has been estimated over one fixed 
period during the culture. This allows a comparison of single points 
between different samples but these single point comparisons can be 
misleading as they do not indicate the dynamics of the response. 
Variations of stimulator doses, responding cell concentrations and 
days of culture for harvesting have all been shown to have substantial 
effects on proliferative responses (Stites at al.., 1972; Wara and 
Barrett, 1979) Farrant at al., 1980). Therefore a difference between 
two samples estimated by single points may in fact be due to a shift 
in the dynamics of the response rather than the absolute magnitude; 
for the sample indicating a lower response, the maximal response may 
actually be similar (or even higher) but occurring earlier or at a 
lower cell concentration. Because of these multiple effects, it was 
decided that in order to compare the responses of cells from breast- 
and bottle-fed infants, it was impotant to know whether the speed, 
amplitude or cell kinetics varied between the groups. The recent 
development of Terasaki plate microculture techniques (O'Brien at aL., 
1979) allowed multiple variables to be tested using very small numbers 
of cells. 
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SECTION B- METHODS AND STANDARDISATION OF CUITPURE CONDITIONS 
Peripheral blood mononuclear cells were separated from 
heparinised blood and cultured in serum-free medium (Flow 
Laboratories) in Terasaki plates as described in Chapter 2. Although 
the Terasaki plate microculture system enabled a number of variables 
to be tested on small quantities of blood, it was obviously not 
practical to test wide ranges of cell concentrations, stimulator 
doses, and harvest days. Yet all these variables have been shown to 
affect the results obtained in proliferation experiments (Farrant et 
aL., 1980). In order to assess the kinetics of the responses to the 
stimulators selected in the Terasaki plate system with serum-free 
medium, the following preliminary experiments were conducted. 
1) Doses of stimulators 
Because of the difficulty in obtaining large quantities of cells 
from healthy infants, some of these initial titrations were performed 
using adult cells. Each stimulator was tested at a range of 
dilutions, using several responder cell concentrations and days of 
harvest. In order to illustrate the interrelationships between 
stimulator concentration, responder cell concentration and time of 
culture, these titrations are expressed as three-dimensional graphs. 
To indicate numerically the relative strength of the responses 
coventional two-dimensional graphs are also presented. 
i) PHA 
The proliferative responses of PBM cells from an adult donor, to a 
range of doses of PHA, are shown at different responder cell 
concentrations in Fig 4-1 and 2. The effects of the same PHA 
111 
concentrations, but measuring proliferation on different days after 
stimulation are shown in Fig 4-3. These profiles show that 
different mitogen concentrations (between 0.5 and 5.0µg/ml) will 
induce maximal proliferation, depending on the harvest day or cell 
concentration chosen. An intermediate dose of 1µg/ml was chosen for 
the proliferative response investigations in infants. 
ii) PWM 
Responses of adult cells to a range of PWM concentrations were less 
variable than the PHA driven responses and are illustrated by cell 
concentrations (Figs 4-4 and 5) and by days of culture (Fig. 4- 
6). Although the maximal proliferative response was obtained with 
O. lµg/ml, the response to doses between 0.5 - 5µg/ml was strong and 
fairly constant, and an intermediate concentration of lµq/ml was 
chosen for the studies on proliferative responses in infants. 
iii) Staph. aureus (strain Cowan) (SAC) 
Fig 4-7 shows the responses of various concentrations of adult PBM 
cells, harvested on different days of culture, to serial dilutions of 
the preparation of SAC. A dilution of 1/2000 gave a maximal response 
at all cell concentrations and days of harvest and was used 
subsequently. 
iv) Allogeneic lymphocytes (Mixed lymphocyte reaction - MLR) 
Mitomycin-C treated Cla-4 stimulator cells were diluted to give cell 
concentrations from 0.5 to 4x 106 cells/ml, as estimated by the cell 
count prior to freezing. Estimation of viability by trypan blue dye 
exclusion, indicated that only between 65-70% of these cells were 
viable. Duplicate control wells with stimulator cells only, indicated 
that these cells did not proliferate during the Aa. R assay. Figs 4-8 
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and 9 indicate that the maximal response with adult cells occurs with 
1-2x 106 stimulator cells/ml. A similar titration experiment was 
performed using cells from a3 week old breast-fed infant. Cells were 
harvested on day 3 and day 4 of culture only (Fig. 4- 10). As with 
the adult cells, the maximal responses occurred with a stimulator cell 
concentration of between 1-2x 10 
6 
cells/ml, and a dose of 2x 10 
6 
was chosen for the study. 
v) Tetanus toxoid (TT) 
The average results of three TP titration experiments in 6 week old 
infants are shown in Fig. 4- 11. The maximal reponse on each 
harvest day occurred with a dose of 0.001 Lf units/ml and this dose 
was used in subsequent proliferation experiments. 
2) Responder cell concentrations 
As can be seen from the stimulator titrations using adult cells, 
variation in responder cell concentrations can give enormous variation 
in the proliferative responses, and responses are not always greatest 
at the highest cell concentrations. The responses of varying 
concentrations of infant lymphocytes to all the polyclonal activators 
are shown plotted for differing harvest days (Fig. 4- 12) and for 
each stimulant (Fig. 4- L3). These results are the means from three 
experiments on infants between 10 days and 6 weeks of age. A cell 
concentration of 0.5 x 106 cells/ml gave little proliferative 
response. Maximal responses occurred with 4x 10 
6 
cells/ml, but 
responses with lower cell concentrations tended to reach maximal 
proliferation later in the culture period. Because of these results, 
and the previously reported effects of varying cell concentration 
(Knight and Parrant, 197$) it was decided to test the infant 
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lymphocytes at a minimum of 3 cell concentrations (1,2 and 4x 106) 
and also at 8x 20 
6 
cells/ml where cell numbers permitted. 
3) Days of culture for harvesting 
Proliferative responses of PBM cells from a 10 day old infant for 
each stimulant are shown according to the harvest day in Fig 4- 14. 
Maximal response for PHA occurred between the second and third days of 
culture; for all the other stimuli maximal responses occurred between 
day four and five of culture. This was 1-2 days earlier for each 
stimulant than the responses of adult lymphocyte (shown for PHA, PWM 
and MLR in Fig 4- 15). The harvest days chosen for the study were 3 
and 5, with an extra harvest on day 4 when cell numbers permitted. 
4) Statistical analyses. 
The statistical analysis was similar to that employed by 
Harrison, Lee and Farrant (1981). Briefly, data were log-transformed 
to normalise the distribution and the geometric means of duplicate 
samples were calculated. Analysis of variance was performed on the 
data from each mitogen, taking into account the fact that both 
between-infant and within-infant sources of variation were present 
(Winer, 1971). Significant interactions between variables, obtained 
by the analysis of variance, indicate a significant modification by 
one variable on the effect of another variable. For example, if the 
two groups yield similar proliferative responses at early ages but 
substantially different responses at later ages, this is observed as a 
significant interaction between age and group in their effects on 
proliferation. If this phenomenon is observed at a low cell 
concentration but not at a high concentration, this is manifested as a 
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significant three-factor interaction of group, age and cell 
concentration. 
Because of the marked lack of balance with respect to cell 
concentration (less observations were available at the highest cell 
concentrations), data were further divided into cell concentrations 
and the analysis of variance reapplied. This lack of balance is 
illustrated in Table 4-1, which shows the numbers of observations 
(infants) available for each cell concentration and day of culture at 
each age for the spontaneous proliferation and mixed lymphocyte 
reaction data. Numbers for other stimuli were intermediate between 
these two. 
Where individual comparisons between groups were required at 
specific ages, days of culture or cell concentrations, Bonferroni 
t-tests were performed (Gill, 1978). These take into account the 
circumstance of multiple tests and so are rather more conservative 
than pooled t-tests. For the purposes of these tests, the appropriate 
variance estimates, derived from the analysis of variance procedure, 
were used. Where confidence intervals were constructed, these 
incorporated variability both between and within infants. Confidence 
intervals (95%) are shown on all figures illustrating significant 
interactions or differences between groups, where proliferation was 
averaged over several cell concentrations and/or days of culture but 
have been omitted from the detailed graphs for the purposes of 
clarity. 
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Figure 4-3 
Proliferative responses of adult PBt( cells to varying doses of PHA, 
harvested on different days of culture 
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Figure 4-6 
Proliferative responses of adult PBK Dells to varying doses of PM, 
harvested on different days of culture 
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Figure 4-B 
Proliferative responses of adult PBti cells to varying concentrations 
of allogeneic lymphocytes (Cla-4 B cell line) at different responder 
cell concentrations 
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Figure 4-9 
Three-dimensional representation of Fig. 4 - S. Height of peaks 
represents incorporation of 
3H-Tdr. 
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Figure 4- 10 
Proliferative responses of infant PBX cells to varying concentrations 
of allogeneic lymphocytes at different responder cell concentrations. 
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Figure 4- 12 . Effect of responder cell concentration on 
proliferative responses of infant PBM cells to different stimuli : - 
No stimulus; O PHR; 0 PWK; " SAC;   Allogeneic lymphocytes. 
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Figure 4- 13 
Effect of responder cell concentration on proliferative responses of 
infant PBM cells, harvested on different days of culture. 
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Figure 4 -14 
Effect of culture period on proliferative responses of different 
concentrations of infant PON Dells. 
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SECTION C- GENERAL OBSERVATIONS ON PROLIFERATION BY INFANT PBM CELLS 
1) Comparison of spontaneous proliferation by infant and adult cell 
cultures. 
Spontaneous proliferation was low in all cultures (always less 
than 400cpm) compared with proliferative reponses to mitogens (up to 
7000cpm). However it was higher in infant cell cultures than adult 
cell cultures. For the cultures of adult cells, the geometric mean 
from 6 experiments on the peak harvest days 3 and 4 was 40cpm. For 
the cultures of infant cells, spontaneous proliferation resulted in 
geometric mean counts from 50 to 300cpm, depending on age and feeding 
group (i. e. up to 7-fold higher than for adult cells. ). 
2) Effect of differing cell concentrations. 
As expected from the initial titrations, cell concentration had a 
significant effect on proliferation (P c 0.0001). The geometric means 
for the two feeding groups for each stimulant (averaged over days of 
culture and age) are shown in Fig 4- 16. For spontaneous 
proliferation, the highest cell concentration (8 X 106 cells/ml) 
showed greatest proliferation. The responses to all five stimuli were 
maximal at 4X 106 cells/ml. Proliferation was always lowest at 1X 
106 cells/ml. 
3) Effect of harvesting on different days of culture. 
Again, as indicated by the initial titration experiments, there 
was a significant difference between harvest days (P c 0.0001), which 
is illustrated for each stimulant in Fig 4- 17. Maximal spontaneous 
proliferation occurred on day 4. Cells stimulated with PHA responded 
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most rapidly, with maximal responses on day 3 of culture. Responses 
to all other stimuli were maximal on days 3 to 4 at the higher cell 
concentrations and day 4 at 1X 106 cells/ml. Responses for all cell 
concentrations were at their lowest on day S. This maximal response 
was slightly earlier than had been indicated by the initial titrations 
(days 4 to 5, see Fig 4- 14). 
4) Effect of age on proliferation. 
There was a significant effect of age on the proliferation in 
unstimulated cultures and for all stimulants used. This change with 
age was generally different for the two feeding groups and these 
results are therefore discussed in more detail below. Spontaneous 
proliferation was greatest at 6 weeks for the breast-fed infants and 
at 6 to 9 months for the bottle-fed group. Responses to PHA were 
highest for both groups at 6 weeks and 9 months (P - 0.0018). There 
was a slight decline in responses to PWM from 6 days to 3 montho 
followed by an increase from 3 to 9 months. However this difference 
between ages for PWM did not quite reach the level of significance (P 
- 0.070). There was a significant effect of age on the proliferative 
responses to allogeneic lymphocytes (P - 0.015) with maximal responses 
at 6 weeks and 9 months of age. For MTJR there was also an interaction 
of harvest day with age (P < 0.0001). This arose because although the 
maximal proliferation always occurred on the 4th day of culture, 
proliferation on day 3 was higher than day 5 for infants aged 6 days 
and 6 weeks but from 3 to 9 months, proliferation on these days was 
similar, indicating that the response was more rapid in the younger 
infants. 
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Figure 4 -16 
Effect of Dell concentration on proliferative responses of PHM Dells 
from breast- and bottle-fed infants. Results are averaged over days 
of culture and age. 
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Figure 4 -17 
Effect of period of culture on proliferative responses of PBM cells 
from infanta at different cell concentrations. Results are averaged 
over feeding group and age. 
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SECTION D- DIFFERENCES IN PROLIFERATION BETWEEN FEEDING GROUPS 
1) Spontaneous proliferation. 
When the data were examined for differences between feeding 
groups, no significant differences were found between the overall 
group means (averaged over all cell concentrations, days of culture 
and ages; Br 65cpm, Bo 52cpm). Nor were there any interactions 
between feeding group and cell concentrations or harvest days. A 
significant interaction was noted however, between feeding group and 
age (P - 0.012), i. e. the change in spontaneous proliferation with 
age was different for the two groups. For each individual cell 
concentration, the significance of this interaction between feeding 
group and age was: - 4X 106, P-0.0013] 2X 106, P-0.0073; 1X 
106, P-0.0091. This difference between groups is summarised in Fig. 
4- 18 where the results are averaged over 4 cell concentrations and 3 
harvest days. Each point therefore represents between 100-150 
observations. At 6 days and 6 weeks, the spontaneous proliferation in 
breast-fed infants was more than double that in bottle-fed infants. 
By 3 months, the differences between the groups were minimal but by 6 
and 9 months, the bottle-fed infants had a significantly higher rate 
of spontaneous proliferation. 
Fig. 4- 19 shows a more detailed investigation of these 
differences between the feeding groups for different days of culture 
and cell concentrations. The highest cell concentration (8 X 106) has 
been omitted from this figure as the number of samples studied at this 
level was low. For the remaining cell concentrations, points 
represent the average of duplicate samples from 12-15 infants per 
group (Table 4- 1). It can be seen that the higher level of 
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spontaneous proliferation in breast-fed infants at 6 days and 6 weeks 
of age, occurred at all cell concentrations and on all days of 
culture. The differences between groups were greatest at the highest 
cell concentration (4 X 106) and on the maximal harvest days 3 and 4. 
2) Responses to mitogens. 
i) PHA 
There were no significant differences between the overall means for 
the two feeding groups, nor were there any interactions between 
feeding group and day of culture. There was a significant difference 
between responses of the two feeding groups at different cell 
concentrations (P - 0.039) with lower responses (averaged over all 
days of culture) in the breast-fed group at 1X 106 cells/ml (see Fig. 
4-16). 
A test for interaction of age with feeding group by analysis of 
variance (found to be highly significant for spontaneous proliferation 
- see above) did not quite reach the level of significance (P 
0.058). However, when tested at individual ages (using a Bonferroni 
t-test) there was a significantly greater response in the bottle-fed 
group than the breast-fed group at 3 and 9 months (P c 0.05) and 6 
months (P c 0.01). These results are illustrated in Fig 4- 20, 
averaged over all cell concentrations and days of culture. When the 
interaction of age and feeding group was examined in more detail (Fig. 
4- 21) it could be seen that at the time of maximal proliferation 
(day 3) there was a significant interaction between group and age (P 
0.007) and this is illustrated (averaged over all cell concentrations) 
in Fig. 4- 22. At 6 days and 6 weeks of age, the proliferative 
reponses were higher in breast-fed infants. By 3 months of age, the 
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responses were higher in the bottle-fed group and this greater 
response was maximal at 6 and 9 months. 
ii) Responses to PWM. 
The data were analysed for interactions of feeding group with age, 
cell concentration and days of culture. None of these overall 
interactions was significant. A detailed analysis of the data is 
illustrated in Fig. 4- 23. Responses were similar between the two 
feeding groups at 6 days and 6 weeks of age at all cell concentrations 
and on all days of culture. However, from 3 to 9 months, 
proliferative responses were greater in the bottle-fed group and this 
difference was significant (Bonferroni t-test, P<0.05). The 
difference between groups was most apparent at the time of maximal 
proliferation on day 4 of culture and at the lowest cell concentration 
(Fig. 4- 24). Although the interaction of group with age was again 
not significant at this cell concentration, there was a significantly 
greater response in bottle-fed infants at 3,6 and 9 months 
(Bonferroni t-test Pc0.05). The overall group mean at 4X 106 
cells/ml (averaged over all days of culture and ages) was also 
significantly higher for the bottle-fed group (Br - 1152cpm, Bo 
1399cpm; P-0.023). 
iii) Responses to SAC. 
The pattern of proliferative responses to SAC were very similar to PWM 
responses (Fig. 4- 25 compared with Fig. 4- 23). The responses 
were similar in both feeding groups at 6 days and 6 weeks of age but 
from 3 to 9 months the responses were again greater in the bottle-fed 
group. This difference is illustrated averaged over all cell 
concentrations and days of culture in Fig. 4- 26a. Although the 
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overall interaction of group with age (analysis of variance) was not 
significant, there was a significant difference between the groups at 
6 months (Bonferroni t-test, Pc0.01) with the bottle-fed infants 
showing a greater proliferative response to SAC. The interaction of 
group with age was however, significant for the peak cell 
concentration (4 X 106cells/ml, P-0.014) but not the peak day of 
culture (day 4, Fig. 4- 26b). 
3) Proliferative responses to allogeneic lymphocytes. 
There was a significant difference between the overall group 
means (averaged over all ages, cell concentrations and harvest days) 
(P - 0.0040) with the geometric means for the bottle-fed group being 
higher (Br - 690cpm= Bo - 1032cpm). There was also a significant 
interaction between age and feeding group (P - 0.029) which is 
illustrated in Fig. 4- 27a. The responses (averaged over all cell 
concentrations and days of culture) were similar between the two 
groups at 6 days and 6 weeks, but from 3 to 9 months the responses 
were substantially lower in the breast-fed group. When the data were 
analysed in more detail (Fig. 4- 28) it could be seen that this 
difference between groups occurred on all days of culture and at all 
cell concentrations, although the difference was most marked at the 
lowest cell concentration (1 X 106 cells/ml, P-0.024). Also, at 6 
days of age, the proliferative responses of the breast-fed infants 
were slightly greater than the bottle-fed infants on days 3 and 4 of 
culture (see Figs. 4- 27b and 29), whereas the bottle-fed group 
showed higher proliferation on day 5. This indicates that although 
there was no difference in the overall response at this age (Fig. 4- 
27a), the responses of PBM cells from breast-fed infants occurred 
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earlier in the culture period. 
4) Proliferative responses to tetanus toxoid. 
Stimulation of infant PSM cells with tetanus toxoid (TT) was not 
included at the beginning of the study and was only set up when all 
other tests had been done on the cells. For this reason, the numbers 
of infants in each group were much smaller than for the other stimuli, 
as is shown in the following tables- 
AGE 
6days 6weeks 3mths 6mths 9mths 
Breast-fed na222 11 10 
Bottle-fed n- 3539 12 
Because of these low numbers, no significant interactions were 
detected by the analysis of variance. However, when the average 
results (for all days of culture and cell concentrations) were 
examined for differences between ages (Fig. 4- 29) a similar pattern 
was seen as for the other stimuli, with a greater response of 
breast-fed infants at 6 days of age (Bonferroni t-test, Pc0.05), 
maximal proliferation in both groups at 6 weeks and lower responses in 
breast-fed infants from 3 to 9 months. This was similar for all days 
of culture and cell concentrations (Fig. 4- 30). 
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Figure 4 -18 
Spontaneous proliferation in PBM cells 
from breast and bottle-fed infants 
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Figure 4 -19 
Spontaneous proliferation by PBK cells from breast- and bottle-fed 
infants at three cell concentrations and days of culture. 
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Figure 4- 20 
Proliferative responses of PBX cells from breast- and bottle-fed 
infants to PEA (lµg/ml). Geometric means (±95% C. i. ) of four cell 
concentrations and three days of culture. 
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Figure 4- 21 
Proliferative responses of PBX cells from breast- and bottle-fed 
infants to PHA (lµq/ml). Results are illustrated at each cell 
concentration and day of culture. 
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Figure 4- 22 
Proliferative responses of PBX cells from breast- and bottle-fed 
infants to PHA (1µg/ml) on maximal day of culture. Geometric means 
(±95% C. I. ) over four cell concentrations. 
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Figure 4- 23 
Proliferative responses of PBK Delle from breast- and bottle-fed 
infants to PWK (lµq/ml), illustrated at four cell concentrations and 
three days of culture. 
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Figure 4- 24. Proliferative responses of infant PBX cells to PWM. 
Geometric means (j95% C. I. ) over all cell concentrations * and days of 
culture: 
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Figure 4- 25 
Proliferative responses of PBK cells from breast- and bottle-fed 
infants to SAC (1/2000), illustrated for each cell concentration and 
day of culture. 
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Figure 4- 26. Proliferative responses of infant PBM cell to SAC. 
Geometric means over all days of culture (a), and for maximal day 4 (b) 
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Figure 4- 27. Proliferative responses of infant PBM cells to allogeneic 
lymphocytes. Averaged over all days of culture (a), and for day 4 (b). 
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Figure 4- 28 
Proliferative responses of PBK cells from breast- and bottle-fed 
infants to allogeneic lymphocytes (Cla-4 B cell line). Results are 
illustrated for each cell concentration and day of culture. 
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Figure 4- 29 
Proliferative responses of PBM cells from breast- and bottle-fed 
infants to tetanus toxoid. Geometric means (±95% C.!. ) over all cell 
concentration and days of culture. 
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Figure 4- 30 
Proliferative responses of PBM cells from breast- and bottle-fed 
infants to tetanus toxoid. Results are illustrated for each cell 
concentration and culture day. 
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SECTION E- DISCUSS ION 
1) General responses by infant and adult cells. 
This study of proliferation by infant PBM cells, using Iscove's 
serum-free medium (Iscove and Melchers, 1978) has shown that although 
the spontaneous proliferation is considerably lower using this medium 
than reported in other studies using serum-containing media, the 
substantially greater responses of infant cells than adult cells 
remain. The average spontaneous proliferation by infant PBM cells was 
7-fold greater than that by adult cells. Spontaneous proliferation by 
infant cells increased steadily with increasing cell concentration and 
was maximal on day 4 of culture. 
As outlined in Chapter 1, previous workers have shown that cord 
blood lymphocytes (CBL) and infant PBL have a higher rate of 
proliferation in 'unstimulated' cultures than adult PBL (Stites at 
GL., 1972; Alford, Cartwright and Sell, 1976] Ben-Zwi at at.., 1977) 
which is probably due to higher proportions of infant PBL cells 
proliferating (Stiehm, Winter and Bryson, 1979). This increased 
proliferation has been attributed to partial activation of the cells 
fn vivo (Stites at at.., 1972; Weber, Santesson and Skoog, 1973), 
possibly due to foetal cellular responses to materno-foetal 
incompatabilities (Faulk at at., 1973). However these studies have 
all used media containing serum, which is known to have mitogenic 
properties and therefore, in contrast to this current study, this 
'unstimulated' proliferation could not confidently be called 
spontaneous. 
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In this present study, responses of infant PBL to mitogens, 
allogeneic lymphocytes and tetanus toxoid have also been investigated. 
Using a single dose of mitogen but multiple cell concentrations and 
days of culture, maximal proliferative responses of infant cells were 
greater and occurred earlier than those of adult cells in response to 
all mitogens tested (PEA, PWM, SAC). Maximal responses by infant PBM 
occurred on day 3 for PHA driven cells and day 4 for PWM and SAC 
stimulated cells, although lower cell concentrations tended to reach 
maximal proliferation slightly later in the culture period. This was 
1 to 2 days earlier than the (lower) maximal responses by adult cells. 
Unlike spontaneous proliferation, responses to mitogens were maximal 
at 4x 106 cells/ml and further increases in cell concentration 
resulted in lower responses. 
For the mixed lymphocyte reaction, the optimal stimulating dose 
of cells was similar for adult and infant responding cells, but 
responses of infant cells were more vigorous than adult cells. As 
with the response to mitogens, proliferation of infant PBM in response 
to allogeneic lymphocytes was more rapid and maximal responses were 
greater than adult cells. Although a direct comparison was not made 
between infant and adult responses to TT, all infants gave good 
proliferative responses to this antigen, even prior to immunisation. 
Previous studies on CBL and infant PBL have given conflicting 
results. Some workers have indicated that these cells respond more 
vigorously than adult cells to T cell mitogens such as PHA and 
Concanavalin A (Eile st at., 1974= Alford, Cartwright and Sell 1976; 
Ben-Zwi et at., 1977; Gill et at., 1979) and this response occurs 
earlier after stimulation (Weber, Santesson and Skoog, 19731 Yoffey 
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at aL. , 1978). However, other workers have reported similar 
proliferative responses by infant and adult cells (Andersen at a&., 
1973) or lower responses by infant cells (Jones, 1968) Pittard, 
Miller and Sorensen, 1994). This discrepancy has been attributed to 
the variability of responses by infant and adult PBL when different 
mitogen doses, cell concentrations and days of culture are used 
(Stites et at., 1972= Wara and Barrett, 1979). It now seems clear 
that this variability has produced misleading results because only 
single points were assessed. 
Proliferative responses to mitogens such as PWM and SAC which 
stimulate B cells, have also been reported as higher in normal 
newborns than adults (Wu et aL., 1976; Ruuskanen et aL., 1980). 
However in another study, the same group of workers reported similar 
responses between neonates and adults to these mitogens using a single 
mitogen dose, cell concentration and day of culture (Pittard, Miller 
and Sorensen, 1984). Unander, Hammarstrom and Smith (1983) found 
proliferative responses to PWM and SAC were lower in infant cells than 
adult cells. This discrepancy may again be due to the fact that the 
optimal stimulating dose of these mitogens is higher for adult cells 
than for infant cells (Stites et aL., 1972; Ben-Zwi et aL., 1977). 
Proliferative responses of infant PBL to allogeneic lymphocytes 
has been reported as comparable to adult cells (Stiehm, Winter and 
Bryson, 1979). Responses of CBL or infant PBL to antigens such as 
tetanus toxoid have been variably reported as absent in unimmunised 
infants (Leitren and Oppenheim, 1970; Alford, Cartwright and Sell, 
1976) to lower than adults (Gill et aL., 1979). The observation that 
all infants in this present-study gave good proliferative responses to 
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tetanus toxoid, even before they had been immunised with this antigen, 
may indicate that the TP preparation used had some mitogenic 
properties. This will be discussed further in Chapter 5. 
2) Differences between breast- and bottle-fed infants. 
Significant differences were noted in the responses of breast- 
and bottle-fed infants for spontaneous proliferation and proliferative 
responses to all stimuli. These differences were associated with age 
and fell into two main categories; those occuring in newborn infants 
(6 days and 6 weeks of age) and those occurring in older infants (3 to 
9 months). 
Newborn breast-fed infants showed significantly greater rates of 
spontaneous proliferation than bottle-fed infants and this occurred at 
all cell concentrations and on all days of culture. Spontaneously 
proliferating cells have been characterised as non-T/non-B cells (as 
determined by inability to rosette sheep red blood cells or possess 
surface Ig) and since the proportions of T cells are increased after 
spontaneous proliferation, these proliferating cells may be a 
population of T cell precursors (Treves, Barak and Fuks, 1980). The 
greater proliferation in infant cells than adult cells has been 
attributed to partial activation of these cells to vivo (see above). 
it is possible that this substantially increased spontaneous 
proliferation in the breast-fed infants may be due to further 
stimulation to vtvo by soluble factors, present in human milk and 
capable of stimulating lymphocytes to vitro, which have been absorbed 
by the breast-fed neonate. A number of such factors have been 
described (Emodi and Just, 1974; Klagsburn, 1978; Pittard and Bill, 
1979a and b; Lucas and Mitchell, 1980; Keller et a!., 1981; Blau et 
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at., 1983; Klagsburn and Shing, 1984). Cells from breast-fed infants 
were also more responsive to PHA at this time, and responses to 
allogeneic lymphocytes occurred slightly earlier in this group. Both 
these stimuli have been shown to affect T cells rather than B cells 
(Chapter 1), and this suggests that T cells may therefore also be 
partially activated to utvo by these factors in milk. Proliferative 
responses to tetanus toxoid were also significantly greater at 6 days 
in breast-fed infants. Since these infants were not vaccinated, it is 
unlikely that this was an antigen specific response and could 
therefore be due to a mitogenic effect of TT (as mentioned above) 
which could be stimulating T or B cells. Proliferative responses to 
the mitogens known to stimulate B cells (PWM and SAC) were similar (at 
all cell concentrations and days of culture) in breast- and bottle-fed 
infants during this early neonatal period, suggesting that B cell 
responses were comparable in the two feeding groups at this time. 
By 3 to 6 months of age, spontaneous proliferation and 
proliferative responses to all stimuli (PHA, PWM, SAC, MLR and Tr) 
were significantly greater in the bottle-fed group. This difference 
was apparent at all cell concentrations and on all days of culture but 
tended to be greatest on the maximal day of culture. This suggested 
that all classes of lymphocytes (non-T/non-B, T and B cells) were 
receiving greater stimulation in vivo in the bottle-fed infants. This 
could be the result of a combination of effects. First, by this age 
there may be a reduced intake of lymphokines and growth factors from 
milk in the breast-fed infants. Beardmore, Lewis-Jones and Richards, 
(1983) and Read et aL., (1984) have shown reduced levels of epidermal 
growth factor in mature milk while other components in milk such as 
antimicrobial proteins still remain at a fairly high level (Carlsson 
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at at., 1976; Ogra, Weintraub and Ogra, 1978). Second, there is a 
continual uptake of macromolecules from the gut in both groups of 
infants, but the lack of protective antibodies from human milk may 
result in an increased uptake of potentially antigenic molecules in 
the bottle-fed group, and this may result in a general increase in the 
stimulation of the systmic immune system. This will be discussed in 
more detail in Chapters 6 and 8. 
S(JNIIMARY 
Spontaneous proliferation and proliferative responses of PBM 
cells to a number of stimuli have been studied in breast- and 
bottle-fed infants and compared with responses of adult cells. 
Spontaneous proliferation and responses to T and B cell mitogens, 
allogeneic lymphocytes and tetanus toxoid occurred earlier in infant 
cells than adult cells, and the maximal responses were greater. When 
breast- and bottle-fed infants were compared, spontaneous 
proliferation and responses to the T cell mitogen PHA and the antigen 
tetanus toxoid were significantly greater in the breast-fed group at 6 
days and 6 weeks of age. One possible explanation for this greater 
proliferation in breast-fed infants is that it may be attributable to 
absorption by breast-fed infants of soluble factors (lymphokines) from 
human milk. Responses to PWM and SAC were similar at this time, 
suggesting that T or non T/non B cells rather than B cells were being 
affected by these factors. In contrast, from 3 to 9 months of age, 
responses to all stimuli were significantly greater in the bottle-fed 
group. This indicates that during this period, all cell types were 
more responsive in this group. It is suggested that this is due to a 
higher level of antigenic stimulation in the bottle-fed infants. 
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CHAPTER 5 
B CELL DIFFERENTIATION AND IIrMUNOGLOBULIN PRODUCTION IN VITRO 
In the previous chapter, the proliferative responses of infant 
mononuclear cells to various stimuli have been examined. After 
stimulation with the appropriate mitogen or antigen, a proportion of B 
cells will not only proliferate but will also differentiate and become 
immunoglobulin or specific antibody secreting cells (Fauci and Pratt, 
1976). The culture conditions required for specific antibody 
production are more critical than those required for proliferative 
responses; culture medium, cell densities, monocyte numbers and T/B 
ratios all have a profound effect on B cell differentiation (Rich and 
Pierce, 1973; Fauci and Pratt, 1976; Waldmann and Broder, 1982). 
Controlling T/B ratios and monocyte numbers to vttro requires cell 
separation procedures, techniques which need larger numbers of cells 
than those available from newborn infants. 
This Chapter is therefore divided into two sections. The first 
section will describe experiments conducted to vitro using peripheral 
blood mononuclear (PBM) cells which were separated from heparinised 
infant blood on a Ficoll- Paque gradient and cultured without any 
attempts to adjust the proportions of T cells, B cells or monocytes 
(called unseparated PBM). These cultures therefore contained 
suboptimal proportions of these cells for to vitro immunoglobulin and 
antibody production. The second section will describe experiments, 
mainly using cells from adult blood, in an attempt to develop 
techniques to enhance the culture conditions and cell ratios 
sufficiently for specific antibody production to vitro, using smaller 
numbers of cells than were needed for the currently available 
100 
techniques. 
SECTION A- D*WNOGLOBULIN PRODUCTION BY UNSEPARATED 
INFANT 1+DNONUCLEAR CELLS 
1) Introduction. 
Mitogens such as pokeweed have been extensively used to stimulate 
B cells to secrete immunoglobulin (Cooper, Lawton and Bockman, 1971= 
Fauci and Pratt, 1976; Waldmann and Broder, 1982. ). Unseparated 
peripheral blood mononuclear cells from adults, grown in media 
containing serum, show an increase in imaunoglobulin secretion when 
stimulated with PWM, although optimal ratios of T/B cells for Ig 
production to uttro are lower than those found in peripheral blood (De 
la Concha et at., 1977 Janossy et at., 1977). Specific antigen 
stimulates a much smaller proportion of human PBM and the quantity of 
immunoglobulin produced is therefore much less than in mitogen driven 
systems. Antigen stimulation of cells grown in FCS-containing media, 
however, gives misleading results, as batches of FCS which support B 
cell growth are themselves mitogenic (Brenner, 1981). In order 
therefore, to study the effect of antigen alone, initial experiments 
were conducted using the serum-free medium of Iscove and l4elchers 
(Flow Laboratories, see Chapter 2) which has been successfully used 
for LPs-induced plaque formation in murine studies (Iscove and 
Meichers, 1978). 
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2) Spontaneous imnunoglobulin production by unstimulated infant PBM 
Dells 
Cultures were set up as described for experiments on 
proliferation. After 8 days of incubation, the Terasaki culture 
plates were stored at -70°C. supernatants from pooled duplicate wells 
were diluted 1/3 initially, followed by serial 2-fold dilutions in 
blocking buffer and assayed for immunoglobulins and specific 
antibodies by RIA as described in Chapter 2. 
i) Influence of infant age on immunoglobulin -production by 
unstimulated cells. 
Few samples from infants at 6 days, 6 weeks and 3 months of age 
provided sufficient cells for studies of both proliferation and 
immunoglobulin production (n- 3,3 and 2 respectively). All but one 
of these infants were bottle-fed. The effect of age on total IgM and 
IgG production by 29 samples at 3 cell concentrations is shown in Fig. 
5-1. IgM production was low in all cultures (geometric mean - 150 
ng/ml at 4X 106 cells/ml) and changed little with age. IgG 
production was more variable. It was low in all 3 samples from 6 day 
old infants, (75-740 ng/ml at 4X 106 cells/ml) but was considerably 
higher in the 3 cultures from 6 week old infants (1040 - 1825 ng/ml at 
4X 106 cells/ml). From 3m to 9m the geometric mean of IgG secreted 
remained constant, although there was wide variation, with the range 
at 4X 106 cells/ml being 160 - 3620 ng/ml. 
ii) Influence of breast- or bottle-feeding on immunoglobulin 
production by unstimulated PBM. 
The absence of sufficiently large blood samples from breast-fed 
infants at 6 days and 6 weeks prevented any comparisons at this age. 
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In retrospect, this was particularly unfortunate as the proliferative 
responses in unstimulated cells showed the greatest differences 
between the two feeding groups at these two ages (see Fig 4- 18). 
Fig. 5-2 shows IgM and IgG production from breast- (n-15) and 
bottle-fed (n-8) infants between 3 and 9 months. Although the mean 
IgM secretion was slightly lower in the breast-fed group and IgG 
secretion was slightly higher in this group, particularly at lower 
cell concentrations, these differences were not significant. 
3) Response to PWM 
Cultures were stimulated with 0.1 or 1.0µg/ml PWM. Total IgG 
production showed a small rise (less than 2-fold) in only 2/8 
breast-fed and 0/8 bottle- fed infants. IgM production was slightly 
increased in 4/16 infants (in 3/16 increases were 2-fold or less) but 
for the remaining infants, IgM production was similar to or lower than 
in unstimulated cultures (Table 5- 1). 
4) Response to Tetanus Toxoid. 
i) Titration for optimal dose of antigen. 
Many of the cultures were set up with a range of tetanus toxoid doses. 
The antigen titration curve shown in Fig. 5-3 is an average of the 
results from 17 experiments. The optimal dose of TT for total IgM 
production was 0.001 Lfu/ml, with higher and lower doses inducing 
slightly lower quantities of IgM. This dose was used subsequently. 
ii) Total igM production. 
Fig. 5-4 shows the increase in total IgM production in response to 
0.001 Lfu/ml TT at 3 cell concentrations for both breast- and 
bottle-fed infants. These results, together with the ages and 
iGý 
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TABLE 5-1 
IgM response to PWM stimulation 
4X 106 Cells/ml 
Feeding Infant Age 
group no. 
Breast 12 6m 
14 
17 
16 
N 
N 
N 
05 9m 
02 
14 
09 
12 
N 
N 
N 
N 
Bottle 26 6wk 
20 3m 
19 N 
15 6m 
01 9m 
04 
30 
M 
M 
PWM (Ng/ml) 
0 0.1 1.0 
Fold- 
increase 
ýýýýý___----ý--------- 
so* 690 487 
30 53 
235 - 235 
445 - 310 
61 - 57 
96 - 96 
49 86 106 
192 - 350 
93 114 136 
46 - 30 
72 30 
242 - 252 
65 - 127 
114 - 150 
215 - 240 
1434 - 1434 
6 
2 
2 
2 
* IgM in ng/ml 
iG6 
Figure 5-3 
Titration of tetanus toxoid for imaunoglobulin production to vitro. 
300 -1 
250 . 
200- 
. -. 
U 1507 
tri 
c 
i1oo 
50m" 
0 r 
4x 106 cells/ml 
2x106 II 
N 
0.5 0.1 0.01 0.001 0.0001 0 
Tetanus toxoid ( Lfu/mI ) 
107 
Figure 5-4 
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TABLE 5-2 
TOTAL IgN PRODUCTION IN RESPONSE TO STIMULATION 
WITH 0.001 Lfu/ml TETANUS T XDID 
FEEDING INFANT AGE VACCINATION FOLD- 
GROUP NO. DOSES INCREASE* 
BREAST 31 6dy -3 
11 6m - 1.5-3 
12 2-4 
17 - 2-8 
12 9m 
1 
10 6m 1 2-3 
14 
18 S 
02 9m 
14 
09 
05 
ý 
M 
N 
I 
2 
0-2 
0-3 
1.5-3 
0-5 
2 0-2 
2 2-3 
30 
BOTTLE 26 6wk -0 
20 3m - 0-10 
19 -0 
15 6m 2 2-3 
04 9m 2 2-5 
01 
29 
30 
N 
N 
M 
2 4-7 
20 
20 
* Increase over 1gM production in unstimulatgd PBM cells 
for 3 cell concentrations; 1,2 and 4X 10 cells/ml. 
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vaccination status of the infants are also shown in Table 5-2. In 
9/12 breast-fed and 4/8 bottle-fed infants, there was more than a 
2-fold increase in IgM production on stimulation with TT. Increase in 
total IgM was not correlated with age or vaccination status, as some 
newborn or older non-vaccinated infants showed up to a 10-fold 
increase in IgM production, while some vaccinated infants showed no 
increase in response to TT stimulation. There were no significant 
differences between the two feeding groups in total IgM production 
after TT stimulation. 
iii) Total IgG production. 
Stimulation with Tr (0.0001 to 0.5 Lfu/ml) produced little or no 
increase in total IgG production by unseparated cells. Only 2/13 
breast-fed and 0/9 bottle-fed infants showed an increase, and this 
increase was less than 2-fold (Table 5- 3). 
iv) Specific antibody production. 
All supernatants were assayed for IgG anti-TP antibodies and some were 
also assayed for IgM anti-RT. Specific antibodies were not detected 
in any supernatant (i. e. levels were c5ng/ml). The increased IgM 
produced in TT stimulated cultures must therefore be the result of 
antigen non-specific polyclonal activation of B cells. 
5) rgA production to uttro. 
Pittard and Bill (1977) have demonstrated a factor in milk which 
stimulates cord blood lymphocytes to differentiate into IgA secreting 
cells to vitro. It was therefore decided to investigate 
tn-vttro 
synthesis of IgA by cells from a few breast- and bottle-fed infants. 
The results from cultures at 4x 106 cells/ml of 7 breast-fed and 6 
1W0 
TABLE 5-3 
EFFECT OF TETANUS TO7DID ON TOTAL IgG SECRETION 
BY UNSEPARATED INFANT PBM CELLS. 
CELL CONCENTRATION X 106/ml 
Age 
INF 
NO. 
BREAST-FED 
31 6dy 
10 6m 
11 
12 
17 "" 
14 
1B 
12 9m 
02 " 
14 " 
17 " 
09 " 
05 " 
GEOMETRIC 
1 
0 TT 
170* 140 
190 170 
170 100 
155 130 
37 15 
50 50 
65 30 
98 98 
300 280 
150 210 
200 200 
140 170 
34 25 
111 120 
2 
O TT 
380 300 
453 686 
343 226 
453 453 
150 60 
65 50 
220 150 
268 268 
1114 1114 
560 485 
1300 1300 
258 310 
95 85 
315 273 
4 FOLD- 
0 TT INCREASE 
740 643 
1370 1670 
850 600 
940 1000 
280 180 
160 300 
620 425 
820 820 
3620 2950 
1280 2840 
1050 3000 
665 1080 
288 210 
731 915 
MEAN 
BOTTLE-FED 
26 6wk 
20 3m 
19 " 
15 6m 
13 9m 
01 " 
04 " 
30 
200 126 
50 50 
100 100 
134 95 
130 120 
Be 37 
100 100 
70 85 
201 83 
394 437 
343 130 
299 140 
318 378 
365 217 
268 101 
210 268 
757 378 
344 225 
1040 690 
640 450 
1040 520 
1242 1010 
640 522 
540 290 
600 350 
2485 1160 
GEOMETRIC 
MEAN 
905 562 
0-2 
0-3 
* IgG n9/ml 
TT - 0.001 Lfu/ml 
TABLE 5-4 
FEEDING 
CROUP 
TOTAL IgA PRODUCTION BY INFANT PBL tN VZTRO 
NO. AGE 
BREAST 31 6dy 
17 6m 
18 
12 
I, 
12 9m 
02 
09 
BOTTLE 15 6m 
04 9m 
13 
01 
29 
30 
n 
N 
I 
ý 
ý 
n 
STIMULATED WITH 
0 TT PWM 
15* 15 
110 96 96 
160 160 210 
350 350 310 
675 775 510 
940 710 660 
548 1023 1550 
608 590 460 
490 410 390 
370 210 100 
460 255 187 
200 230 
2350 1662 1175 
IgA as a$ 
of IgG 
2 
39 
26 
37 
82 
30 
82 
49 
82 
62 
85 
56 
95 
* IgA in ng/ml 
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bottle-fed infants are shown in Table 5-4. No significant 
differences were apparent between the IgA production in the two 
groups, although the number of infants in each feeding group of the 
same age was small. Both breast- and bottle-fed infants at 6 and 9 
months secreted IgA at between 25-80% of IgG levels. The one 6 day 
infant tested (breast-fed) did not secrete detectable levels of IgA 
(cis ng/ml). in general, Igg secretion to vitro was not increased by 
stimulation with TT or PWM (Table 5- 4). 
SECTION B- PRODUCTION OF SPECIFIC ANTIBODY 
1) Standardisation of lipid in serum-free medium. 
After this study had begun, work on adult B cell function in 
serum-free medium indicated that B cells had a critical requirement 
for lipid and that the lipid in commercially prepared powders used in 
the experiments above was poorly soluble, resulting in loss of lipid 
on filter sterilisation (Farrant at aL., 1984). The poor buffering 
capacity of the serum-free medium in air also resulted in an 
unacceptably high pH during long cell separation procedures. A series 
of cultures on infant cells was therefore set up using Leibovitz 
medium (L-15, Flow Laboratories) for cell preparation and a serum- 
free medium base (Gibco) supplemented with soybean lipid, transferrin 
and delipidated BSA for culture (see Chapter 2). Cells were 
stimulated with PWM (0.05µg/ml) and TT (0.001Lfu/ml). The results 
shown in Table 5-5, indicate proliferative responses at days 3 and 4 
of culture and total IgM and IgG production by 8 days, using the 
unsupplemented and supplemented media. Proliferative reponses were 
slightly increased at 1X 106 cells/ml but were similar at 2 and 4X 
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106 cell concentrations. Total IgM and IgG production were also 
slightly enhanced using this medium, particularly at lower cell 
concentrations, but no specific anti-ITT antibody was detected 
following stimulation with T'. 
2) Addition of growth and differentiation factors for B cells. 
Work on adult PBM cultures indicated that addition of a 
lectin-free supernatant from PWM stimulated cultures increased the 
proportion of immune donors showing an to-vttro specific antibody 
response to Tr antigen (North and Brenner, 1983). Samples of these B 
cell growth and differentiation factors (BCGP') were kindly donated by 
Dr M. K. Brenner. Briefly, BCGF had been prepared by culturing 
irradiated T cells with autologous B cells (4: 1 T: B cells) from 
TI'-immune donors in serum-free medium containing 4µg/ml PWM. After 48 
hours, cells were washed and recultured for a further 72 hours in 
fresh serum-free medium. PWM was removed from the culture 
supernatants by passage down a sepharose 4B column to which rabbit 
anti-PWM had been coupled and the supernatant used contained less than 
3ng/ml PWM (c150pg/ml of final culture medium). Addition of these 
supernatants to cultures of adult cells, in addition to enhancing 
specific antibody secretion in an antigen-dependent manner, also 
induces polyclonal IgM and IgG synthesis (North and Brenner, 1983). 
Effect of addition of BCGF to unseparated infant PBL is shown in Table 
5-6. Proliferative responses measured in parallel are also shown on 
this table for day 4 of harvest from the 9 month sample of infant 17. 
BCGF alone increased polyclonal IgM synthesis 2-12 fold in 6/7 
infants, but caused little increase in total IgG, in spite of greatly 
increased proliferative responses. Addition of Tr to cultures 
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containing HCGF, stimulated a further increase in IgM secretion in 3/7 
infants, with the lower cell concentrations showing the greatest 
increases. However, no specific antibody was detected, even in 
cultures from vaccinated infants. 
3) Depletion of monocytes. 
Although the presence of monocytes is essential for 
immunoglobulin production to vitro (Cnelig-Myeling and Waldmann, 
1981), the percentage in unseparated adult PBM has been shown to be 
greater than optimal for antibody production (Montazeri at W.., 1980). 
Experiments were therefore conducted, using immune adult donors, to 
try to obtain specific antibody secretion in unseparated PBM with 
reduced monocytes. 
i) Adult cell cultures. 
PBM were separated from heparinised blood as described previously 
(Chapter 2). Cells were washed twice in L-15 medium and resuspended 
in Iscove's serum-free medium containing added supplements of lipid, 
TF, BSA and 10% beat inactivated FCS. The cell concentration was 
adjusted to 5x 106 cells/ml. Cells were then transfered to a SOmm 
plastic petri dish (Nunc) and placed in a humid incubator containing 
5% COZ, at 37°C for 90 minutes to allow the cells to adhere. The 
petri dish was rocked gently several times and non-adherent cells were 
removed, washed twice in L-15 and resuspended in IMDM plus supplements 
and antibiotics for culture. Culture supernatants were assayed for 
total IgM and IgG anti-TT only and the results are shown in Table 5- 
7. 
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TABLE 5-7 
EFFECT OF MJNOCYTE DEPLETION ON IqM AND SPECIFIC ANTIBODY 
PRODUCTION IN VITRO BY ADULT PBM CELLS 
DONOR SS 4X106 CELLS/! Q, 
Additions 
to cultures 
Total IgM 
(ng/ml) 
IgG anti-IT 
(ng/ml) 
Adherence 
F TP PWM Pre- Post- 
ýý _. _ýý ---------ý 
72* 25 
+ 
+ 
+ 
++ 
+-+ 
72 <20 
1120 2090 
1380 910 
395 3165 
790 1950 
F-B cell growth factors 
Tr - Tetanus toxoid, 0.001 Lf units/ml 
PWM - Pokeweed mitogen, 0.05 µg/ml 
* Results are from pooled duplicate wells 
Adherence 
Pre- Post- 
c10 <10 
<10 c10 
<10 20 
94 c10 
<10 370 
<10 <10 
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a) Total IgM secretion. 
Cells cultured without depletion of monocytes responded to PWM or BCGF 
alone (but not TT) with production of over 1µq/ml IgMi addition of 
BCGF and PWM together did not further increase IgM production. After 
depletion of monocytes, the IgM response to PWM was enhanced, with 
production of 2µq/ml IgM in the presence or absence of BCGF. In the 
presence of BCGF and TT, even larger quantities of IgM were secreted 
(>3µg/ml). 
b) IgG anti-'TT antibody secretion. 
Cells cultured without depletion of monocytes and in the absence of 
BCGF secreted no detectable IgG anti-ITT antibody. Addition of BCGF 
induced secretion of a small quantity of IgG anti-TT (94ng/ml), but 
this was not enhanced by the addition of TT to the cultures. After 
monocyte depletion, in the presence of BCGF and TT, considerably 
higher levels of IgG anti-RT were secreted (370ng/ml) than in the 
presence of BCGF or TT alone. This experiment was also conducted, 
using defibrinated blood to ensure that platelets were not having an 
inhibitory effect but no specific antibody was detected in these 
cultures (results not shown). 
ii) Infant cell cultures. 
Five experiments were then set up using heparinised blood from 9 
month-old vaccinated infants. The results are shown in Table 5-e. 
Unlike the adult cells (see Table 5- 7), total IgM production was not 
enhanced by the addition of PWM and in only one infant was it enhanced 
by the addition of BCGF and TT together, although it was enhanced up 
to 20-fold by BCGF alone in 3/5 infants. In the presence of BCGF and 
TT, IgG anti-Pr was detected in only 2/5 infants and at very low 
levels. One infant (25) produced more IgG anti-TT in response to Ti' 
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in the absence of BCGF than in its presence. 
4) Depletion of T cells. 
The observation that infant PBM cells proliferate but do not 
synthesise large quantities of immunoglobulin in the presence of BCGF 
and TT, could be explained if the T cells were proliferating at a 
greater rate than the B cells. This might actively suppress B cell 
differentiation or might produce non-specific inhibition by depletion 
of nutrients. It was therefore decided to attempt to reduce the 
proportion of T cells present by using monoclonal antibodies to 
surface antigens. 
i) Method for depletion of T cells. 
The technique involved mixing the PBM cells with the appropriate 
monoclonal antibody and then removing the coated cells by panning on a 
petri-dish coated with anti-mouse IgG. Monoclonal antibodies were the 
gift of Dr P. Beverley (I. C. R. F. Tumour Unit, University College, 
London). UCHT 1 was a pan-P monoclonal directed against all human T 
cell subgroups (equivalent to OKT3). UCHT 4 was directed against 
supressor and cytotoxic T cells (equivalent to OKTa). 
a) coating of plates with anti-mouse IgG. 
The procedure was conducted using aseptic techniques and all solutions 
were filter sterilised. Petri-dishes (50mm, Nunc) were coated with 
7ml of a solution containing 100µg/ml poly-L-lysine (Sigma, 300,000 Mw 
for tissue culture) in O. 1K carbonate buffer, pH 9.6, for ihr at RT. 
The dishes were washed three times in PBS. Affinity purified rabbit 
anti-mouse igG (from Dr P. Beverley) was diluted in 0.05M trio buffer, 
PH 9.4, to 4Oµg/ml and 7m1 of this was added to the poly-L-lysine 
coated dishes. Plates were incubated overnight at 4°C in a humid box, 
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washed three times in PBS, filled with 7ml PBS containing 5% BSA and 
incubated a further ihr at RT. The dishes were again washed three 
times in PBS and then once in PBS containing 5% heat inactivated FCS. 
b) Reaction of T cells with monoclonal antibodies 
PBM cells were separated from heparinised blood from a TT-immune adult 
donor in the usual way and washed 3 times in L-15 medium. Cells were 
resuspended in IMDM plus supplements to give 5X 106 cells/ml. The 
cell suspension was aliquotted into four lOml conical base centrifuge 
tubes (Falcon Plastics) and to these were added one of the following: - 
UCHT 1 1/50 final concentration 
LlQiT 1 1/500 
UHT 4 1/50 
LlCf3T 4 1/500 
of 
I 
N 
The tubes were rocked and placed on ice for 30-35 minutes. Cells were 
then spun, washed twice in L-15 and resuspended in 2ml PBS containing 
5% heat inactivated FCS. T cells coated with monoclonal antibodies 
were then removed by incubating these cell suspensions in the rabbit 
anti-mouse IgG coated petri-dishes for 70min at RT. The dishes were 
swirled half-way through this incubation. Non-adherent cells were 
removed by gentle squirting with a Pasteur pipette, washed 3 times in 
L-15 and cultured in IMDM plus supplements and Pen/Strep. Cultures 
were set up at 1,2 and 4X 106 cells/ml and supernatants were assayed 
for total IgM and specific IgG anti-IT only. 
ii) Antibody production 
Maximal Icy! was produced at the highest cell concentration and these 
results are shown in Table 5-9. After depletion of all T cell 
subsets with UCAT 1,1gM secretion was greatly increased by PWM and TT 
stimulation but not BCGF. After suppressor cell depletion, large 
4 ü" 2 
TABLE 5-9 
EFFECT OF T CELL DEPLETION ON IMMUNOGLOBULIN SECRETION BY ADULT PBL 
DONOR BC 4X106 CELLS/MI 
Total IgM (ng/ml) 
Additions 
P '! T PWM 
+ 
+ 
+ 
++ 
+-+ 
t1G'H'P 1 
1/50 1/500 
<50 <50 
610 800 
900 600 
<50 60 
200 300 
50 1000 
UCHT 4 
1/50 1/500 
160 <50 
100 950 
1430 3450 
2665 1180 
220 1050 
2320 2550 
No IgG anti--Tr was detected in any supernatant 
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quantities of igM (up to 3µq/ml) were secreted in response to PWM and 
®CGF stimulation and sma]7er quantities in response to TT (for the 
1/500 dilution of UCHT 4). However, no specific IgG anti-TI' was 
detected in any of the supernatants. 
SEC"PION C- DISCUSSION 
1) Imnunoglobulin production by unseparated PBM cells. 
Experiments with unseparated PBM cells, using hanging-drop 
mic: rcx: ulturee in serum-free medium and RIA to assess Ig secreted into 
the supernatants, have shown that unstimulated infant cells will 
secrete IgM and IgG to vitro. When cultured at 4X 106 cells/ml, Ig! 
(bOOng/ml) is detectable in the supernatants of cell cultures from 6 
days of age onwards, but synthesis does not appear to increase 
significantly with age up to 9 months. IgG is also detectable in 
supernatants from 6 days of age and although levels were higher in the 
supernatants Lroin older infants, sample numbers were too low to draw 
any firm conclusions. IgA secretion was also detected in the few 
infants tested at 6 and 9 months but not in the one 6 day infant 
tested. Previous studies on cord blood lymphocytes (CBI. ) and infant 
PBL using plaque-forming cell (PFC) assays have detected very low 
numbers of PFC's in cultures of unstimulated cells (Andersson, Bird 
and Britton, 1980= Unander, Bamsnarstrom and Smith, 1983). 
Stimulation by PWM induced a small increase in IgM secretion in 
on I. y halt" the samples tested and did not enhance IgG or IgA secretion. 
Previous studies on CBL using serum-containing culture media and a PFC 
assay have also indicated reduced responses to PWM compared with adult 
lea 
PBL, with no detectable IgG or IgA PFC and a reduced number of IgM PFC 
(Wu at aL., 1976; Hayward and Lawton, 1977; Andersson, Bird and 
Britton, 1980; Miyagawa at a&., 1980; Unander, Hamnarstrom and 
Smith, 1983). This reduced IgM response has been attributed to a 
helper T cell defect (Hayward and Lawton, 1977; Andersson, Bird and 
Britton, 1980) which disappears during the first few months of life 
(Andersson, Bird and Britton, 1981). PWM has also been shown to 
induce prosuppressor T cells in CBL cultures (Waldmann and Broder, 
1982). Andersson at at., (1983) have demonstrated a population of 
suppressor T cells from PWM-induced CBL which will inhibit 
imaunoglobulin secretion by adult B cells. 
When T independent B cell activators such as EBV (Andersson, Bird 
and Britton, 1981) or SAC (Unander, Hannarstrom and Smith, 1983) are 
used, CBL can be induced to secrete adult levels of IgM. IgG PFC were 
also induced in SAC (but not EBV) stimulated cultures, although these 
workers used a culture medium containing human AB serum which is known 
to give misleading results in adult systems (Waldmann and Broder, 
1982). The finding in this current study that IgG was detectable in 
the supernatants of unstimulated serum-free cell cultures from all 6 
day and 6 week old infants may reflect a greater sensitivity of the 
RIA technique over PFC assays. The results of studies on IgA 
secretion in this serum-free system were consistent with previous work 
on IgA secretion. IgA PFC were not induced in cultured CBL by PWM, 
EBV or SAC (Andersson, Bird and Britton, 1981; Unander, Hammarstrom 
and Smith, 1983), although sequential studies indicated IgA PFC 
appeared between 2-6 months of age (Andersson, Bird and Britton, 
1981). 
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In the present study, stimulation with Tr increased IgM 
production (up to 10-fold) in almost all samples but did not increase 
IgG or IgA secretion. Work on adult cells has also indicated an 
increase in polyclonal IgM response to this antigen (Brenner and 
Munro, 1981). However, no increase in specific antibody was detected 
in the Tr-stimulated infant cell cultures. Although it is possible 
that TT is acting as a mitogen, there has been no evidence from 
previous work that Tr is mitogenic. This non-specific stimulation is 
possibly due to endotoxin in the Tr preparation (Rethy, 1983). 
Comparison of immunoglobulin synthesis in breast- and bottle-fed 
infants was difficult due to the small number of samples with cells 
remaining for these studies, particularly in the younger infants. A 
comparison between the older infants indicated slightly higher levelt 
of IgM in the supernatants from bottle-fed infants but the differences 
were not significant. This was particularly unfortunate since the 
largest differences in spontaneous proliferative responses occurred in 
the 6 day and 6 week old infants. 
2) Attempts to enhance immunoglobulin and specific antibody production 
tn vttro. 
The modifications to the lipid content of the serum-free medium 
and use of a more highly buffered medium during cell separation 
procedures have been shown to enhance B cell function in adult 
cultures (Farrant at aL., 1984). In the cultures of infant cells, 
total IgM and IgG secretion were enhanced, particularly at the lower 
cell concentrations, but this modification alone was not sufficient to 
allow specific antibody production. 
lEG 
Addition of B cell growth and differentiation factors to the 
cultures greatly enhanced IgM secretion, but unlike adult cultures 
(North and Brenner, 1983) did not stimulate cells to differentiate and 
secrete IgG. Addition of TT to these BCGF stimulated cultures further 
enhanced total IgM production, but no specific antibody was detected, 
even in cultures of cells from vaccinated infants. In adults, it has 
been shown that, even using optimal T, B and monocyte numbers, only in 
a very low proportion of TT-immune donors can PBM be stimulated to 
secrete specific antibody to vitro (Brenner at aL., 1983). This 
proportion of 'tn-vitro responders' can be greatly increased by 
addition of lectin-free supernatants from PWM-stimulated PBM cell 
cultures which contain growth and differentiation factors for B cells, 
but there remains a proportion who still fail to respond to vitro 
(Brenner at aL., 1983). It is therefore not clear whether the 
unseparated infant PBM cells were not secreting specific antibody 
because they were 'Ifn-vitro non- responders', whether they were 
generally immature in some way, or whether conditions were still 
sub-optimal. 
The presence of nanocytes has been shown to be critical in adult 
immunoglobulin and antibody producing systems to vttro (Qnelig-Myeling 
and Waldmann, 1981) but the optimal level is about 5% compared with 
the higher percentage in PBM (Montazeri et aL., 1980). In this 
present study, depletion of monocytes in adult PBM preparations by 
adherence to plastic not only enhanced total IgM production in the 
presence of PWM or BCGF, but in the presence of BCGF and Tr, 
stimulated secretion of specific IgG anti-'IT antibodies. Similar 
monocyte depletion procedures in 9 month old vaccinated infants did 
not, however, have the same effect. With infant cells, total IgM 
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secretion was still not enhanced by PWM, although in some infants it 
was enhanced by BCGP. This supports the finding of Andersson at aL., 
(1981) that the lack of response to PWM by CBL is due to a helper T 
cell defect, rather than aB cell defect. Also, addition of BCGF and 
TT stimulated only very low levels of specific antibody in 2/5 
infants. It is possible that these infants are in the 'tn-vttro 
non-responders' group, as clearly they had made vigorous specific 
antibody responses to Tr vaccination to vtvo. However, it was also 
possible that the helper T cell deficiency, apparent in PWM driven 
systems, was retarding specific antibody production to uttro. The 
possibility of suboptimal conditions still remains. 
Attempts to enhance further specific antibody production in adult 
cell cultures by depletion of T cells proved unsuccessful. Use of 
monoclonal antibodies showed that depletion of the 
suppressor/cytotoxic subset of T cells considerably enhanced IgM 
secretion in the presence of BCGF or PWM, but did not induce specific 
IgG anti-'IT in an adult donor known to be an Iin- vitro responder'. 
The technique still required large cell numbers and was not felt to be 
advantageous in that respect over conventional T cell rosetting 
techniques. 
It would seem from these studies, that the B cells in peripheral 
blood of infants cannot be induced to secrete specific antibody to 
vttro without using large quantities of cells. Although absolute B 
cell numbers in newborn infant blood are higher than in adult blood, 
the ratio of suppressor T to helper T cells is also significantly 
higher (Thomas and Linch, 1983). In adult cultures using separated T 
and B cells, it has been noted that irradiated T cells (2000 cads) 
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give better help than non-irradiated cells (North and Brenner, 1983), 
and this has been attributed to the greater radiosensitivity of 
suppressor T cells than helper T cells (Keightly, Cooper and Lawton, 
1976; Moretta et at., 1977). Since infant PBM cells have a higher 
proportion of suppressor cells, it may be that separation and 
irradiation are crucial steps in attempts to get specific antibody 
production to vitro. The fact that two infants did produce small 
amounts, indicates that the appropriate cells are present in infants 
by 9 months. 
The observation that infant cells respond to B cell growth and 
differentiation factors with production of IgM but not IgG, suggests 
that the large numbers of B cells present are early B cells. In 
adults, BCGF has been shown to act on activated B cells only, that is 
memory B cells or B cells which have been activated to vttro by the 
appropriate T cells (Brenner et aT.., 1984). The fact that they do not 
act on resting B cells would indicate that the majority of infant B 
cells have not yet met antigen and the pool of memory cells is 
therefore much smaller than in adults. 
SUMMARY 
Unseparated infant PBK cells have been cultured in serum-free 
media using Terasaki plate hanging-drop microcultures and the 
supernatants have been examined by RIA for production of 
imnunoglobulins and specific antibodies. 
In unstimulated cultures, IgM was detectable at low levels (100 
ng/ml or less) in supernatants from infants from 6 days of age, but at 
higher cell concentrations only. IgG was detected in all cultures 
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from infants of all ages and increased slightly with age. IgA was not 
detected in cultures from one 6 day old baby but was detected in 
cultures from all 6 and 9 month old infants. 
In contrast to adult PBL cultures, PWM enhanced IgM production 
only slightly in a few older infants and had no effect on IgG or IgA 
secretion. Tetanus toxoid enhanced IgM production in most infants 
(15/20) but did not stimulate IgG or IgA production. In none of the 
cultures of unseparated PBM cells was specific anti--TT antibody 
detected, in spite of good proliferative responses to this antigen 
(see Chapter 4). 
Comparison of inmunoglobulin production in breast- and bottle-fed 
infants was difficult as the numbers in each group at each age were 
small, particularly under 3 months of age. At 6 and 9 months, igM 
production was slightly higher in the bottle-fed group and IgG 
production was slightly higher in the breast-fed group but these 
differences were not significant. Nor were there any significant 
differences in the total IgM response to TT. It has therefore not 
been possible to correlate the differences in proliferative responses 
of cells from the two feeding groups (see Chapter 4) with to vitro 
immunoglobulin or antibody production. 
Attempts to enhance inmunoglobulin and specific antibody 
production in cultures of unseparated PBM produced further information 
about lymphocyte function in newborn infants. Addition of B cell 
growth and differentiation factors to cultures of infant PBM greatly 
enhanced IgM but not IgC production. In these BCGF stimulated 
cultures, PWM still failed to induce further immunglobulin synthesis 
of any isotype. This suggests that the B cells in infant blood are 
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capable of secreting IgM up to adult levels, but the reduced 
differentiation into IgG and IgA secreting cells indicates that either 
the helper T cells necessary for differentiation into IgG secreting 
cells may be absent or immature, or that most of the B cells present 
in infants are early B cells and activated or memory B cells are 
greatly reduced. Depletion of monocytes from the infant PBM cells 
enhanced IgM secretion in the presence of BCGF, but did not enhance 
PWM induction of IgM, suggesting that high numbers of monocytes may 
also be having a suppressive effect. 
Cultures were also assayed for specific IgG anti-TT in response 
to TT stimulation. In adult PBL cultures, depletion of monocytes, 
followed by addition of BCGF and TT resulted in specific antibody 
production in a TT- immune donor but in infant cell cultures, gave 
only very low levels of IgG anti--TT in 2/5 vaccinated infants tested. 
This low level of specific antibody production could be due to 
sub-optimal culture conditions, but might also be due to low numbers 
of to vtvo TT-activated B cells or the helper T cell defect apparent 
in the PWM driven cultures. All these infants responded to IT 
vaccination to vtvo with production of large quantities of specific 
IgG anti-. 7T, suggesting that the poor to vttro response may be a 
defect in the signals provided for the B cells under the present 
culture conditions. Techniques using monoclonal antibodies to reduce 
the numbers of all T cell subsets or the suppressor/cytotoxic subset, 
used large numbers of cells and were unfortunately not suitable for 
infant studies. 
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CHAPTER 6 
IN VIVO STUDIES ON INFANT SERA 
SECTION A- INTRODUCTION 
1) Absorption of milk inmunoglobulins 
The extent of the absorption of intact macromolecules by the gut 
of the neonatal infant has been investigated for over 50 years, 
(reviewed by Leissring, Anderson and Smith, 1962). Most of the 
earlier studies used the technique of feeding high titre antisera to 
the infant, and measuring the increase in antibody titre in the 
infants' blood. The failure to demonstrate uptake by the neonatal gut 
has been attributed to the inaensitvity of the techniques used to 
detect these antibodies. Improvement of the sensitivity for 
detection, has indicated that serum antibodies can be absorbed by the 
neonatal gut during the first few days of life (Leisaring, Anderson 
and Smith, 1962). Initial attempts to show absorption of antibodies 
from human milk in breast-fed infants, by measurement of total IgG and 
IgM antibodies in the sera of these and bottle-fed infants, were 
unsuccessful (Vahlquist, 1958). However, following the discovery of 
serum IgA and a separate secretory immune system (Hanson, 1961), there 
was renewed interest in the gut absorption of immunoglobulins. The 
results of more recent studies are still somewhat conflicting. Yengar 
and Selvaxaj, (1972) reported that IgG in the serum of breast-fed 
infants increased between birth (cord blood) and 5 days, whereas it 
decreased in bottle-fed infants. Ogra, Weintraub and Ogra (1977) 
demonstrated that IgA antibodies to polio appeared rapidly in the sera 
of newborn infants fed colostrum containing these antibodies, but 
absorption only took place during the first 24 hours after birth. 
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Saarinen, Pelkonen and Siimes (1979), however, showed an accelerated 
postnatal increase in the serum IgA levels of formulae-fed infants, 
which was apparent as early as 1 month, and was still significant at 6 
months. They suggested that this was due to a higher antigenic load 
in the gut of the bottle-fed infant. Higher serum IgA in bottle-fed 
babies has also been recorded in pre-term infants (Savilahti, 
Jarvenpaa and Raiha, 1983), although these workers also noted that 
babies receiving mostly their own mother's milk had higher serum IgA 
levels than those receiving human milk-bank milk. Other workers have 
found no differences in the serum immunoglobulin levels of breast- and 
bottle-fed infants (Ammann and Stiehm, 1966j Kletter at aL, 1971; 
Yap at aL, 1979). 
2) Stimulation of immunoglobulin production to vivo 
Recently the demonstration of factors in milk which can stimulate 
cell growth and differentiation to vitro has led to the suggestion 
that these factors may have a similar function to vtvo. Factors which 
can stimulate the growth of gut and epithelial tissues (Klagsburn, 
1978,1980: Tapper, Klagsburn and Neuman, 1979) Carpenter, 1980) are 
thought to be important in enhancing the maturation of the gut 
epithelium in the breast-fed infant. 
Pittard and Bill (1979a, 1979b) have demonstrated that there are 
factors in milk which can stimulate adult peripheral blood lymphocytes 
to differentiate into IgA secreting plasma cells (but not into IgG 
secreting cells). Other workers have demonstrated fn vitro secretion 
of lymphokines by breast milk cells (Goldman, 1977; Keller et aL, 
1981; Blau et aL, 1983). It is possible that these factors may be 
absorbed by breast-fed infants and their immune systems stimulated to 
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mature. 
To determine whether there is any early neonatal absorption of 
milk immunoglobulins, or stimulation of immunoglobulin production by 
growth factors absorbed from milk, it was decided to investigate not 
only total IgG, IgM and IgA, but also to assess the response of 
breast- and bottle-fed infants to specific antigens by measurement of 
serum antibodies. For this purpose, two antigens commonly encountered 
in early infancy were chosen. The first was tetanus toxoid, a protein 
antigen administered systemically in the standard vaccination 
protocol, and the second was E. co Lt lipopolysaccharide (LPS) '0. 
antigen from a pool of commensal strains to which the infants would 
almost certainly be exposed via their normal gut flora very early in 
life. 
3) Techniques 
For the total imaunoglobulin levels, the sera were assayed by 
laser nephelometry. This technique was very reliable for IgG, 
but 
proved insufficiently sensitive for the small quantities of IgM and 
IgA present in the sera of newborn infants. Total immunoglobulins 
were therefore also estimated by RIA. For the E. coLt antibodies, 
indirect haemagglutination (IHA) was tried, but this technique used 
fairly large quantities of serum, and so both ELISA and RIA techniques 
were investigated. The relative technical merits of each assay were 
compared, and the insensitivity of IRA for detecting IgG antibodies 
is 
discussed below. The IHA technique was found to give very misleading 
results for the sera of newborn infants. 
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Tetanus toxoid antibodies were estimated routinely by a 
solid-phase RIA. Again, an ELISA technique was investigated, but the 
greater sensitivity of the RIA technique, together with the 
availability of a computer link for calculation of RIA results made 
this the method of choice. The standardisation of this assay with a 
monoclonal igG anti-Tr antibody and an affinity purified anti--TT serum 
standard resulted in an accurate and reproducible assay (see Chapter 
2). The use of RIA for all immunoglobulin and antibody estimations 
enabled all the assays to be performed on as little as 50µl of serum. 
SECTION B- IMMUNOGLOBULIN AND ANTIBODY ASSAYS 
1) Nephelometry for Total IgG, IgM and IgA 
These assays were done either by the Haematology Department, NPH, 
or the Division of Immunological Medicine, CRC. A laser nephelometer 
(Hyland, N. V. Travenol Laboratories S. A., Belgium) was used and fresh 
samples (stored at 4°C for up to 4 days) were assayed against LAS-R 
Multiparameter Reference standards (Set A, Hyland). 
2) IHA for E. coLt Antibodies 
The technique of Neter, Bertram and Arbesman (1952) was adapted. 
Human group 0 red blood cells were washed in saline and O. lml packed 
cells were coated with 5ml E. coLt '0' LPS antigen for 30min at 37°C. 
These sensitised cells were washed and adjusted to a 1% suspension. 
Serum samples were inactivated for 30min at 56°C, 0.1ml of serum was 
then mixed either with O. lml phosphate buffered saline (PBS), or O. 
lml 
of O. iM 2-mercaptoethanol (2-ME) in PBS. After incubation at 37°C 
for 
30min, serial twofold dilutions were made in 25µl volumes in 'U' well 
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microtitre trays (Sterilin) and 25µl of coated RSC suspension added. 
Trays were incubated 3 bra at 37°C and then overnight at 4°C. The 
titre was expressed as the highest dilution showing at least 20% 
agglutination of red cells. Titres resistant to 2-ME were assumed to 
be due to IgG antibodies (Robbins, Kenny and Suter, 1965). 
3) ELISA for E. col4 Antibodies 
Flat bottomed microtitre trays (Dynatech) were coated with 100µ1 
of a 1/10 dilution of the E. colt antigen pool in coating buffer (0.05M 
carbonate pH9.6, Don Whitley Scientific Ltd., West Yorkshire) for 2 
hrs at 4°C and washed 3 times in PBS/Tween (Don Whitley). This 
optimal dilution was determined from a preliminary titration 
experiment (Fig 6- 1). Serial dilutions of antisera were made in 
PBS/Tween, dispensed in l00µ1 volumes and the trays incubated 3 bra at 
room temperature (RT). After further washing, l00µ1 of alkaline 
phosphatase conjugated rabbit anti-human IgG (Miles Laboratories), or 
similarly conjugated -IgM (Don Whitley) were added and incubated 
overnight at 4°C. Trays were washed and l00µ1 of substrate 
(p-nitrophenyl phosphate lmg/mi, Sigma Chemical Co. Ltd., London) in 
diethanolamine buffer, (Don Whitley) added. Colour change was read on 
an ELISA plate reader (Titretek Multiscan, Flow Laboratories, 
Scotland) using a 405nm filter. Readings were taken at intervals up 
to 3 hrs. Initial experiments indicated that the optimal time for 
colour development was 30min for IgG antibodies and 2hrs for IgM 
antibodies. 
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Figure 6-1 
E. coZt antigen titration curve for ELISE, 
2'01 Anti-IgM 
1.5-i 
. -. ev 
Anti-IgG 
o_JJ- III 
Serum dilutions 
A 1/10 
v 1/20 
o 1140 
  1/80 
0 1/1280 
10 50 100 500 
Reciprocal E. coil antigen dilution 
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4) Solid-phase Radioimmunoassay method (RIA) 
The assay was set up as described in chapter 2. Sera were 
diluted in blocking buffer. Initial dilutions were 1/5, followed by e 
serial 4-fold dilutions. This gave a detection range of between 
lOng-100µq/ml for specific antibodies, and 30ng-lmg/ml for total 
immunoglobulins. For levels of immunoglobulin higher than this, the 
dilution error was found to result in unacceptable reproducibility of 
the test (see below). 
5) Statistics 
Results of serum immunoglobulins and specific antibodies were 
log-transformed to normalise the distribution and means expressed are 
therefore geometric. Results were analysed by analysis of variance 
and significance was assessed by the F-test. Where differences 
between groups were tested for on single sampling occasions, a pooled 
t-test was used. 
SECTION C- RESULTS 
1) Comparison of Nephelometry and RIA for Total Immunglobulins 
i) IgG 
When the variability of results for total IgG assayed by RIP were 
compared with the variability of the results by nephelometry, (using 
the method of Grubbs, 1948, as described by Shukla, 1973) RIA was 
found to have a significantly higher measurement error than 
nephelometry (t-4.17, P-O. 00028). For total IgG estimations, 
therefore, the nephelometry results were used. 
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ii) IgM and Igg 
The minimum sensitivity of the nephelometry technique for detecting 
these inmunoglobulins in o. lml serum was 0.1mg/ml. All 6 day samples 
and most 6 week samples had less than this quantity of IgA, and most 6 
day samples had less than this quantity of IgM. Above this minimum 
level, correlation between the two tests was very good, (r-0.638 
P-c0.001) and results expressed are the averages of the two tests. 
2) Comparison of IHA, ELISA and RIA for E. co! t Antibodies 
i) Correlation of the tests 
In preliminary experiments, 4 sera (2 adult and 2 infant) were 
assessed for E. coLt antibodies by all three techniques. Antibody 
titration curves by ELISA and RIA, for these sera are shown in Figs 6 
- 2, and 6-3. Before the availability of the purified standards, 
difficulties arose in expressing the relative titres of IgG and igM 
antibodies as the slopes of the curves were not parallel. In Table 6 
-1 the results are expressed as a percentage of the highest titre 
serum and compared with the values for the same 4 sera obtained by 
IHA. Comparison of the three methods shows good correlation between 
them. The RIA and ELISA techniques have similar sensitivity (although 
the ELISA test used 5 times as much sample), but the IHA teat was far 
less sensitive (see below). 
ii) Quantification of E. coLt antibodies 
The purification and standardisation of an anti-E. coLt serum, made 
possible the quantitation of class-specific E. coLt antibodies. RIA 
was chosen in preference to ELISA because of the lower volume of serum 
required for a similar sensitivity. Initial experiments indicated 
surprisingly high levels of IgG antibodies in the infant sera even 
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Figure 6-2 
Titration curve for S. coLt antibodies by ELISA. Two adult (33 and MB) 
and two infant sera are shown. 
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TABLE 6-1 
DONOR AGE 
a 
MB 
1A 
SS IA 
BV I 2wk 
JA 9m 
COmpARISON OF IHA, ELISA AND RIA TECHNIQUES 
+ 
(M) 
IEtA 
2-HE 
(G) 
b 
256 64 
256 4 
<2 <2 
<2 <2 
ELISA 
IgM IgG 
C 
100 100 
72 15 
cO. 1 4.3 
4.0 0.4 
a A-Adult 
b Reciprocal of titres 
c Results expressed as % of positive control (MB), 
mean of 3 experiments 
RIA 
100 100 
85 17 
<0.1 5.4 
6.5 0.7 
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though these had negative titres by IHA. It was therefore decided to 
estimate the sensitivity of MA for detecting IgG antibodies. Table 6 
-2 shows a comparison of 19 infant and 2 adult sera by the two 
techniques. Quantitative antibody estimations by RIA indicate that 
the two normal adults had high levels of IgM (20µg/ml) but also had 
similar quantities of IgG (5-40)iq/ml) and IgA (4-25µg/ml) antibodies 
against E. coLt. The 2-ME resistant IHA titres however, (previously 
thought to indicate IgG and/or IgA antibodies) were considerably lower 
(1/8 and 1/32 compared with 1/256 for IgM). The infants had very low 
levels of specific IgM and IgA in the early neonatal period (15ng/ml 
or less) confirming the IHA titres (<1/2-1/10). Infants at 1 and 6 
weeks of age, however, had high levels of IgG antibodies to E. coLt, up 
to normal adult levels (5-10µg/ml) even though these antibodies were 
only just detectable by IHA. The older infants had lower IgG antibody 
levels, which were often undetectable by MA. Comparison of RIA and 
IM techniques therefore shows the minimum sensitivity of IRA for IgG 
antibodies is about 4µq/ml (i. e. 1000-fold less sensitive than RIA). 
The minimum sensitivity for IgM antibodies by IRA is about 1µg/ml 
which is 4 times higher than for IgG. This discrepancy between IgM 
and IgG detection is also seen by comparison of sample 20E (IgM 
11,000ng/ml) and sample 16E (IgG 11,000ng/ml), the corresponding IRA 
titres are 1/256 and 1/8 respectively. 
3) Total Imnunoglobulins in the sera of breast- and bottle-fed infants 
The geometric means (+95% C. I. ) of IgG, IgM and IgA for the 15 
infants in each group on each of the five sample occasions are shown 
in Fig 6-4. 
NVi 
/ 
TABLE 6-2 
COMPARISON OF IEfA AND RIA FOR E. C OLZ ANTIBODIES 
SAMPLE AGE 
NUMBER (WKS ) 
MB A* 
SS A 
18A 1 
12A 1 
12B 6 
05A 1 
O5D 26 
IgM 
RIA IHA 
IgG 
RIA IRA 
IgA 
RIA 
25500 
4000 
<10 
29000** 256*** 
19000 256 
<10 10 
15 20 
15 10 
<5 10 
170 <2 
15B 6 <20 <10 
20D 26 11000 256 
20E 39 10500 256 
28D 26 5000 64 
28E 39 8850 128 
16E 39 4150 128 
22E 39 840 c2 
04E 39 
02E 39 
11E 39 
26E 39 
OlE 39 
09E 39 
13E 39 
1800 16 
4000 64 
1140 32 
2400 128 
2085 32 
2800 64 
9350 64 
39400 64 
5000 4 
8500 c10 
6400 20 
4200 10 
5280 10 
750 c2 
1870 c10 
270 2 
2400 8 
720 2 
5000 8 
11000 8 
150 c2 
125 c2 
700 c2 
500 c2 
6400 c2 
500 2 
2050 2 
500 c2 
* A-Adult 
** Results expressed as ng/ml specific antibody 
*** IHA titres expressed as reciprocal of highest dilution showing 
at least 20% agglutination 
<5 
65 
c5 
10 
130 
130 
1890 
100 
460 
30 
30 
20 
140 
10 
120 
175 
400 
65 
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Figure 6-4 
Total iamunoglobulin levels in the sera of infants. Geometric means 
(n-15) ± 95% C. I. 0 Breast-fed 0 Bottle-fed 
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i) IgG 
At 6 days, serum IgG levels were almost as high as adult levels, with 
a geometric mean of 7mg/ml. The quantity of IgG declined from the 6 
day sample until 3-6 months when the mean was 3mg/ml. By 9 months IgG 
had increased over the 6 month level in all but 4 infants. 
ii) IgM 
Total IgM levels increased steadily from an average 160µg/ml at 6days 
to 600µg/ml at 9 months, although the range was wide (280-2170{tg/ml at 
9 months). 
iii) IgA 
All infants had detectable levels of IgA at 6 days, the mean being 
1.91 (1.34-2.69) (95%C. I. ) and 1.7 (1.29-2.24) µg/ml in the breast and 
bottle-fed groups respectively. Although the mean IgA at 6 days was 
slightly higher in the breast-fed group, this difference was not 
significant (P-O. 39). IgA rose rapidly to 80 (43-115) µg/ml at 6 
weeks of age and to 190 (140-275) gg/ml by 9 months. There was a 
significant correlation in the IgM and IgA levels of the infants of 
both groups, (r-0.768, Pc0.001), and this was highest from 6 weeks 
onwards. 
The results for total inm unoglobulins of all three classes in the 
sera of all infants fell within the normal limits for infants, 
published by other workers, as shown in Table 6-3. There were no 
significant differences in ranges or mean values between the two 
feeding groups for the three Ig classes on any sample occasion. 
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TABLE 6-3 
TOTAL IMQCNOGLOBULINS IN THE SERA OF BREAST- AND BOTTLE-FED INFANTS 
1 WEEK 
IgG (mg/ml) 
BREAST- 7.24* 
(4.7-12.1) 
BOTTLE- 7.26 
(4.7-12.3) 
NORMAL* * 10.04 
COMPARED WITH NORMAL RANGES 
AGE 
6 WEEKS 3 MDNTRS 
4.78 
(2.6-8.3) 
4.71 
(2.8-8.8) 
2.92 
(1.6-6.0) 
3.52 
(2.5-6.5) 
6 MONTHS 
3.09 
(1.8-5.3) 
2.98 
(1.2-6.7) 
3.65 3.81 
9 lDMPEiS I 
4.40 
(2.9-6.8) 
3.99 
(2.0-7.7) 
4.88 
(5.98-16.72) (2.18-6.1) (2.28-6.36) (2.92-8.16) 
IgM (ftg/ml ) 
BREAST- 138 
(30-660) 
BOTTLE- 138 
(55-220) 
NORMAL 90 
2@2 
(100-1100) 
309 
427 
(160-870) 
427 
(110-660) j (170-830) 
240 
J 
380 470 
676 
(160-2100) 
562 
(240-1340) 
(60-150) (110-510) (20-600) (180-1240) 
IgA ()ug/ml ) 
BREAST- 1.91 
(0.45-6.1) 
BOTTLE- 1.7 
(0.5-3.65) 
NORMAL c50 
69.2 115 
(22-230) (30-200) 
91 112 
(40-200) (45-230) 
160 220 440 
* Figures are geometric means with ranges in parentheses 
** Normal Ranges from Nathan, D. G. and Oski, F. A. (Eds) 1981 
166 
(76-270) 
148 
I 
i 
(80-330) 
427 
(160-870) 
468 
(210-1500) 
195 
(90-76) 
178 
(95-385) 
I 
1 
Haematology of Infancy and Childhood. W. B. Saunders Co. 
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4) Tetanus toxoid antibodies 
i) General response 
The precise timing of vaccination varied considerably within and 
between- the groups and this had a significant effect on the antibody 
levels at 6 and 9 months. The infants were therefore allocated to 
vaccine groups for analysis of the results, as shown in Chapter 3 
(Table 3- 8). The five vaccine groups were 
I-1 dose only 
II -1 dose between 3-6 months, 2nd dose between 6-9 months 
III -2 doses between 3-6 months 
IV -2 doses between 6-9 months 
V-3 doses between 3-9 months 
Infants receiving DT and DTP vaccine were analysed together as there 
were no detectable diferences in the magnitude of their responses. 
The only vaccine groups with sufficient numbers to compare responses 
between feeding groups, were vaccine groups II and III. Since the two 
infants (05 and 31) in group V receiving three doses of vaccine during 
the study period did not appear to differ in their responses from 
those receiving only two doses, they were included in groups iI and 
III for analysis. The IgG and IgM resposes of the individual infants 
in groups II and III to tetanus toxoid are shown in Figs 6-5 and 6 
respectively. The means of these and the IgA results are shown in 
Table 6-4. 
a) IgG anti-'1T 
All infants responded to one or two doses of vaccine with production 
of large quantities of specific IgG antibodies. The increases 
folowing the second dose were up to 10,000-times the prevaccinaton 
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level, resulting in as much as 100µg/ml specific antibody. This 
increase was not affected by the presence of maternal antibodies 
specific for tetanus toxoidt comparison of the responses in infants 
with more than 500ng/ml of maternally acquired IgG anti-'LT (mean 
123ong/ml,. n=e), with those having less than this amount (mean 
46ng/ml, n-13), showed no significant difference between the maximal 
amount of IgG antibodies produced (P-O. 46). In addition the maximal 
IgG antibody level was unaffected by the timing of the vaccinations, 
i. e. group II or group III. The age at which this maximal response 
occurred (6 or 9 months) was, however, affected by the vaccination 
timing, causing significant differences between the vaccine groups 
(P-O. 016). Since there were unequal numbers of breast- and bottle-fed 
infants in each group, these results could not be pooled for analysis. 
b) IgM anti-IV 
Not all infants responded to a single dose of vaccine with an increase 
in specific IgM, but increases in IgM antibodies occurred in all 
infants following their second dose of vaccine. The maximal specific 
IgM response was, however, considerably lower than the specific IgG 
response, with only an average 10-fold increase, resulting in a 
maximum of 1µq/ml (compared with 100µg/ml IgG). This compared with a 
2-fold increase in total IgM over the same time period (3-9 months). 
c) IgA anti-APr 
specific IgA antibodies were found in only a few infants, and the 
levels were low. Only one infant had IgA antibodies above bong/ml 
(infant 15 at 6 months, 1300ng/ml). 
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Figure 6-5 
IgG and IgN anti-RT antibodies in the sera of breast- and bottle-fed 
infants. Each line represents the average of duplicate assays on 
individual infants. Matching symbols for G and K antibodies represent 
the same infant. 
Vaccine group II - see text for details 
Breast-fed 
0 
Bottle-fed 
6903 
Age in months 
69 
t Vaccination 
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Figure 6-6 
IgG and IgM anti-TI' antibodies in the sera of breast- and bottle-fed 
infants. Each line represents the average of duplicate assays on 
individual infants. Hatching symbols for G and M antibodies represent 
the same infant. 
Vaccine group III - see text for details 
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TABLE 6-4 
Antibody Responses of Breast- and Bottle-fed Infants to Two Doses 
of Tetanus Toxoid Vaccine 
VACCINE FEEDING NO. 
a 
GROUP GROUP INFANTS 
IgG 
AGE 
I WK 6 WK 3 MTH 6 MTH 9 MTH 
b 
II Breast 7 224 135 85 1,445 15,136 
Bottle 5 78 40 31 1,288 33,884 
III Breast 3 59 3 24 15,850 4,570 
Bottle 6 460 250 59 19,050 4,470 
i 
1 
rym 
II Breast 7 
Bottle 5 
III Breast 3 
Bottle 7 
IgA 
II Breast 7 
Bottle 5 
III Breast 3 
Bottle 7 
10 10 18 68 209 
23 23 60 295 324 
16 45 66 182 560 
15 19 27 257 263 
<10 <10 <10 12 14 
c10 <10 <10 12 17 
<10 <10 <10 25 21 
c10 <10 <10 39 24 
a See text for vaccination details 
b Results are geometric means of data shown in Figs. 6-5 
and 6-6, expressed as. ng/ml of specific antibody 
ii) Comparison of breast- and bottle-fed infants 
There were no significant differences between breast- and bottle-fed 
infants in both vaccine groups, either in the rate or magnitude of the 
specific IgG, IgM or IgA anti-tetanus toxoid responses. The slightly 
lower means of IgM levels of the breast-fed infants in vaccine group 
iI at 6mths (Table 6- 4) resulted from the failure of two infants to 
show an IgM response at this time (i. e. after only one dose, Fig. 6 
- 5); the difference was not significant (P-0.07). 
5) Antibodies to E. coLt 'O' antigens 
The geometric means for IgG-, IgM- and IgA- E. coLL antibodies are 
shown in Fig. 6-7. 
i) IgG anti-E. coLi 
All infants had high levels of IgG antibodies to commensal E. coLt 
antigens at 6 days (range 700-14,000ng/ml), which declined at a 
similar rate to the total IgG levels over the first 3 months. There 
were no significant differences between the levels in breast- and 
bottle-fed groups at any age, although the bottle-fed group showed a 
slight increase in specific IgG at 9 months which was not found in the 
breast-fed group (P-0.12). 
ii) IgM anti-E. coLt 
In contrast to the similarity of IgG anti-E. coLt antibodies, there 
were highly significant differences between the breast- and bottle-fed 
groups in the quantity of IgM antibodies (P<0.0001) with higher levels 
in the bottle- fed infants. This difference was apparent as early as 
6 days when only 2/15 breast-fed infants had detectable antibody 
compared with 7/15 in the bottle- fed group. The differences in the 
quantities of igM antibodies were greatest at 3 and 6 months when 
z12 
Figure 6-7 
Z. coLt antibodies in infant sera. 
O-O Breast-fed 3,7 months (ns12)jI---f Breast-fed <2 months (n-3)j 
f--I Bottle-fed (n-15); Geometric means ±95% CI. 
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there was very little overlap in the range of antibodies between the 
two groups (<1o-150ng/ml in the breast-fed infants compared with 
80-1110ng/ml in the bottle-fed infants at 3 months). The three 
breast-fed infants who were weaned before 3 months, were analysed 
separately (Fig 6- 7). Each produced IgM anti-E. co&t antibodies at 
levels similar to the breast-fed infants up to 6 weeks, but by 6 
months had antibody levels as high as the bottle-fed infants. The 
rate of increase of IgM anti-S. coLt antibodies in bottle-fed infants 
was far greater than the rate of increase of IgM anti-tetanus toxoid 
and of total IgM, as can be seen from comparison of Figures 6-4 to 
7. 
ii) IgA anti-E. coLt 
There was also a greater increase in IgA antibodies to E. coLt in the 
bottle- fed group, but there was wide variation within the groups and 
the difference was not significant (Pa0.17 at 9 months). The three 
breast-fed infants weaned early, again had IgA anti-E. coLi antibodies 
similar to those found in bottle- fed infants. 
SECTION D- DISCUSSION 
1) Total immunoglobulins 
There have been many studies of human infants to determine 
whether the large quantities of secretory IgA and other 
inmunoglobulins in breast milk are absorbed by the neonate. Results 
from these studies have been conflicting, with reports that both IgG 
(Yengar and Selvaraj, 1972), and IgA (Ogra, Weintraub and Ogra, 1977) 
were absorbed by breast-fed infants, that there was no difference 
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between the groups (Anunann and Stiehm, 1966; Kletter at at, 1971; 
Yap at at, 1979) and that there was increased IgA in bottle-fed 
infants (Saarinen, Pelkonen and Siimes, 1979; Savilahti, Jarvenpaa 
and Raiha, 1983). Many of the earlier studies used insensitive 
techniques which failed to detect the small amounts of IgA present in 
the sera of newborn infants. The results from the present study 
indicate that all full-term healthy infants tested had detectable IgA 
in their serum by 6 days of age, and extend the findings of Kletter at 
at, (1971) who showed no differences in levels of IgG, IgM or IgA in 
the sera of breast- and bottle-fed infants on any occasion up to 7 
months. This study indicates a wide range of immunoglobulin levels in 
the sera of infants at each sample occasion from 1 week to 9 months, 
but all levels fell within the normal ranges, and there were no 
differences in the ranges or the mean values for any class of 
immunoglobulin on any sample occasion between the two feeding groups. 
The study included one breast-fed atopic infant. This infant had 
serum IgA at about the 5% confidence level from 6 weeks of age 
(45µq/ml, to 100µq/m1 at 9 months) although levels at 6 days were 
higher than average (3.4µq/ml). Soothill and colleagues (Taylor at 
at., 1973) have suggested that atopy in infants is due to a transient 
IgA deficiency in early infancy and this infant could fall into this 
category. However there were other infants in this study who had even 
lower IgA levels, yet showed no signs of allergic disease. 
These results on serum IgA levels indicate that either milk 
inmunoglobulins are not absorbed in significant quantities, or that if 
any of the IgA in breast milk is absorbed, it is cleared rapidly 
from 
the blood. Peppard at at, (1981) have shown in rats that dimeric IgA 
injected intravenously is cleared rapidly via the hepatic cells into 
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the bile. This mechanism is thought to be mediated by receptors on 
the hepatic cells, which have been identified as secretory component 
molecules. Such a mechanism has yet to be demonstrated in the human, 
but is unlikely to operate for sIgA, which already has a molecule of 
secretory component attached. 
2) Specific antibody responses 
i) Responses to tetanus toxoid vaccination 
Quantification of antibody responses to tetanus toxoid has shown that 
all infants studied responded to two doses of toxoid with an average 
400-fold increase in specific IgG. The rate of response was affected 
by the time interval between vaccine doses, but the maximal response 
was similar in all infants regardless of the timing of the doses, or 
the quantity of maternally acquired IgG anti-, TT present. IgM 
responses did not always occur after a single vaccine dose, but all 
infants showed an increase in specific IgM after their second dose. 
This was of a low magnitude (average 4-fold increase) compared with 
the IgG response. This is similar to the responses in adults to a 
booster dose of tetanus toxoid (Brenner, 1981). As would be expected 
from a systemically administered antigen, serum IgA responses to 
tetanus toxoid were low or undetectable. For all three classes of 
immunoglobulin, there were no significant differences between the 
responses of breast- and bottle-fed infants to tetanus toxoid. This 
is in agreement with the findings of Zoppi et aL. (1983) who showed a 
similar total specific antibody response to tetanus toxoid, diphtheria 
toxoid and pertussis vaccination in breast-fed infants and those fed 
cow milk formulae with a high protein content (although those fed low 
protein formulae showed a reduced response with a more rapid decline 
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of the antibodies produced). This similarity in the antibody response 
of breast- and bottle-fed infants suggests that their capacity to 
respond to a systemically administered protein antigen develops at a 
comparable rate. 
ii) Responses to normal gut flora 
a) Disparity between IRA and RIA 
Quantification of E. coLt antibodies by RIA has shown that specific IgG 
anti-E. coLt antibodies at 6 days were high in both breast- and 
bottle-fed infants (up to adult levels). Previous measurements (Meter 
at a&., 1955) indicated low or undetectable antibodies to E. coLt. 
However these studies had used indirect haemagglutination (IHA), a 
technique known to favour the detection of IgM antibodies and to be 
relatively insensitive for IgG detection (Ahistedt at al., 1975). 
Comparison of the RIA and IRA techniques in this study has shown that 
the limit of detection for IgG anti-E. colt antibodies by IHA is about 
4,000ng/ml. Indeed many of the sera collected at 6 days which had 
high IgG but undetectable IgM E. coLt antibodies by RIA, had titres of 
1/4 or less by IHA, indicating how misleading IHA can be in assessing 
antibody levels in neonates. 
b) Differences in responses to gut antigens 
In contrast to the similar responses of breast- and bottle-fed infants 
to a systemically administered protein antigen, responses to an 
antigen encountered in the gut indicated major differences between the 
two feeding groups, particularly in the IgM and IgA classes of 
antibodies. First, although the IgG E. coLt antibody levels were 
similar in breast- and bottle- fed infants up to 6 months, more of the 
bottle-fed infants showed an increase from 6-9 months than the 
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breast-fed infants. 
Second, although the IgM anti-E. cotf response showed a rapid rate 
of increase in both groups, with up to a 1000-fold increase in 
specific IgM, there was a significantly greater increase in IgM 
anti-E. cat antibodies in the bottle-fed group, as early as 6 days. 
This higher level was maintained and was maximal by 3-6 months 
(P<o. 001). 
3) Reduced systemic exposure to gut antigens in breast-fed infants. 
As total immunoglobulin levels and the specific antibody response 
to tetanus toxoid suggest that immune potential is similar in the two 
feeding groups, then the differences in antibody levels to E. coLt 
indicates a difference in systemic exposure rates to these organisms. 
The neonatal gut is known to be more permeable than the adult gut to 
macromolecules (Chandra, 1979), and there are several reasons why the 
bottle-fed infants could have a higher rate of systemic exposure to 
E. cott antigens from the gut than breast-fed infants. 
i). Normal gut flora 
Some studies have indicated that there may be greater numbers of 
E. coLt in the gut of the bottle-fed infants. It has been shown that 
the lower buffering capacity of human milk, together with the presence 
of a factor which encourages the growth of Lactobacilli, produces a 
more acidic environment in the gut of breast-fed infants which 
discourages the growth of coliform organisms (Bullen, 1961). 
Examination of the stools of breast- and bottle-fed infants has shown 
a higher number of coliforms in the stools of bottle-fed infants 
(Bullen and Willis, 1971). The balance of normal gut flora has also 
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been shown to be important in mice in limiting translocation of E. coLt 
from the gut to the mesenteric lymph nodes (Berg 1980), so the higher 
numbers of Lactobacilli found in the stools of breast-fed infants 
could be helping to limit translocation of E. coLt in these infants. 
ii) Milk antibodies 
Human milk contains large quantities of sIgA antibodies and many of 
these antibodies are directed against organisms colonising the 
mothers' gut, including E. coLt (Goldman and Smith, 1973 ). These 
antibodies can be shown to vitro to have anti-adhesive properties 
(Williams and Gibbons, 1972), and are thought to have an important 
role to vtvo in preventing gastrointestinal passage of gut antigens 
(Skogh, Edebo and Stendhal, 1983). 
iii) Foreign protein 
Another possible reason for the increased serum antibodies in the 
bottle-fed infants could be an adverse reaction to cow-milk protein. 
Large amounts of cow milk protein antigens can be shown to cross the 
neonatal gut wall and stimulate production of serum and secretory 
antibodies (Kletter at at, 1971; Eastham and Walker, 1977,1979). 
This immune reaction may cause inflammation and thus further increase 
the permeability of the gut to macromolecules. 
iii) Epithelial growth factors 
Human milk also contains factors which stimulate maturation of gut 
epithelium to vitro and perhaps accelerate maturation of an intact 
mucosal barrier (Walker, 1977). Breast-fed rabbits have been shown to 
have a lower uptake of orally administered bovine serum albumin, which 
was not due to anti-BSA antibodies in the milk, and was again 
attributed to increased maturation of gut epithelial cells (Udall et 
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at., 1981). This enhanced maturation may prevent passage of E. coLt 
antigens across the gut wall in breast-fed human infants. 
4) Overall similarity of sera from breast- and bottle-fed infants 
This comparison of serum antibody responses of breast- and 
bottle-fed infants has not indicated whether breast milk provides 
factors - lacking in cow milk formulae - which stimulate the 
maturation of the immune system. Even if such factors were present, 
their action may be masked, for the bottle-fed infant undoubtedly 
receives greater stimulation to its immune system in the form of 
increased antigenic challenge from gut antigens. This increased 
antigenic challenge may itself cause endogenous release of growth 
factors which may act on cells of the immune system and stimulate them 
to mature. Endotoxins from gut bacteria are known to be mitogenic to 
vttro, particularly for B cells, and have been shown to enhance 
specific antibody production to utvo in mice (Lagrange et at, 1975a 
and b) and in humans (Rethy, 1983). In Germany, an oral vaccine 
consisting of live E. cott and Strep. faecaLts has been administered to 
humans and animals for the last 20 years in the therapy of chronic and 
recurrent infections, not only of the gut, but also of the respiratory 
tract and for allergies. The mechanism of action is not fully 
understood, but recent animal work suggests a non-specific stimulation 
of the immune system (Rusch, Hyde and Luckey, 1983). If bottle-fed 
infants are receiving immunological stimuli in the form of increased 
antigenic challenge and increased absorption of gut endotoxins, then 
the similarities in total immunoglobulin levels and responses to 
tetanus toxoid suggest that the breast-fed infants may be receiving a 
similar stimulus from growth factors in milk. There is evidence that 
2 ýo 
human colostral and milk cells can secrete growth factors (epidermal 
growth factor) and lymphokines (including lymphocyte-derived 
chemotactic factor, y-interferon, and prostaglandins E and F) to uttro 
which are capable of stimulating lymphocytes to mature (Goldman, 1977; 
Keller at at., 1981; Blau at at., 1983). 
This overall similarity in the capacity to produce systemic 
antibodies may therefore obfuscate the different ways by which the 
immune system is stimulated to mature in breast- and bottle-fed 
infants. The difference in mechanism is of more than theoretical 
interest. Stimulation by normal gut flora may not constitute a great 
hazard in developed countries such as the U. R. which are relatively 
free from disease, but could cause severe problems in countries where 
enteropathogenic disease is hyperendemic. 
SUMMARY 
The effects of breast- and bottle-feeding on serum immunoglobulin 
levels and specific antibody responses in infants have been examined. 
No significant differences were found between the two feeding groups 
in total immunoglobulin levels of G, N and A classes on any sample 
occasion. All infants responded to two doses of a systemically 
administered tetanus toxoid vaccine with production of large 
quantities of specific IgG antibodies, regardless of the initial level 
of (maternally derived) anti-tetanus toxoid IgG. Again there were no 
significant differences between the breast- and bottle-fed infants, 
suggesting that the capacity of the two groups to make serum 
antibodies develops similarly. Concentrations of antibodies to 
commensal E. coLt lipopolysaccharide (LPS) antigens were significantly 
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greater in the bottle-fed group, and it is suggested that this 
difference is due to an increase in the exposure of the systemic 
immune system to these gut antigens in the bottle-fed infants. There 
are several possible explanations for this increased exposure and the 
resulting effects on the infants' immune system. 
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CHAPTER 7 
IN VIVO STUDIES ON SECRETIONS 
SECTION A- INTRODUCTION 
The lack of antigenic stimulation to utero means that the 
secretory immune system is functionally immature at birth. This 
results in very low levels of immunoglobulins in secretions. In order 
to determine the effects of breast- feeding on the development of this 
system, it was necessary to choose a secretion which was easy to 
obtain in sufficient quantities, without causing inconvenience to the 
infants or mothers. Saliva is the simplest secretion to collect in 
infants, but has the disadvantage that it is impossible to obtain 
samples from breast-fed infants which are not contaminated with the 
immunoglobulins from milk. Roberts and Freed (1977) considered that 
the higher concentration of IgA in the saliva of 6 day old breast-fed 
infants was due to an active stimulation by factors in human milk. 
However, Gross and Buckley (1980) suggested that contamination by IgA 
from milk was a more likely explanation. The latter workers found no 
differences between breast- and bottle-fed infants when samples were 
collected at least 4 hours after the last feed. For the present 
study, although mothers were requested not to feed their infants for 
at least 2 hours before sample collection, it was felt unethical to 
withold food for up to 4 hours if the infants were obviously hungry. 
Monoclonal antibodies to allotypic markers, which could distinguish 
between maternal and infant IgA, were not available. The IgA measured 
in the saliva of breast-fed infants prior to weaning, could therefore 
be of either maternal or infant origin. However, since this study 
continued beyond the weaning period for many of the breast-fed 
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infants, and since the Igh in the saliva of the bottle-fed infants 
will be totally derived from the infant, it was felt that the study of 
salivary imaunoglobulins might indicate differences between the two 
groups. 
SECTION B- METHODS 
1) Processing of saliva samples. 
Undiluted saliva samples, or saliva samples washed from the 
catheter with 20oµ1 PBS (see Chapter 2) were homogenised by forcing 
frozen/thawed samples repeatedly through a fine bore pasteur pipette. 
Sonication in a sonicating water bath was also tried but this did not 
improve homogenisation and had the disadvantage of causing a 
considerable rise in temperature. Other workers have used 
centrifugation or passage through a millipore filter to remove debris 
but this was considered unsatisfactory since there would also be an 
inevitable lose of immunoglobulins, which might be attached to cells 
or mucins. 
All samples were tested for contamination with blood, by using 
Uemastix (Ames Reagent strips, ! tiles Laboratories Ltd. ) and all were 
negative. 
2) Total protein estimations 
Total protein assays were carried out on all saliva samples. 
Immunoglobulins were expressed as µg/mg protein; where sufficient 
sample was available (6 weeks to 9 month samples only) immunoglobulins 
were also expressed as µg/ml undiluted saliva. A protein-dye binding 
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microassay was used (Bradford, 1976). This technique involves the 
binding of Coomassie Brilliant Blue dye to protein, which causes a 
shift in the absorption maximum of the dye from 465 to 595nm. The 
bovine gamma globulin (BOG) standard (Bio-Rad) was diluted in PBS to 
give a range of concentrations (usually six) between 1 and 25µq/ml. 
Samples were diluted to give protein concentrations within this range 
(a 1: 1000 dilution was found to be appropriate). Standards or samples 
were dispensed in lml volumes in 1/2 inch test-tubes and 250µl of 
Bio-Rad dye reagent concentrate (containing Coamassie Brilliant Blue 
G'-250, phosphoric acid and methanol) was added. Samples were mixed 
thoroughly on a vortex mixer (Hook and Tucker Instruments Ltd. ) and 
absorbance was measured between 5-60 minutes at 595nm on a 
spectrophotometer (Perkin-Elmer, Model 6/20). The absorbance of the 
standards was plotted against protein concentration (as shown in Fig 7 
- 1) and the concentrations of the samples were read from this curve. 
3) Radioimmunoassay for immunoglobulins. 
This assay has been described in Chapter 2. Saliva samples were 
initially diluted 1/5, followed by eight serial 4-fold dilutions in 
blocking buffer. The minimal sensitivity of this assay for detecting 
immunoglobulins in secretions was IgG 0.01µg/ml, IgM 0.02µg/ml and Igh 
o. oaµg/ml. 
4) Statistics 
Imiounoglobulin concentrations were log-transformed to normalise 
the distribution. Differences in immunoglobulin and total protein 
concentrations between feeding groups were assessed by the pooled 
t-test. 
Figure 7-1 
standard curve for estimating total protein concentrations in saliva 
sasples. A standard curve using bovine y-globulin was included in 
each assay. 
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SECTION c- RESULTS 
1) Total immunoglobulin levels in undiluted saliva. 
on no occasion was sufficient saliva obtained from a6 day old 
infant to make an intial measured dilution, however from 6 weeks, 
satisfactory samples were obtainable from most infants. Pigure 7-2 
shows the geometric means (± 95% C. I. ) of IgG, IgM and IgA 
concentrations. These means and the ranges are shown in Table 7-1. 
i) IgG 
At 6 weeks, the mean concentration of igG in saliva was lµg/ml, about 
0.02% of the concentration in serum at this time. The level declined 
until 6 months (average 0.44µq/ml), but by 9 months had risen in 11/15 
breast-fed infants and 12/14 bottle-fed infants. There were no 
significant differences between the two feeding groups. 
ii) IgN 
I9M levels rose slightly in both groups between 6 weeks and 9 months. 
On all occasions IgM was higher in the bottle-fed than the breast-fed 
group, and this difference was significant at 3,6 and 9 months 
(P-0.017,0.022 and 0.04 respectively). In breast-fed infants the 
concentrations rose from 0.5 to 1µg/ml and in bottle-fed infants from 
1 to 2µg/ml. IgM concentrations in saliva were approximately 1% of 
those in serum. 
iii) Iglu 
Concentrations of Iglu in saliva declined slightly from 100 to 25µg/ml 
from 6 weeks to 9 months. I9A levels were up to 100 times the 
concentration of IgG or igM. At 6 weeks salivary IgA was comparable 
with the IgA level in serum (96%) but by 9 months the concentration in 
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Figure? -2 
Immunoglobulins in undiluted saliva 
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TABLE 7-1 
IlMLJNOGIABULIN CONCENTRATIONS IN SALIVA 
FEEDING age- 6 DAYS 6 WKS 3 1'fIHS 6 KI'HS 9 KI' BS 
GROUP 
IgG 
BREAST ný 
lü*. AN 
RANGE 
BOTTLE n i 
HEAR 
RANGE 
P 
Ism 
BREAST MEAN 
RANGE 
BOTTLE MEAN 
RANGE 
P 
IgA 
BREAST MEAN 
RANGE 
BO'1TLZ MEAN 
RRN('E 
P 
0 10 14 15 15 
1.05* 0.50 0.42 0.72 
0.35-8.0 0.12-1.85 0.16-1.8 0.2-1.7 
0 12 14 15 14 
0.89 0.6 0.45 0.82 
0.27-4.5 0.09-4.9 0.2-2.2 0.4-1.7 
0.74 0.44 0.76 0.9 
0.47 0.53 1.0 0.96 
0.0-9.0 0.04-3.8 0.24-3.0.35-7.6 
1.14 3.31 2.51 2.40 
0.14-20 0.1-40 0.4-18 0.95-20 
0.20 0.017 0.022 0.040 
61.66 33.11 25.70 24.55 
13-485 14-280 6-73 5-135 
93.33 77.63 26.30 28.84 
9-190 19-250 9-130 10-108 
0.4 0.048 0.93 0.61 
* Iamunoglobulin concentrations in µg/ml saliva 
2 ti9 
TABLE 7-2 
GEOKETRIC MEANS OF Igle CONCENTRATIONS IN SERUM AND SALIVA FRON 
BREAST- AND BOTTLE-FED INFANTS 
AGE 6 WIC 3K 6M 9M 
BREAST-FED 
SERUM 69* 115 166 195 
SALIVA 62 33 26 25 
PERCE TAGE 90 29 16 13 
BOTTLE-FED 
SERUM 91 112 148 178 
SALIVA 93 78 26 29 
PERCENTAGE 102 70 18 16 
* Immunglobulin concentrations expressed, an µg/ml 
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saliva had fallen to 15% of serum IgA (Table 7- 2). As with salivary 
IgM, the IgA levels were higher in the bottle-fed group, and this 
difference was significant at 3 months (P-0.045). 
2) Total protein estimations 
Quantitative measurement of total proteins are shown in Fig 7- 
3. Large variations were found, particularly in the earlier samples. 
Concentrations in the two feeding groups were similar at 6 weeks, but 
from 3 to 9 months there was a higher total protein concentration in 
the bottle-fed group] this difference was significant at 6 and 9 
months (P-0.0025 and 0.025 respectively). 
This difference in total proteins could not be explained by the 
differences in IgN or Igh concentrations alone. In adult saliva, the 
enzyme amylase constitutes a high proportion of the protein content. 
In order to determine whether this enzyme was responsible for the 
differences in protein content of the two feeding groups, two infant 
saliva samples (6 month) were selected from each feeding group with 
high (bottle) or low (breast) total protein content. These samples 
were assayed for amylase activity in the Haematology Department of NPS 
using the Phadebas kit (Pharmacia). The results (Table 7- 3) 
indicate 3-4 fold higher amylase activity in the saliva samples from 
the bottle-fed infants. 
3) Inmunoglobulin concentrations expressed per milligram of protein. 
The results of salivary immunoglobulins expressed as µg/mg of 
protein showed a similar pattern generally to the concentrations per 
ml of undiluted saliva, except that the 3 to 9 month samples fr-- 
bottle-fed infants had a relatively lower concentration due to the 
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Figure 7-3 
Total protein estimations in saliva 
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TABLE 7-3 
PROTEIN CONCENTRATIONS IN SALIVA FRAM BREAST- AND BOTTLE-FED INFANTS 
SAMPLE I FEEDING 
M1E®. ER 
17 D 
27 D 
15 D 
GROCTP 
BREAST 
N 
BOTTLE 
TOTAL 
PROTEIN 
(mg/ml) 
1.04 
1.17 
1.84 
28 DIa12.22 
I14M41NOGLOBULIN 
(pg/ml) 
GMA 
0.99 0.36 12.0 
0.36 0.66 19.8 
0.24 1.25 14.0 
0.21 0.67 9.1 
AMYLii13E 
(IU/Ml) 
82,000 
77,000 
284,000 
281,000 
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higher total protein content. Geometric means of these results are 
shown in Fig 7-4 and the ranges are shown in Table 7-4. 
i) IgG 
IgG concentrations in 6 day samples were higher than 6 week samples. 
The pattern of IgG per mg of protein was otherwise similar to the 
levels per ml of saliva, and again there were no significant 
differences between the two feeding groups. 
ii) rcpt 
At 6 days, rgM was undetectable in 8/13 bottle-fed and 3/12 breast-fed 
infants tested (i. e. CO. Olµg/mg protein). The average concentrations 
for the two groups at 6 days were 0.10µg/mg (breast) and 0.03µg/mg 
(bottle). This difference was significant (P-0.014). By 6 weeks, 
there was an enormous rise in the levels of rgM in the saliva of the 
bottle-fed infants, resulting in 3 to 4 times the concentration of rgM 
in the saliva of the bottle-fed group than the breast-fed group. This 
higher level per mg protein remained until 9 months, and was 
significantly greater than that of the breast-fed group for the 3 
month sample (P-0.015). 
iii. ) Igk 
At 6 days, Iglt was undetectable in the saliva of 5 bottle-fed infants 
(<0.1µg/mg), but was detectable in all breast-fed infants, with levels 
up to 50µq/mg. This difference between the groups was significant 
(P<0.0001). By 6 weeks however, Igh was detectable at high levels in 
all infants, with a higher concentration in bottle-fed than in 
breast-fed infants. There were no significant differences between the 
groups from 6 weeks to 9 months. 
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TABLE 7-4 
IP4IUNOGLOBULIN OONMNTRATIONS IN INFANT SALIVA IN RELATIOl1 
TO TOTAL PROTEIN CONTENT 
FEEDING 
GROUP 
AGE- 6 DY 6 WK 3M 6K 9K 
IgG 
BREAST n- 12 14 15 15 15 
MEAN 1.62* 0.65 0.31 0.35 0.52 
RANGE - 0.91-2.52 0.11-1.80 0.14-0.67 0.10-1.67 0.16-1.41 
BOTTLE n- 
1 13 14 14 15 15 
MEAN 1.60 0.63 0.37 0.27 0.48 
RANGE 0.2-4.6 0.11-1.72 0.05-1.4 0.10-0.66 0.18-2.0 
p 0.98 0.93 0.46 0.52 0.74 
IgM 
BREAST MEAN 0.13 0.54 0.41 0.87 0.78 
RANGE 0.02-2.45 0.04-5.4 0.03-3.3 0.21-4.1 0.18-3.86 
BOTTLE MEAN 0.02 1.64 1.91 1.41 1.23 
RANGE 40.01-1.3 0.12-18 0.08-16 0.21-10.4 0.17-10 
p- 0.014 0.14 0.015 0.25 0.22 
IgA 
BREAST MEAN 2.34 36.3 22.9 22.4 17.4 
RANGE 0.12-63.5 6.3-195 5.6-154 3.6-60 4.2-88 
BOTTLE MEAN 0.05 53.7 39.8 17.0 15.2 
RANGE <O. 01-0.42 11.5-220 17-91 4.0-76 2.6-69 
p- 
1 
1 0.000 0.28 
0.07 0.42 0.68 
* Immunglobulin concentrations in µg/mg total protein 
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4) Relationship between immunoglobulin concentrations in the saliva of 
breast-fed infants and the time since the last milk feed. 
Although northers were asked not to feed their infants within 2 
hours of sample collection, this did not always prove practical and 
samples were collected from between 1 to 6 hours after feeding. To 
estimate whether those breast-fed infants who had the highest IgA or 
IgM levels were those who had most recently been breast-fed, Ig levels 
were correlated with the time since the last intake of breast milk. 
No significant correlation was found for IgM (r-0.039) or IgA 
(r-0.004). 
However, for one 6 day old infant, saliva was collected shortly 
after a feed and again 2 hours later. IgG rose during this time from 
0.8 to 1.9µg/mg. IgM fell from 1.2 to 0.3µg/mg and IgA fell from 61 
to 2OJag. 
5) Relationship between salivary and serum immunoglobulin levels. 
i) IgG 
When data from all five sample occasions were pooled, there was a 
significant correlation between IgG in serum and saliva for both 
feeding groups (r-0.573 breast: r-0.405 bottle, DF-85, P<0.001). 
However when each of the five occasions was analysed separately, this 
correlation did not reach a significant level for either feeding 
9rouP" 
ii) 1gK 
When results fray 6 day to 9 month samples were pooled, there was a 
significant correlation between serum and salivary IgK in both feeding 
groups (r-0.539 breast; r-0.64 bottle; Pc0.001). When analysed on 
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each occasion, there was significant correlation at 6 weeks in the 
breast-fed group, and at 6 weeks and 6 months in the bottle-fed group. 
iii) IgA 
When results from all 5 occasions were pooled, for the breast-fed 
group there was a high degree of correlation between levels of serum 
and salivary IgA (r-0.579, P40.001), which was also significant when 
analysed by occasion at 6 weeks, 6 and 9 months. In the bottle-fed 
group however, there aas no correlation overall (r-0.092) or on 
sample occasion between Igg in serum and saliva. 
6) Specific antibodies in saliva. 
any 
Saliva samples were assayed for G, K and A antibodies to tetanus 
to, ooid and S. coLL. These results are summarised in Table 7-5. 
TABLE 7-5 
SPECIFIC AMPIBODIES IN THE SALIVA OF INFANTS 
IgG 
Tested + µg/ml 
anti-iT 20 1 135 
anti a. cott 20 1 90 
Igm 
Tested + µg/ml 
20 0 c5 
Igh 
Tested + µg/ml 
20 0 c5 
32 4 60-100 1 141 127 5-500 
i) Antibodies to tetanus toxoid 
Twenty samples of undiluted saliva from 2 breast-fed and 6 bottle-fed 
infants, between 6 weeks and 9 months of age, were assayed for IgG, 
IgN and Igh antibodies to tetanus toxoid. The 
limit of sensitivity of 
the teat for each immunoglobulin was 5-10ng/ml in undiluted saliva. 
One infant had 135ng/ml IgG anti-'PT (sample 25E). No other 
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TT-specific antibodies of any of the three classes were detected. The 
corresponding serum IgG anti-Pr for the one positive saliva sample was 
315µg/al, which was the highest serum antibody titre recorded. 
ii) Antibodies to a. co&t 
IgG antibodies to a. coLt were estimated in 20 samples of undiluted 
saliva from 2 breast-fed and 6 bottle-fed infants, at 6 weeks to 9 
months of age. One infant had 90ng/ml IgG anti-a. cotß, but antibodies 
were undetectable in the remainder (c10ng/ml). 
IgM a. coLt antibodies were estimated in 32 samples from 4 
breast-fed and 7 bottle-fed infanta. IgM anti-L coo antibodies at 
60-b0Ong/m1 were detected in 1 sample from a breast-fed infant 
(post-weaning) and 3 samples from bottle-fed infants. In all 4 
infants, IgM anti-a. coLt was undetectable in subsequent samples. 
Igh anti-S. colt antibodies were detectable at 6 days in 7/11 
breast-fed and 2/13 bottle-fed infants (>lOng/mg protein). The higher 
level of antibodies in the breast-fed infants was significant 
(P-0.0089). By 6 weeks, Igh anti-a. colt antibodies were detectable at 
low levels in all infants (5-300ng/mg protein). These antibody levels 
rose very slightly with age (Pig 7- 5). There were no significant 
differences between the feeding groups from 6 weeks to 9 months of 
age. 
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Figure 7-5 
IgA antibodies to Escherichia coli in saliva 
of breast- and bottle-fed infants 
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SECTION D- DISCUSSION 
1) Development of IgG in saliva of infants. 
There have been several studies on the development of IgA in 
saliva and other secretions but very little work has been carried out 
on the development of salivary IgK and IgG in infants. Work in adults 
has indicated that the concentrations of these two ininunoglobulins in 
saliva are much lower than their concentrations in serum (Brandtzaeg, 
Fjellander and Gjeruldsen, 1970). The present study has shown that 
this also applies to newborn infants. igG levels were only 0.02% of 
the serum levels. Seiner, Merrill and Claman (1968) used 
electroimmunodiffusion to study salivary IgG in newborn infants but 
they could only detect it in infants between 1-10 days of age, and 
could not detect it in older infants. They suggested that this low 
level of IgG was due to leakage of maternally derived IgG from the 
serum. The limit of detection for their assay was 2kg/ml. Using the 
more sensitive RIA technique, the present study has indicated that IgG 
could be found in the saliva of all infants tested on all occasions 
between 6 days and 9 months, although it was frequently at 
concentrations below 2pg/ml, particularly in the samples collected at 
6 and 9 months. The pattern of a decline in IgG during the first 3 
months followed by a rise, as immunoglobulin synthesis by the infant 
increased, was the same as for serum IgG. The finding that serum and 
salivary IgG concentrations were not correlated at any individual 
sample occasion (although there was an overall correlation), suggested 
that although these antibodies may have been the result of leakage 
from the serum, either the permeability varied considerably between 
infants, or there was local IgG synthesis which was independent of the 
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systemic immune system. The demonstration of IgG anti-TT only in the 
infant who had the highest level of serum IgG anti-TT would suggest 
some leakage from serum does occur. This is in agreement with studies 
in adults who have high levels of diphtheria antitoxin (Remington .t 
at, 1964). Eiowever, since the IgG anti--TT in the positive saliva 
represented only 0.04% of the antibody level in serum, a similar 
diffusion rate in the other infants would have been below the 
sensitivity of the RIA test. Clearly, IgG diffusion from serum to 
saliva occurs at a very low level. 
2) Development of IgM in infant saliva. 
Seiner, Merrill and Claman (1968) investigated salivary IgM in 52 
samples from 20 infants between birth and 6 weeks and were unable to 
detect IgM in any of the samples (the minimal sensitivity of their 
test was egg/ml). In the present study, the minimal sensitivity was 
0.02gq/ml, and IgM was detected as early as 6 days in half the 
bottle-fed infants (thus showing it was solely of infant origin). By 
6 weeks, all infants had detectable IgM, although in only 2 infants 
was the concentration above egg/ml. The levels found in bottle-fed 
infants over 6 weeks of age were similar to those found in adults 
(Brandtzaeg, Pjellanger and Gjeruldsen, 1970). These workers found a 
ratio of IgG: IgK in adult saliva of 6.8611, which compares with a 
ratio of 0.36: 1 in the infants in this study at 9 months. IgK 
therefore represents a higher proportion of the total immunoglobulins 
in infant saliva, which supports the view that IgM is relatively more 
important in the secretions of infants than adults (Ranson and 
Brandtzaeg, 1980). 
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3) Development of IgP in infant saliva. 
Many more studies have investigated Iglu levels in secretions, 
particularly in saliva, the easiest secretion to collect. Haworth and 
Dilling (1966) and Seiner, Merrill and Claman (1968), were unable to 
detect Igo in saliva before 8-14 days but after that time both groups 
were able to demonstrate a rapid rise in Igh levels. Burgio et at, 
(1980) have confirmed these findings, although their work indicated 
adult levels were achieved more slowly, not until 6-8 years rather 
than the few months suggested by the earlier studies. The findings 
reported in the present study also suggest that very low levels of Igel 
are secreted in the newborn infant, but that there is an enormous 
increase in production over the first 6 weeks to reach up to 100µg/ml 
igA. This is similar to the corresponding concentration in serum 
(96%) and is approximately 50% of adult salivary levels (Brandtzaeg, 
Fjellanger and Gjeruldsen, 1970). From 6 weeks to 9 months of age the 
salivary Iglu levels declined slightly. Gleeson et al.., (1982) have 
also noted a decline in salivary Iglu from 2-6 months. These workers 
attributed this to a negative feedback, regulated by mucosal T cells, 
following the initial heavy antigenic challenge by the microbial 
flora. it might also be due in part to a dilution effect, as the 
volume of saliva increases during this time and therefore the total 
daily output will continue to increase. Gleeson and colleagues 
claimed however, that there were no differences in salivary Igo 
between breast- and bottle-fed infants, although no data was presented 
to support this statement. 
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in this present study, the strong correlation of salivary and 
serum IgA in breast- but not bottle-fed infants could be due to 
absorption of breast-milk IgA. However, previous studies do not 
support this hypothesis (see Chapter 6). It could also be due to 
ingestion of soluble milk factors, which may regulate local IgA 
synthesis. The existence of such factors has already been described 
(Pittard and Bill, 1977a and b). The lack of correlation between 
salivary and serum IgA in the bottle-fed group may simply reflect the 
independent routes of local and systemic stimulation by antigens. A 
similar lack of correlation between secretory and serum antibodies has 
been described by previous workers (Haworth and Dilling, 1966). 
Although no mention was made of breast or bottle-feeding in this 
study, it was conducted in Saskatchewan at a time when breast-feeding 
rates had reached a nadir in this area. 
4) specific antibodies in saliva. 
The specific antibody responses to the two antigens tested were 
very low in both groups of infants, with only Igh antibodies to B. coLt 
being at a detectable level in most infants. These developed 
similarly in both groups but represented only a very small percentage 
of the total Igh present (0.1%). Evans and Nergenhagen 
(1965) 
demonstrated antibodies to Shigella and Salmonella in human parotid 
fluid but were unable to detect antibodies to E. coLt. Gleeson et aL., 
(1982) also failed to detect a. coLt antibodies in saliva up to 1 year 
of age, but these workers used indirect 
haemagglutination (an 
insensitive technique known to detect predominantly IgK - see Chapter 
6) with a pool of enteropathogenic rather than commensal serotypes. 
Secretory antibodies to mouth organisms such as Streptococcus mutans 
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have been demonstrated in adult saliva, (Arnold, Mestecky and McGhee, 
1976) but because of the high levels of these antibodies in colostrum 
at the same time, the authors suggested that the gut rather than the 
mouth was the most important site of priming. Bienenstock has 
suggested a common mucosal associated immune system in which precursor 
cells are primed in the gut, migrate via the mesenteric lymph nodes to 
the general circulation and preferentially relocate at all secretory 
sites (Bienenstock and Befus, 1980). However, the low level of 
antibodies to a. coLL found in the saliva of infants in the present 
study suggests that the number of cells secreting antibodies to the 
normal gut flora which relocate higher up in the alimentary tract 
(i. e. the mouth) is very low compared with the number of cells at 
that site which secrete antibodies to other antigens (presumably mouth 
organisms such as Streptococci, Neisseria and Bacteroides, and food 
antigens). There is good evidence that infants can produce local 
antibodies to S. coLL in the gut at this time. Lodinova, Jouja and 
Wagner (1973) have demonstrated the appearance of local K. coLt 
coproantibodies in the stools of infants within 2 days following 
artificial intestinal colonisation with strain 083, but these workers 
did not look for antibodies at any other secretory sites such as 
saliva. 
5) Differences in salivary iamunoglobulins in breast- and bottle-fed 
infanta. 
As with the serum IgG levels, salivary IgG was unaffected by the 
type of milk the infant was receiving, suggesting that the capacity of 
the two feeding groups to synthesise IgG develops similarly. 
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IgK and IgA levels were, however, significantly higher in the 
saliva of breast-fed infants at 6 days, and although it is possible 
that this is due to enhanced synthesis, contamination frasi milk 
immunoglobulins is a more likely explanation. The use of monoclonal 
antibodies to allotypic markers would be one way to answer this 
question. The level of these two inmiunoglobulins in the bottle-fed 
group at 6 days was often below the level of detection. 
The synthesis of both IgK and IgA increased rapidly in all 
infants during the first 6 weeks of life. The significantly higher 
levels of IgK and IgA per millilitre of saliva in the bottle-fed group 
from 3 to 9 months was associated with a general increase in total 
protein in this group. However, when this was taken into account, the 
IgK levels were still significantly higher at 3 months, suggesting a 
greater antigenic stimulation in the bottle- fed group than the 
breast-fed group. 
The microbial flora in the mouth probably represents the greatest 
source of antigenic challenge to the local immunocyte population. 
Salivary antibodies to several oral micro-organisms have been 
demonstrated (Arnold, Mestecky and McGhee, 1976). The minor salivary 
glands are thought to be more important than the parotid gland in the 
regulation of the organisms in the oral environment, as they are more 
accessible to antigenic stimulation and can produce up to a third of 
the Igh in the oral cavity (Crawford, Taubman and smith, 1975). In 
the breast-fed group, the infants will be receiving large quantities 
of milk sigh antibodies to the microbial flora of the mouth 
(Goldman 
and smith, 1973). These antibodies may coat these organisms and 
prevent them from adhering to the buccal mucosa (Williams and Gibbons, 
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1972) where they could proliferate and stimulate the local immune 
eystea. 
The bottle-fed infants will also be receiving a greater 
stimulation from the highly antigenic cow milk proteins. The 
specificity of the antibodies produced has not been determined by the 
present studies. However, the fact that the antibodies are not 
against gut organisms such as ä. colt, in spite of increased serum 
antibodies against B. coLf, in the bottle-fed group (Chapter 6), 
suggests that immunocytes stimulated in the gut are not relocating to 
any significant degree in the oral cavity. This is in contrast to the 
suggestion of Bienenstock (Bienenstock and Befus, 1980) that 
immunocytes at secretory surfaces are part of a common muoosal 
associated lymphoid system, with lymphocytes primed in the gut 
relocating at other secretory sites. 
6) Total protein levels in saliva. 
Finally, the differences in the total protein levels in breast- 
and bottle- fed infants at 6 and 9 months is interesting. The 
preliminary investigations suggest that this may, in part, be due to 
increased amylase activity in the bottle-fed group. It is possible 
that the different carbohydrate content of cow milk, compared with 
human milk, 'is stimulating enzyme secretion and this finding warrants 
further investigation. 
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SU[+M41RY 
The total IgG, Igl( and IgA levels and specific antibodies to 
tetanus toxoid and S. colt have been examined in the saliva of infants. 
. 
IgG levels were low, only 0.02% of serum levels. Incomplete 
correlation between levels of salivary and serum IgG suggests some 
local production, although detection of IgG anti- TT only in the 
infant with the highest serum concentration of this antibody, 
indicated some salivary IgG may be of systemic origin. There were no 
significant differences in salivary IgG between the two feeding 
groups. 
In contrast, concentrations of IgX and Igh were significantly 
higher in the breast-fed infants at 6 days= this is most probably due 
directly to colostral and milk antibodies. IgM and IgA antibodies 
were frequently below the level of detection at 6 days in the 
bottle-fed infants. IgM and IgA levels increased rapidly in all 
infants during the first 6 weeks of life, presumably as a result of 
colonisation with micro-organisms and exposure to food antigens. The 
IgM in infant saliva represented a higher proportion of the total 
immunoglobulins than in adult saliva. By 3 months, IgM and Igo levels 
were significantly higher in the saliva of bottle-fed infants than 
breast-fed infants. It is suggested that this is due to higher local 
antigenic stimulation in the bottle-fed group, partly from cow milk 
proteins and partly from oral micro-organisms. In the breast-fed 
infants, the protective effect of milk antibodies against organisms in 
the oral cavity may be reducing their attachment and replication on 
the buccal mucosa. The correlation of salivary and serum IgA in the 
breast-fed but not the bottle-fed group supports the hypothesis that a 
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soluble factor in breast milk could be enhancing Igo secretion both 
locally and systemically. 
Specific IgM and IgA antibodies to tetanus toxoid were 
undetectable in all infants tested. IgG and IgM antibodies to S. coLt 
were low or undetectable. IgA antibodies to E. coLt were detected in 
all infants by 6 weeks but at very low levels and there were no 
significant differences between the feeding groups. Lymphocytes 
stimulated in the gut which relocate in the oral cavity therefore 
appear to represent only a very small proportion of the local ig 
secreting cells at this site in infants. 
The total protein concentration in the saliva of the bottle-fed 
infants was higher than that in the saliva from breast-fed infants. 
This could not be attributed solely to the higher imnunoglobulin 
levels, and preliminary investigations indicated that it may be due to 
increased amylase activity in the bottle-fed group. 
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CHAPTER 8 
GENERAL DISCUSSION 
There are many factors in human milk which have antimicrobial 
activity to vitro and are thought to have an important role in passive 
protection within the gut of the breast-fed infant. The aim of this 
study was to determine whether, in addition to the local passive 
protective effect of these antimicrobial factors, there was any active 
role of the lymphokines and growth factors demonstrated in human milk, 
in stimulating the development of immune responses in infants. 
Although the results obtained have highlighted a number of areas where 
the development of immunity differs between breast- and bottle-fed 
infants, these differences are not always attributable to an active 
enhancing effect of breast milk. it appears that both passive 
protection and active enhancement interact to affect immunological 
development. 
1) Differences between the feeding groups 
The results obtained from the studies on systemic and local 
immunity to vivo, and the examination of lymphocyte proliferation and 
function in vitro fall into three broad categories. They are those in 
which immune function appears :- a) enhanced in breast-fed infants, b) 
equal in both groups of infants, c) enhanced in bottle-fed infants. 
It is clear from the data that these categories depend primarily on 
the age of the infant. 
a) The functions which appear enhanced in breast-fed infants 
become apparent during the first few weeks of life. They are the 
spontaneous proliferation of peripheral blood mononuclear cells (PBM), 
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the proliferative responses of these cells to stimuli such as the 
mitogen PHR and the antigen tetanus toxoid, and a more rapid response 
to allogeneic lymphocytes. While it is not possible to draw any firm 
conclusions about the cell types responsible for producing this 
different pattern of proliferation between breast- and bottle- fed 
infants, a provisional assessment is feasible. Thus, spontaneous 
proliferation has been attributed to a population of non-T/non-B cells 
which are possibly T cell precursors (Treves, Barak and Fuks, 1980) 
whereas PUA and allogeneic lymphocytes stimulate primarily T cells 
(Rich and Pierce, 1973; Kuntz, Inns and Weksler, 1976). In 
contrast, tetanus toxoid may stimulate both T and B cells. Therefore, 
T cell precursors, Tcells and possibly some B cells may all be 
proliferating more in newborn breast-fed infants and this could be 
attributable to stimulation by lymphokines or other growth factors in 
human milk. It should also be noted that cells from both breast-fed 
and bottle-fed infants have in general a higher rate of spontaneous 
and mitogen induced proliferation than do adult cells. This has been 
attributed to a partial activation of infant cells to vivo (Stites at 
a&., 1972; Weber, Santesson and Skoog, 1973). It was unfortunate 
that limited cell numbers did not permit correlation of this increased 
proliferation in breast-fed infants with immunoglobulin production to 
vttro and this is an area which warrants further investigation. 
Breast-fed infants also had higher levels of IgA and IgM in their 
saliva at 6 days of age than bottle-fed infants. clearly, the 
protective efffect of breast-feeding lasts beyond the disappearence of 
milk from the oral cavity, although whether this is due to the 
attachment of milk immunoglobulins to receptors on the buccal mucosa 
(Roberts, Wincup and Barnes, i1980) or to induction of local IgA and 
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Igll synthesis by growth factors in milk is not known. 
b) The immunological functions that were found. to develop 
similarly in the two feeding groups were the total immunoglobulin 
levels in serum, the antibody responses to TT vaccination and the 
total IgG levels in saliva. This indicates that the general capacity 
to mount antibody responses to antigens developed at a comparable rate 
in both groups. This conclusion is also supported by the findings of 
Zoppi at. aL., (1983) who showed similar antibody responses to 
diphtheria and pertussis vaccination in breast-fed and well nourished 
bottle-fed infants. In addition, most studies of serum 
immunoglobulins and antibodies, designed to determine whether breast 
milk immunoglobulins are absorbed by the neonatal gut, have shown 
similar immunoglobulin levels in both groups. There is still the 
possibility that some dimeric IgA may be absorbed from milk, yet not 
detected in the serum because it is being rapidly transported from the 
blood back into bile via secretory component receptors on the 
hepatocytes. This is a transport mechanism that has been demonstrated 
in rats (Orlans et aL., 1978). However, studies in humans have 
indicated that this is not such an. important mechanism as in rodents 
(Delacroix st aL., 1982). 
c) it was the third group of results, in which bottle-fed infants 
had enhanced immune responses over those of the breast-fed infants, 
that were initially the most surprising: they were also statistically 
the most significant! The functions which were enhanced in bottle-fed 
infants were systemic IgM responses to coamensal E. coLt from 6 days 
onwards, local IgM and Igh production in saliva from 6 weeks of age, 
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and from 3 to 9 months of age the spontaneous proliferation of PBM 
cells and proliferative reponses to all stimuli tested. This was in 
contrast to the increased proliferative responses which occur from 6 
days to 3 months in the breast-fed infants - see a) above. All these 
enhanced immune responses in bottle-fed infants can be explained by 
the single phenomenon of increased exposure to gut antigens (Chapter 
6). There are three possible reasons for this increased exposure in 
bottle-fed infants. First, there is a higher antigen intake, in the 
form of cow milk proteins. Second, the protective effects of human 
milk antibodies and other antimicrobial proteins are lacking. Third, 
the absence of epithelial growth factors present in human milk may 
delay the maturation of gut impermeability. 
i) The role of cow milk antigens. 
Human milk is not devoid of material which is potentially 
antigenic to the infant, in fact food antigens such as egg protein, 
cow milk proteins and theobromine from chocolate are known to be 
transfered to the infant by this route (Resman, Blumenthal and Jusko, 
19771 Jakobsson and Lindberg, 1978). However antibodies against food 
antigens are also transferred in the milk and these antibodies have 
been shown to inhibit uptake of undegraded food molecules by the gut 
of the infant (Cruz, 1983). Cow milk proteins such as casein however, 
which are present in such large quantities in cow milk formulae, are 
known to be highly antigenic (see Chapter 6) and to stimulate not only 
local immune tissues but also a high level of systemic IgG antibodies 
in bottle-fed infants (Kletter et at., 1971). Soy-protein based 
formulae are equally antigenic (Easthan st a?., 1978). Tolo, 
Brandzaeg and Jensen (1977) have shown that IgG antibodies limit the 
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systemic uptake of homologous antigen but will actually enhance uptake 
of unrelated antigens. This increased permeability is probably due to 
release of lysosomal enzymes by phagocytic cells which take up the IgG 
immune complexes. Systemic IgG antibodies to cow milk proteins might 
therefore be enhancing the uptake of other gut antigens such as those 
from commensal organisms of the normal gut flora. 
ii) The role of passive protective factors in human milk in 
modulating antigenic exposure. 
An important requirement for the pathogenesis of many 
micro-organisms is that they should be able to adhere to mucosal 
surfaces. Human milk has been shown to have anti-adhesive properties 
of a specific and non-specific nature, as well as bacteriostatic and 
agglutinating properties (see Chapter 1). By reducing attachment and 
the subsequent replication and invasion of organisms, these passive 
protective effects will simultaneously protect the local immune system 
from antigenic challenge; such challenge is itself a potent 
stimulator of proliferation and differentiation in lymphoid tissues. 
In fact in mice, both food antigens and normal gut flora have been 
shown to be important in stimulating the appearence of Iglu containing 
cells in gut tissues (Sagie st at., 1974). It is these contrasting 
effects which sake it so difficult to separate the passive and active 
roles of milk in the development of immune responses in infants, as 
they act in opposite directions. 
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iii) Active protection of infants by growth factors in milk. 
In addition to the possible effects of lymphokines in human milk 
modulating the development of local and systemic lymphoid tissue in 
breast-fed infants, (which has been discussed above) there remains the 
possibility that growth factors for epithelial cells could be having 
an indirect effect on development of immune responses by decreasing 
antigenic exposure. In newborn infants the gut mucosa is more 
permeable to all macromolecules than in adults (Chandra, 1979). This 
gives rise to uptake of microbial and food antigens. In breast-fed 
infants epithelial growth factors may be stimulating the maturation of 
gut epithelium and thereby enhancing the gut closure to 
macromolecules. 
2) The role of normal gut flora in development of immune responses. 
Since the evidence presented suggests a difference between the 
two groups in systemic exposure to components of the normal gut flora, 
it is interesting to note some possible effects of gut flora on the 
development of immune responses. The commensal gut flora starts to 
become established within hours of birth, when the infants secretory 
immune system is particularly immature (see Chapter 1). Many factors 
control the development of this flora (Borriello and Stephens, 1984) 
and human milk has a modulating effect. One of the bacterial 
components reported to be higher in the flora of bottle- fed infants 
than breast-fed infants is the gram-negative Enterobacteriacaea. 
These include commensal organisms such as E. coLt but also include 
potential pathogens such as Shigella, Salmonella, Vtbrio choLsras and 
enteropathogenic and enterotoxigenic B. coLt, all known to be important 
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causes of infections in neonates. These organisms also have, in their 
cell walls, lipopolysaccharide (LPs). LPS from normal gut flora is 
known to have regulating effects on immune responses, not only in 
animal models (Lagrange at at,., 1975a and b; Cebra at a&., 1980) 
Kiyono, McGhee and Michalek, 1980 Citron and Michael, 1981) Jacobs 
at at., 1983, Tlaskalova-Hogenova at a&., 1993) but also in humans 
(van der Waaij and Heidt, 1977 Hand and Smith, 1981). In fact the 
latter workers noted the similarities between biologically active 
molecules produced by S. coLt (cytokines) and lymphokines. The results 
from the serum studies described in this thesis indicate that systemic 
specific antibody responses to S. coLt LPS are greatly increased in the 
bottle-fed infants, suggesting that this antigen has indeed penetrated 
the gut mucosa. Perhaps more importantly, LPS can also act as a 
non-specific mitogen/adjuvant. This role has been put to positive use 
in adults by administration of LP3 to enhance systemic reponses to 
antigens such as tetanus toxoid (Rethy, 1983). Live S. coLt and 
Streptococcus faecatta have also been administered as an oral vaccine 
to relieve a variety of non-specific ailments such as chronic and 
recurrent respiratory tract infections and skin disorders (Rasch, Hyde 
and Luckey, 1983). Experiments in mice indicate that these vaccines 
stimulate an increase in non-specific immunity but their mechanism of 
action is not fully understood. 
Clearly there are many reasons why the effects of increased 
antigenic challenge from cow milk proteins and increased exposure to 
gut micro- organisms could have a profound effect on the development 
of immune responses in bottle-fed infants. The observations of 
increased immunity to locally encountered antigens and increased 
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proliferative responses of lymphocytes from 3 to 9 months of age in 
bottle-fed infants might lead one to think that bottle-feeding is 
actually better than breast-feeding at stimulating the development of 
immunity. Certainly the relative infection rates in the two groups of 
infants in this study showed no greater susceptibility of bottle- fed 
infants to infections, although it must be emphasised that infection 
rates were generally low in both groups. Also, it is clear that 
breast milk does not totally protect infants from the infections to 
which they are exposed. The correlation of lower sibling numbers with 
lower infection rates confirms the belief that it is more important to 
limit the exposure of newborn infants to infectious agents. The 
enormous improvement in infant morbidity and mortality in developed 
countries over the last 50 years has been largely due to the general 
reduction in exposure rates and this lower exposure rate is an 
important fact when considering the additional benefits of 
breast-feeding. However, given that it is impossible to reduce the 
risk of contact with infectious agents to zero, the question arises of 
what is the best way to reduce the risk of contracting infections? 
Breast-feeding, although not providing total protection, is still 
the best option and mothers must be encouraged to pursue this method 
of feeding wherever possible. The period during which the stimulatory 
effects of breast milk on lymphocyte proliferation and differentiation 
are most apparent, is the first few weeks of life when the infant is 
most vulnerable due to the naivity of the immune system. For 
this 
early period, breast feeding should clearly 
be an advantage, 
particularly in areas of high disease incidence. The role of 
breast 
milk in providing antigen exclusion and modulation of lymphocyte 
function is certainly more than an to vitro artefact. Antigen 
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exclusion may be particularly important in infants who have a high 
risk of developing atopic disease. In contrast, the modulation of 
immune responses in bottle-fed infants by increased antigenic exposure 
may have a similar stimulating effect, but these effects may come too 
late. It also seems rather like playing Russian roulette, all may go 
well providing the stimulating antigen is not enteropathogenic E. coLt 
or some other potentially lethal organism. It is possible that the 
differences between the breast- and bottle- fed groups would be more 
marked if this study had been done in an underdeveloped country with 
its more hazardous antigenic environment. 
Modification of the commercially available milk formulae is 
obviously possibile. Complementary DNA lymphokines and epidermal 
growth factors are now becoming available and there is a possibility 
that these products could be added to cow milk preparations, although 
work still needs to be done to identify which of the lymphokines in 
milk are important to the newborn infant. However, this is only one 
aspect of the regulation of development of immunity. It is difficult 
to imagine how the balance created by the combined effects of antigen 
exclusion, protective and cell growth factors, and modulation of 
normal gut flora, could be recreated with an artificial cow milk (or 
soy protein) based formula. In order to achieve exclusion of large 
quantities of foreign protein one would have to start with a human 
milk base. Preservation of this product by any technique would result 
in loss of many of the antimicrobial proteins (Editorial, 1979). 
However potentially, these could be added back together with immune 
modulators and growth factors. One might even consider adding small 
quantities of LPS to this product to stimulate further immunological 
development) This would make a product which would be prohibitively 
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expensive for general use but could be used for children at high risk 
of infections or allergic disease who for some reason cannot be fed by 
their own mothers. At present this need is being satisfied in some 
areas by the use of human milk banks and human milk is still being 
used to control outbreaks of diarrhoea where antibiotics have failed 
(McFarlane and Miller, 1984). However, the problems of milk 
collection, preservation and storage without gross microbial 
contamination or destruction of antimicrobial proteins still remain 
great. Perhaps a more practical (but less commercial) alternative 
would be the return of wet nursing! 
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APPENDIX 
COMPOSITION OF INFANT FEEDS (per lOOml) 
fiUi4AN 
PROTEIN g 
FAT 9 
CARBOHYDRATE g 
Na mg 
K« 
C1 0 
Ca 
Mg of 
p« 
Fe N 
cu N9 
Zn mg 
Na meq/1 
K 
C1 
N 
N 
Vit A pg 
Vit C mg 
Vit D }ig 
1.2 
3.8 
7.0 
15 
55 
43 
33 
4 
15 
0.15 
40 
0.4 
6.5 
14.1 
12.1 
5B 
4.3 
o. ol 
SMA 
1.5 
3.6 
7.2 
15 
55 
41 
42 
4 
33 
0. @ 
40 
0.3 
6.5 
14.1 
11.5 
80 
5.3 
1.1 
OSTERIrIIL1C 
1.8 
3.0 
9.3 
45 
83 
68 
60 
6.2 
50 
1.0 
19.6 
21.2 
19.0 
105 
7.0 
1.0 
GOON AND GATE 
2.4 
1.9 
7.0 
41 
104 
84 
12.6 
65 
0.2 
0.5 
17.9 
26.6 
100 
3.5 
1.1 
8.9 
Values from DHSS report, 1974 
